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2. Summary 
During mouse embryonic development, the spatio-temporal expression of 
genes is controlled by both interlinked signalling pathways and interactions 
between transcription factors and their target cis-regulatory modules. To gain 
global insights into the roles of a trans-acting transcriptional regulator in a 
specific tissue, the genome-wide profiling of its target regulatory regions and 
their association with the putative target genes are essential. Therefore, I have 
combined several types of genome-wide analyses such as ChIP-seq using 
epitope-tagged transcription factors with ATAC-seq and RNA-seq to study the 
functions of HAND2 and SMAD4 during heart and limb bud development, 
respectively. 
In Hand2-deficient embryos, we observed that cells of the atrioventricular canal 
do not undergo the endothelial-mesenchymal transition that underlies cardiac 
cushion development. By combining HAND23xF ChIP-seq and RNA-seq 
analysis, we have identified the HAND2 gene regulatory network involved in 
these processes and show that HAND2 is a key regulator of heart valve 
development. 
Limb bud outgrowth and patterning are regulated by a self-regulatory feedback 
signalling system operating between the SHH and FGF signalling pathways that 
critically depends on the BMP antagonist GREMLIN1. However, the 
establishment of these signalling feedback loops requires initiation of Gremlin1 
expression by high BMP activity. For my PhD research, I have investigated the 
roles of the BMP signalling pathway during limb bud initiation by studying the 
functions of the BMP signal transducer SMAD4. By combining genome-wide 
SMAD43xF ChIP-seq, ATAC-seq and RNA-seq analyses, I am able to show that 
SMAD4 participates in activation of Gremlin1 expression by interacting with 
Grem1 coding exon 2 (a putative regulatory region). Furthermore, the 
identification of the SMAD4 gene regulatory network reveals multiple functions 
of SMAD4 during the onset of limb bud development. Especially, SMAD4 
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directly regulates target genes involved in limb bud outgrowth and patterning. 
Rather unexpected, my analysis reveals that SMAD4 directly regulates 
cholesterol homeostasis and controls the gradient and activity of the SHH 
signalling pathway during early limb bud development. 
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3. List of Abbreviations 
7DHC 7-dehydro-cholesterol GRS1 Gremlin regulatory sequence 1 
AER Apical Ectodermal Ridge HAND2 Heart, Autonomic nervous system 
and Neural crest Derivatives 2 
AP Antero-posterior hCG Human chorionic gonadotropin 
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BMPR BMP receptor hrs Hours 
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TSS Transcriptional Start Site WISH Whole-mount in situ Hybridization 
UTR Untranslated Region Wnt Wingless-type MMTV integration site 
UCSC University of California Santa Cruz WT Wild-Type 
WB Western Blot ZPA zone of polarizing activity 
  ZRS ZPA regulatory sequence 
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4. Introduction 
4.1. Cis-regulatory modules and regulation of 
gene expression 
A major open question is how pools of undifferentiated progenitors acquire 
positional information and how their differentiation generates the different cell-
types that give rise to functional tissues and organs during embryonic 
development. Cell fates are controlled by cells responding to different 
extracellular stimuli such as graded signals and morphogens. These cell-cell 
signalling interactions trigger the intracellular signalling cascades that control 
the robustness of spatio-temporal gene expression, which is controlled by 
specific interactions of transcription factor (TF) complexes with gene regulatory 
regions called cis-regulatory modules (CRMs). 
The activity of CRMs is tissue-specific and results in enhancing or repressing 
the transcription of target genes (Bulger and Groudine, 2011; Levine, 2010; 
Ong and Corces, 2011). Gene expression is controlled either by one specific or 
several CRMs which can have additive, synergistic or redundant functions and  
provide a robust regulation of gene expression (Barolo, 2012; Frankel et al., 
2010). CRMs are located either in vicinity to the promoter, intragenic or 
intergenic regions at distances varying from several kilobases (kb) to 2-3 
megabases (Mb, Krivega and Dean, 2012; Zeller and Zuniga, 2007). They 
define the cis-regulatory landscape of the target gene, whose sizes vary 
according to the number of CRMs and their distance to the promoter. During 
limb bud development, many of them have been identified and a recent 
genome-wide study has characterized and classified more than 400 limb-
associated cis-regulatory landscapes (Andrey et al., 2017). One of the best 
studied cases of long range regulation is the ZPA regulatory sequence (ZRS), 
which is a CRM located around 800kb upstream of its transcriptional target 
gene encoding the Sonic Hedgehog (SHH) ligand (Lettice et al., 2003). The 
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ZRS is highly conserved and is located in the intron 5 of the Lmbr1 gene (Zeller 
and Zuniga, 2007). In general, the activity of CRMs correlates with open or 
accessible chromatin, which due to their sensitivity to transposases, can be 
identified by ATAC-seq (Buenrostro et al., 2013, 2015). The interactions of 
CRMs with TF-complexes can be studied by chromatin immunoprecipitaton 
followed by deep-sequencing (ChIP-seq, Figure 1A, Visel et al., 2009).  
 
 
Figure 1: Cis-regulatory modules and 3D genome architecture 
(A) Schematic representation of a cis-regulatory module (CRM) enriched by ChIP-seq 
detecting specific transcription factor complexes (dark green) and decorated by H3K27ac 
marks (light green). ATAC-seq shows that the CRM is overlapping a region of open 
chromatin (grey). Conserved sequences are indicated in dark blue. Bioinformatics analysis 
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associates this CRM with the closest gene, whose expression is altered in the 
transcriptome of a mouse mutant lacking the transcription factor of interest. The distance 
between the CRM and its target gene can be up to 3Mb. (B) Representation of the 3D 
genomic architecture at the locus of interest and the likely chromatin loops that form 
depending on the orientation of the CTCF/Cohesin binding sites. Two converging CTCF 
binding sites will initiate a chromatin looping within a particular topologically associated 
domain (TAD). Diverging CTCF binding sites will form TAD boundaries. 
 
In addition, post-translational modifications of histones in nucleosomes such as 
acetylation of lysine 27 and/or monomethylation of lysine 4 of the histone 3 are 
used as a readout of the activating trans-regulatory activity (H3K27ac and 
H3K4me1, Figure 1A, Shlyueva et al., 2014). The evolutionary sequence 
conservation among different species is an excellent criteria for identifying 
functionally and evolutionary relevant CRMs (Lopez-Rios et al., 2014), even 
though mere sequence conservation does not mean that CRM functions are 
conserved (Nelson and Wardle, 2013). 
Interactions among CRMs with promoter regions are detected using Circular 
Chromosome Conformation Capture (4C) and long-range interactions at a 
genomic scale are identified by Hi-C (Matharu and Ahituv, 2015; Mora et al., 
2016; Whalen et al., 2016). Interactions between distant acting-CRMs and the 
basal transcriptional machinery located at the promoter of the target gene are 
facilitated by chromatin three-dimensional conformation changes and looping 
within the genomic landscape encompassing the target transcription units 
(Dixon et al., 2012; Mora et al., 2016; Stevens et al., 2017). The chromatin 
looping mediates the contacts between the relevant CRMs and the transcription 
start site (TSS) of the target gene (Matharu and Ahituv, 2015). The interactions 
of Cohesin and CCCTC-binding factor (CTCF) complexes with their genomic 
target regions are essential for the formation of chromatin loops: it has been 
shown that the orientation of the CTCF binding site provides the loops with 
directionality (Rao et al., 2014). CTCF-sites in convergent orientations are 
predominantly found in chromatin loops and are associated with domains of 
chromatin interactions or topologically associated domain (TADs, Figure 1B, 
Dixon et al., 2012; Rao et al., 2014). In contrast, enrichment of divergent 
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Cohesin-CTCF complexes is associated with borders between TADs (Figure 
1B, Gómez-Marín et al., 2015). 
However, to associate the distant-acting CRMs to their real target genes can be 
challenging. It is now state of the art to use genome-wide approaches to try to 
associate CRMs to their transcriptional target genes. For instance, a CRM in an 
open chromatin region that interacts specifically with complexes containing TF-
X, can be associated to closest gene, whose expression is altered when TF-X is 
genetically inactivated (Figure 1A). In addition, the cis-regulatory effects of a 
distant CRM are in general limited to transcription units located in the same 
TAD as the CRM (Dixon et al., 2012). The cis-regulatory potential of candidate 
CRMs can be functionally assessed by their capacity to drive the expression of 
a reporter gene in transgenic mouse embryos. 
The developing limb bud is an excellent model to study how signalling 
interactions impact on gene regulation. Research from our group and others 
has shown that limb outgrowth and patterning depends on interconnected gene 
regulators networks (GRNs) that interact in a spatio-temporally highly dynamic 
fashion (reviewed by Zuniga, 2015). 
 
4.2. Signalling interactions during early limb bud 
development 
The tetrapod limb bud originates from the lateral plate mesoderm as a bulge of 
mesenchymal cells enveloped in an epithelium of ectodermal cells. Mouse limb 
buds grow out perpendicular to the body axis and are patterned along three 
distinct axes - the proximo-distal (PD), antero-posterior (AP) and dorso-ventral 
axis (DV, Zeller et al., 2009). In the nascent limb bud mesenchyme, interactions 
between the transcriptional regulators HAND2 and GLI3 and between HAND2 
and the ZRS are essential to activate Shh expression specifically in the cells of 
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the zone of polarizing activity (ZPA, Galli et al., 2010; Osterwalder et al., 2014). 
During outgrowth, limb bud development is controlled by two signalling centers: 
the SHH signalling in the ZPA and the apical-ectodermal ridge (AER), which 
produces several FGF ligands. Between these two signalling centers, the 
SHH/GREM1/FGF feedback loop is established as the expression of Gremlin1 
(GREM1), a Bone Morphogenic Protein (BMP) antagonist, is activated (Khokha 
et al., 2003; Michos et al., 2004; Zuniga and Zeller, 1999; Zuniga et al., 2004). 
During limb bud initiation (embryonic days E9.5-E10.0, Figure 2A), high levels 
of BMP activity are required to establish a functional AER and to initiate Grem1 
expression in the posterior limb bud mesenchyme (Bénazet et al., 2009; Nissim 
et al., 2006; Zeller et al., 2009). The increase in Grem1 expression 
progressively lowers BMP activity in the limb bud mesenchyme, which in turn 
regulates AER length (Bénazet et al., 2009). Between E10.25 to E11.0, the 
propagation of the SHH/GREM1/FGF signalling feedback loop (Figure 2B) 
induces the proliferative expansion of the limb bud mesenchymal progenitors 
(LMPs). After E11.0, the number of mesenchymal cells refractory to Grem1 
expression is increased in the posterior mesenchyme in concert with distal-
anterior expansion of the Grem1 expression domain (Bénazet et al., 2009; 
Nissim et al., 2006). The increase of AER-FGFs negatively regulates Grem1 
expression and contributes to the termination of the epithelial-mesenchymal 
feedback signalling system (Figure 2C, Verheyden and Sun, 2008). During this 
termination phase, the BMP activity increases, which promotes the exit of the 
digit progenitors toward chondrogenic differentiation (Bénazet et al., 2012; 
Lopez-Rios et al., 2012; Pizette and Niswander, 2001). 
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Figure 2: The feedback signalling system that controls limb bud outgrowth 
(A) Initiation phase. High BMP activity (blue) in the mesenchyme maintains the AER-Fgf 
expression (green) and activates Grem1 expression (pink). (B) Propagation phase: GREM1 
antagonises BMP activity. This enables AER-FGF signalling to up-regulate Shh expression 
in the ZPA (red), which in turn enhances Grem1 expression. These interactions define the 
SHH/GREM1/FGF feedback signalling system. (C) Termination phase: Grem1 expression 
is down-regulated as its expression is increasingly inhibited by AER-FGFs and the 
descendants of Shh expressing cells become refractory to Grem1 expression. This 
termination of feedback signalling and GREM1-mediated antagonism results in a renewed 
increase of BMP activity, which allows LMPs to initiate chondrogenic differentiation. Figure 
adapted from Zeller et al., 2009. 
 
The study of cis-regulatory landscapes and the identification of CRMs involved 
in limb bud development leads to a better understanding of how these signalling 
feedback loops are interlinked. For instance, we have more knowledge now on 
how Shh expression is regulated by transcriptional regulators such as HOX 
proteins, HAND2 and ETS transcription factors interacting with the ZRS 
(Capellini et al., 2006; Galli et al., 2010; Lettice et al., 2012; Osterwalder et al., 
2014). The Grem1 cis-regulatory landscape has also been intensively 
investigated to understand how it integrates inputs from different signalling 
pathways (Li et al., 2014; Zeller and Zuniga, 2007; Zuniga et al., 2012). In 
addition, genome-wide analysis of key TF such as HAND2 (Osterwalder et al., 
2014), HOXD13 (Sheth et al., 2016) or TWIST (Lee et al., 2014) allowed to 
decipher their specific roles during limb bud development. However, many TF 
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are expressed in different developing tissues, like HAND2 which is also involved 
in heart development. The same genome-wide approach allows us to study if 
the same or different HAND2 GRNs control heart and limb bud development. 
 
4.3. The BMP signalling pathway during limb bud 
development 
BMP ligands belong to the transforming growth factor beta (TGFβ) superfamily. 
To activate the BMP signalling pathway, BMP ligands bind two types of 
transmembrane receptors (BMPR-IA/IB and BMPR-II), which form hetero-
tetrameric complexes. This triggers the phosphorylation of the receptor-
associated SMAD protein (R-SMADs) SMAD1, SMAD5 and SMAD8. The 
phosphorylated R-SMADs form a complex with SMAD4, which then 
translocates to the nucleus and controls the expression of target genes via BMP 
responsive elements (BREs). SMAD6 and SMAD7 are inhibitory SMADs (I-
SMADs), which negatively regulate BMP signalling transduction. TGFβ 
signalling pathway acts with the same mechanism, but the signal is transduced 
via the R-SMADs SMAD2 and SMAD3 that form complexes with SMAD4. 
Therefore, SMAD4 participates in mediating the transcriptional regulation in 
response to both BMP and TGFβ signal transduction (Pignatti et al., 2014, 
Figure 3). SMAD4 contains two evolutionary conserved MAD homology (MH) 
domains separated by a linker. The MH1 domain located in the N-terminal part 
of SMAD4 interacts with DNA, mediates the protein-protein interactions and 
contains the nuclear localization signal (NLS). The MH2 domain located in the 
C-terminal part is phosphorylated, regulates SMAD oligomerisation and 
contains the nuclear export signal (NES, Moustakas and Heldin, 2009). 
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Figure 3: The BMP/TGFβ signalling pathways 
BMP ligands (yellow) bind the transmembrane BMP-receptors (light blue) and induce 
phosphorylation of SMAD1, SMAD5 and SMAD8 (green). These phospho-R-SMADs form a 
complex with SMAD4 (red) that translocates into the nucleus to regulate the expression of 
BMP target genes. TGFβ ligands (pink) bind the TGFB-receptors (dark blue) to 
phosphorylate SMAD2 and SMAD3 (green). A complex with SMAD4 is also formed that 
translocates into the nucleus to control the expression of TGFβ target genes. SMAD4 is the 
common nuclear mediator of BMP and TGFβ signal transduction. 
 
In the developing limb bud, three BMP ligands are expressed: BMP2, BMP4 
and BMP7. Cooperation between the TGFβ and BMP signalling pathways 
induces the chondrogenic program in forelimb buds after E10.5 (Karamboulas 
et al., 2010). However, outgrowth and patterning require BMP signalling, while 
TGFβ signalling is not required for early limb bud development (Bénazet et al., 
2009; Pignatti et al., 2014). Therefore, we can investigate the roles of the BMP 
signalling during the onset and early phase of limb bud outgrowth (from E9.75 
to E10.0) by studying the functions of the SMAD4 protein. As mentioned above, 
two phases of high BMP activity are required for normal limb bud development. 
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During the late phase (E11.0-E12.0), high BMP activity is required to induce 
chondrogenic differentiation and SMAD4 functions in the initial compaction and 
the onset of chondrogenic differentiation progenitor cells (Bénazet et al., 2012). 
During the onset of limb bud development (E9.5-E10.0), BMP4 and SMAD4 are 
required to initiate Grem1 expression and for the formation of a functional AER 
(Benazet and Zeller, 2013; Bénazet et al., 2009, 2012). However, little is known 
about the range of transcriptional target genes controlled by BMP4/SMAD4 
during limb bud initiation. Mouse embryos deficient for Smad4 die before E7.5 
due to gastrulation defects (Chu et al., 2004). As the Prx1-CRE transgene is 
active in limb bud mesenchyme from E9.5 onward (Logan et al., 2002), 
conditional inactivation of Smad4 in the limb bud mesenchyme (Figure 4B) is 
used to investigate the roles of SMAD4 and the BMP signalling pathway during 
early limb bud development (Bénazet et al., 2012). 
GREM1 is a crucial node in the SHH/GREM/FGF feedback signalling system. 
Grem1 expression is activated by BMP signalling during the onset of limb bud 
development and its dynamic expression from E9.5 to E12.0 is regulated by 
SHH, Wnt and FGF signalling (Figure 4A, B, Bénazet et al., 2009; Capdevila et 
al., 1999; Scherz et al., 2004; Verheyden and Sun, 2008; Zuniga and Zeller, 
1999 and unpublished results). The Grem1 transcription unit consists of two 
exons with a coding exon 2. Its transcriptional regulation is controlled by a large 
cis-regulatory landscape extending 3’ of Grem1 into the neighbouring Formin1 
(Fmn1) gene. The Fmn1-Grem1 genomic landscape contains highly conserved 
non-coding regions able to drive the expression of a LacZ reporter in the limb 
bud mesenchyme in a pattern similar to Grem1 expression (Li et al., 2014; 
Zuniga et al., 2012). However, how these CRMs scattered throughout the 
Grem1 cis-regulatory landscape integrate the different signalling inputs into the 
dynamic spatio-temporal gene expression remains unclear (Figure 4C).  
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Figure 4: The dynamic Grem1 expression is initiated by BMP/SMAD4 and regulated 
by integration of different signalling inputs 
(A) WISH for Grem1 in forelimbs from E9.5 to E12.0. Adapted from Zuniga et al., 2012. (B) 
WISH for Smad4 and Grem1 in WT and Smad4∆/∆c forelimbs at E10.0. Scale bars: 100µm. 
(C) Schematic representation of the Grem1 genomic landscape that must integrate inputs 
from BMP, SHH, WNT and FGF signalling pathways. The Grem1 transcription unit consists 
of 2 exons (in red) and is located upstream of Fmn1 transcription unit with 24 exons (in 
blue). 
 
Little is known about the direct transcriptional targets of SMAD4 and potential 
additional functions of BMP signalling during the onset of limb bud outgrowth. A 
negative feedback between BMP-SHH has been described in chick limb buds 
(Bastida et al., 2009). In particular, BMP activity restricts Shh transcription in the 
ZPA by interfering with FGF and Wnt signalling. However, the mechanism of 
competition between the SHH and BMP signalling pathways is not understood 
in mouse limb buds. 
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4.4. SHH signalling pathway and cholesterol 
functions 
During limb bud development, the SHH ligand is produced by the ZPA cells in 
the posterior mesenchyme (Figure 2, in red) and its graded distribution along 
the AP axis participates in establishing AP polarity in the early limb bud (Zhu 
and Mackem, 2017) and controls proliferation of LMPs (Zhu et al., 2008). 
Therefore, spatio-temporally controlled regulation of Shh expression and 
diffusion of the morphogenetic signal are essential for normal limb development. 
In particular, loss of Shh expression truncates distal limb skeletal structures 
while its anterior ectopic expression causes polydactylies (Chiang et al., 1996, 
2001, Büscher et al., 1997). Therefore, one of the most common human 
congenial malformation is the preaxial polydactyly which is characterized by 
mutations in the ZRS affecting its activity and inducing ectopic anterior Shh 
expression (Sagai et al., 2004; Zeller et al., 2009). In contrast, absence of an 
active ZRS characterizes limbless reptiles and amphibians (Sagai et al., 2004). 
Recently, it has been shown that replacement of the mouse ZRS by the snake 
ZRS sequence is sufficient to “serpentize” the mouse, resulting in a limbless 
mouse (Kvon et al., 2016). 
Autoproteolytic cleavage of the SHH protein releases the N-term signalling 
domain that is then covalently modified by palmitic acid (N-term) and cholesterol 
(C-term) moieties (Figure 5A). The palmilation and the cholesterylation 
modulate the long-range signalling of SHH (Chen et al., 2004; Li et al., 2006a). 
The cholesterol modification impacts on the SHH diffusion as it will be retained 
in the plasma membrane, which restrict its free mobility (Li et al., 2006a; Peters 
et al., 2004; Tukachinsky et al., 2012). The AP spread of SHH ligand is thus 
controlled to avoid too anterior expansion of the gradient (Li et al., 2006a; Zeng 
et al., 2001; Zhu and Scott, 2004). In addition to cholesterol modification of the 
SHH ligand, its receptor Patched1 (Ptch1) and HHIP1 (HH-interacting protein 1) 
are also involved for restricting the spread of the SHH ligand. Interestingly, 
these both SHH-interacting proteins are also direct transcriptional targets of 
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SHH, which points to the fact that cells responding to SHH up-regulate negative 
regulators of SHH signal transduction (Briscoe et al., 2001; Chen and Struhl, 
1996; Chuang et al., 2003). Activation of signal transduction occurs as a 
consequence of SHH binding to its twelve-pass transmembrane receptor Ptch1, 
which in turn releases the inhibition of Smoothened (SMO) by Ptch1 at the 
primary cilia. As a consequence, SMO is cholesterol-modified at both its C- and 
N-terminal domains, which results in a change to its active conformation (Huang 
et al., 2016; Xiao et al., 2017). Intracellular signal transduction is triggered by 
modification of GLI3 full length (GLI-FL) to its GLI3-activator isoform (GLI-A), 
which translocates to the nucleus and activates/up-regulates the expression of 
SHH target genes (Figure 5B, Briscoe and Thérond, 2013). Cholesterol 
modification of the SHH ligand and SMO proteins is essential for graded SHH 
signalling as it regulates the diffusion of the ligand and activation of signal 
transduction in the limb bud mesenchymal cells responding to SHH signalling.  
 
Figure 5: Cholesterol-modifications are crucial for SHH signalling 
(A) SHH is processed by autoproteolytic cleavage in the endoplasmic reticulum. The 
amino-terminal SHH signalling peptide is covalently modified by palmitic acid at the N-
terminus and by cholesterol at its C-terminus. This step is crucial for regulating the diffusion 
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of the SHH ligand. Secreted soluble SHH ligands form multimers, complexed by the 
cholesterol. (B) Activation of SHH signalling in responding cells: SHH binds its receptor 
Patched1 (Ptch1), which relieves the repression of Smoothened (SMO). Active SMO is 
covalently cholesterol modified at both the C- and N-terminal ends. GLI-FL (GLI3-full 
length) becomes GLI-A (Gli3-activator) and participates in regulating the expression of SHH 
target genes. 
 
 
In addition to its roles in steroid hormones, neuroactive steroids, oxysterols and 
bile acids synthesis, the cholesterol homeostasis is critical for normal growth 
and embryonic development. Many human malformation syndromes are caused 
by an inborn error of cholesterol synthesis (Porter and Herman, 2011). During 
early embryonic development, maternal sterols are a major source of 
cholesterol until about E12.0, but the synthesized sterols by the embryo 
eventually become the primary source of cholesterol (Tint et al., 2006). The 
importance of maternal cholesterol for normal embryonic development was 
shown by treating pregnant rats with inhibitors of cholesterol biosynthesis. This 
gives birth defects which phenocopy the Shh loss-of-function phenotype (Porter 
et al., 1996, Roux et al., 1964). However, the importance of endogenous 
cholesterol synthesis by the embryo is revealed by the fact that many inborn 
errors of metabolism are associated with severe development defects (Porter 
and Herman, 2011). Cholesterol biosynthesis is complex and involves many 
enzymes and both positive and negative regulatory feedback loops (Figure 6). It 
includes the TFs sterol regulatory element-binding protein 1 or 2 (SREBF1/2), 
which directly enhances the expression of enzymes depending on intracellular 
cholesterol concentration (Ye and DeBose-Boyd, 2011). The Smith-Lemli-Optitz 
Syndrome (SLOS), lathosterolosis and desmosterolosis are the most common 
congenital metabolic diseases caused by genetic mutations affecting enzymes 
controlling the final steps of cholesterol biosynthesis: these mutations cause 
accumulation of specific precursor sterols.  
 
24 
 
 
25 
Figure 6: The cholesterol biosynthesis pathway 
Cholesterol is synthetized from Acetyl-coA by 20 different enzymatic reactions whose each 
corresponding enzymes are indicated in blue. 
 
In SLOS patients the DHCR7 enzyme is mutated, which results in 
accumulation of the 7-dehydro-cholesterol (7DHC, Porter, 2008). In 
lathosterolosis patients, the Sc5d gene is mutated and the lathosterol 
intermediate is accumulated. In desmosterolosis patients the Dhcr24 gene 
mutated, which results in accumulation of desmosterol (Porter and Herman, 
2011). The diagnosis involves detection of cholesterol intermediate forms by 
gas chromatography / mass spectrometry (GC/MS). These metabolic diseases 
have a large spectrum of phenotypes and are characterized by altered facial 
features, mental retardation and limb defects (Porter and Herman, 2011). Many 
of the associated malformations affect tissues and organs that critically depend 
on SHH signalling during embryonic development (Cooper et al., 2003). In 
addition, mouse models for SLOS and lathosterolosis show a defective 
response to SHH signalling due to impaired SMO activity (Blassberg et al., 
2016; Cooper et al., 2003). This corroborates the importance of the cholesterol 
modification for SHH signalling and signal transduction during embryonic 
development. 
As mentioned before mouse embryonic development depends initially (up to 
about E12.0) on both embryonic cholesterol biosynthesis and uptake of 
maternal cholesterol absorption via the placenta (Tint et al., 2006). As the 
uptake of maternal cholesterol decreases in parallel to the increase in 
endogenous cholesterol synthesis, both processes are tightly balanced to 
ensure normal cholesterol levels in the embryo (Cohen, 2008; Tint et al., 2006). 
As cholesterol is water-insoluble, its transport requires the association of low 
lipoproteins (LDL) with apolipoprotein B (ApoB, Figure 7). In particular, the 
cholesterol uptake by cells depends on the amount of LDL-receptors (LDL-R) 
present at cell membranes. These receptors internalize the LDL complexes by 
endocytosis and are then recycled to the cell membrane. The LDL endosome 
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fuses with a lysosome, which results in degradation of the LDL moiety and 
releases the cholesterol (Figure 7, left part). The cholesterol uptake is controlled 
by the proprotein convertase subtilisin/kexin type-9 (PCSK9), which binds the 
LDL-R and targets the receptor for lysosomal degradation (Figure 7, right part, 
Lagace, 2014; Lagace et al., 2006).  
These studies reveal the complexity of cholesterol metabolism in embryos, but it 
is still unknown how this complex regulation is linked to and modulated by the 
molecular interactions and gene regulatory networks that control embryonic 
development. 
 
 
Figure 7: Cholesterol uptake and regulation by cells 
The extracellular cholesterol is transported by the low density lipoproteins (LDL, pink) in a 
complex with the ApoB protein (dark pink). The cell membrane contains LDL-receptors 
(LDL-R, blue), which recognize and bind the ApoB-LDL complex. The complex is 
internalized by endocytosis and the LDL-R is then recycled to the cell membrane. The LDL-
endosome fuses with a lysosome that degrades the LDL and releases the cholesterol into 
the cell. Degradation of the LDL receptor: the PCSK9 convertase (in green) binds to the 
LDL-R and blocks its recycling. Thereby LDL/LDL-R complex is degraded by fusion with a 
lysosome, which decreases the LDL-R concentration in the cell membrane. 
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5. Aims of the Thesis 
Understanding the mechanisms that drive cell fates during the embryogenesis 
is a fascinating question. During my PhD in the laboratory of Prof. Dr. Rolf Zeller 
and Dr. Aimée Zuniga, I could continue to deepen my knowledge about 
developmental genetics acquired during my Master by focussing on heart and 
limb development. 
First, I had the opportunity to participate in the study of transcriptional gene 
regulation during heart development. In particular, I was involved in the 
identification of direct transcriptional targets of HAND2, which is an essential 
transcription factor for heart development. We have discovered the HAND2-
dependent gene regulatory network controling the endothelial to mesenchymal 
transition during atrioventricular canal development (the publication describing 
these results is presented in the first part of my thesis in its published version). 
In the second part of my thesis, I analysed the roles of the BMP signalling 
pathway during the early limb bud development. I have focussed my study on 
the activity of the BMP signalling transducer SMAD4. I had the chance to 
perform and combine different types of genome-wide analyses to identify the 
gene regulatory networks controlled by SMAD4. As high BMP activity is 
essential for the initiation and outgrowth of the limb bud, I have identified and 
studied the multiple functions of SMAD4 during this decisive early phase of limb 
bud development. First, I studied the role of SMAD4 in the activation of the BMP 
antagonist Gremlin1, which is essential for establishment of the signalling 
feedback loop that drives limb bud outgrowth. Then, my research identified the 
SMAD4-dependent gene regulatory network that is essential for patterning the 
early limb bud. Finally, I have identified a completely novel and highly relevant 
mechanism whereby SMAD4 controls cholesterol homeostasis and indirectly 
modulates the spread of the SHH signal and its signal transduction activity. 
 
 
28 
  
 
29 
6. Results 
6.1. Identification of the direct targets of HAND2 
during heart development 
 
“HAND2 Target Gene Regulatory Networks Control Atrioventricular Canal and 
Cardiac Valve Development” 
Laurent, F., Girdziusaite, A., Gamart, J., Barozzi, I., Osterwalder, M., Akiyama, 
J.A., Lincoln, J., Lopez-Rios, J., Visel, A., Zuniga, A., et al. (2017). Cell Rep. 19, 
1602–1613. 
This article by Laurent et al. focuses on the functional requirement of HAND2 in 
endothelial to mesenchymal transition (EMT) and subsequent migration of the 
delaminating cells into the cardiac cushions of the atrioventricular canal (AVC). 
To this publication, I have contributed to various experiments such as blinded 
determination of cell numbers for the heart explants shown in Figures 3, 6b and 
S5c. Together with Ausra Girdziusaite and Rolf Zeller I have participated in the 
isolation of AVCs for RNA-seq analysis (Figure 4). I have performed the ChIP-
qPCR analysis using Hand23xF/+ hearts to verify the HAND2 transcriptional 
target genes that are involved in EMT processes and AVC morphogenesis 
(Figure 4). In addition, I have performed the bioinformatics analysis using the 
HAND2 ChIP-seq datasets, to identify the HAND2-interacting regions located in 
the topologically associated domains (TADs) of HAND2 direct target genes of 
interest (data not shown). Finally, I have prepared the graphical abstract 
together with Frédéric Laurent. 
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Supplemental Figures 
 
Figure S1 (related to Figure 1). Analysis of the genomic regions enriched in HAND2 
chromatin complexes and associated genes. 
(A) Heat map showing the enrichment of heart-related GO term categories in the list of putative 
HAND2 target genes defined by GREAT analysis. The columns denote ten incremental bins of 
HAND2-bound regions (from 10% to the complete set = 100%). For visualization, hyper-
geometric p-values equal or lower to 1e-30 were set to this value. Terms were hierarchically 
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clustered and re-ordered according to the row-wise mean. GO terms related to the development 
of specific cardiac compartments are highlighted by different colors: outflow tract (green), right 
ventricle (yellow) and atrioventricular cushions (blue). While the general cardiac terms are 
systematically identified in each incremental bin (top term: cardiovascular system phenotype), 
GO terms related to more specific aspects of cardiac development (such as: abnormal heart right 
ventricle morphology) are only detected when considering an increasing number of peaks or the 
entire dataset. (B) Hierarchical clustering of the high-affinity matches for each of the enriched 
known motifs across the HAND2-contacted regions is shown. The top five binding motifs that 
were identified de novo are highlighted on the left. (C) Analysis of the patterns of cell death in 
Hand2-deficient mouse embryos. Panel Lysotracker: whole mount Lysotracker staining reveals 
increased apoptosis in branchial arches (Ba) and frontonasal mass (Fnm) of mutant mouse 
embryos at E9.5 (red fluorescence), while no aberrant apoptosis is detected in the developing 
heart. He: heart; Flb: forelimb bud. Panel TUNEL: analysis of serial section by TUNEL staining 
confirmed that apoptosis in not increased in the mutant heart at E9.5 (TUNEL positive cells 
fluoresce green). Panel KI67: the majority of all cells are KI67 positive (red fluorescence), which 
indicates that there is no major effect on cell proliferation in mutant hearts at E9.5. Right-most 
panel TUNEL: Only by E10.5, the apoptosis is significantly increased in mutant hearts in 
comparison to wild-type controls. Representative images are shown for all samples analyzed 
(n=3). avc: atrioventricular canal; lv: left ventricle; la: left atria; oft: outflow tract. 
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Figure S2 (related to Figure 1). Activities of the VISTA cardiac enhancers that overlap 
genomic regions enriched by HAND2 ChIP-Seq (E10.5). 
Representative transgenic founder embryos from the public VISTA enhancer database collection 
(https://enhancer.lbl.gov; Visel et al., 2007) are shown. The transgenic embryos were not 
generated as part of this study, but images from the database collection were used for the 
purpose of this analysis. For each VISTA enhancer, the HAND2 ChIP-Seq peak identified by 
MACS analysis is indicated by a blue bar. The genomic regions used for LacZ reporter analysis 
 
47 
are indicated by a green bar. mm: mouse element; hs: human element. Nomenclature used is 
according to the VISTA database.  
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Figure S3 (related to Figure 1). HAND2 target genes encoding ligands for signaling 
pathways that function in OFT and/or right ventricle morphogenesis. 
(A) Venn diagram shows the intersection of genes associated with the following mouse 
phenotype and GO terms, respectively: MP:0006126: abnormal outflow tract development; 
MP:0003920: abnormal heart right ventricle morphology; GO:0003151: outflow tract 
morphogenesis; GO:0003205: cardiac chamber development. Numbers and percentages 
indicate how many of the genomic landscapes associated to the terms encode regions enriched 
in HAND2 chromatin complexes. (B) ChIP-qPCR validation of HAND2 target regions associated 
to genes encoding ligands in embryonic hearts at E9.25 (n=2; mean ± SD). (C) Comparative 
WISH analysis of HAND2 target genes encoding signaling ligands in wild-type and Hand2-
deficient mouse embryos. Graphs show the highest enriched HAND2 ChIP-Seq peaks 
associated with the genes analyzed. White arrowheads: reduction/loss of expression in Hand2-
deficient embryos. oft: outflow tract, rv: right ventricle, lv: left ventricle. Scale bar: 100µm. 
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Figure S4 (related to Figure 4). Transcriptome analysis identifies the HAND2 target genes 
with significantly altered expression in Hand2-deficient AVCs. 
(A) Enrichment analysis for mammalian phenotypes including all 1051 DEGs identified by 
comparative transcriptome analysis of Hand2∆/∆ and wild-type AVCs. (B) Top 100 up- and down-
regulated genes in Hand2-deficient AVCs in comparison to wild-type controls. Genes with 
regions enriched in HAND2 chromatin complexes within their TADs are indicated in bold black, 
others in grey. (C) Heat map of up- and down-regulated genes in Hand2-deficient AVCs 
annotated using the following gene ontology categories: MP:0000297 (abnormal AV cushion 
morphology + child terms) BP:0001837 (epithelial-mesenchymal transition) and BP:0010717 
(regulation of EMT). Most of the DEGs in these categories are HAND2 target genes (indicated in 
green). 
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Figure S5 (related to Figures 5 and 6). Analysis of HAND2 target genes in the developing 
AVC. 
(A) WISH analysis of the HAND2 target gene Pitx2, whose transcript levels are significantly 
altered in mutant AVCs by RNA-Seq analysis. No changes in the spatial distribution of Pitx2 
transcripts are detected. (B) Colocalization of HAND23xF proteins (green fluorescence) with the 
SOX9 transcriptional regulators (red fluorescence) in the AVC of wild-type (Hand23xF/3xF) and 
Hand2-deficient (Hand2∆/∆) mouse embryos at E9.5. Asterisks in the enlargement (upper panels) 
point to SOX9-positive delaminating mesenchymal cells in the AVC, which are lacking in the 
Hand2-deficient AVC. Scale bar: 100µm. (C) Infection of wild-type AVC explants with GFP and 
SNAI1-GFP adenovirus (using 6x106 PFU for either virus per sample) indicates that GFP virus 
infects AVC cells slightly more efficiently than SNAI1-GFP virus. Therefore, the observed partial 
restoration of cell migration in Hand2-deficient AVCs infected with SNAI1-GFP virus is likely 
slightly underestimated (Figure 6B). 
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Figure S6 (related to Figure 6). The Snai1 transcript distribution overlaps the CRM+57kb 
activity in craniofacial structures, branchial arches and early limb buds. 
(A) ChIP-qPCR validation of the enrichment of the three CRMs in HAND2 chromatin complexes 
from embryonic hearts (E9.25-E9.5, n=2; mean ±SD). (B) The expression pattern of the Snai1 
CRM+57kb LacZ reporter transgene at E9.5. (C) Snai1 expression and activity of the CRM+57kb 
LacZ reporter transgene in craniofacial structures. The enhancer activity overlaps well with the 
domain of Snai1 transcripts in the nasal prominence (np), maxillary process (mp), fore-midbrain 
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and mid-hindbrain boundaries (white arrowheads). fb: forebrain, mb: midbrain, hb: hindbrain. 
Black arrow points to the epicardium. (D) Expression of Snai1 and the CRM+57kb LacZ reporter 
transgene in migrating cardiac neural crest cells (black arrowheads) enveloping the otic vesicle 
(ov). (E) Snai1 expression is reduced in the 2nd branchial arch (II) and early forelimb buds in 
Hand2-deficient mouse embryos (E9.0)  
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6.2. Identification of the SMAD4 targets during 
mouse limb bud development 
 
As the BMP signalling pathway is crucial for early limb bud development, I have 
studied the impact of BMP signalling on gene expression by analysing the 
functions of the downstream nuclear mediator SMAD4. Recent advances in 
sequencing-based methodologies have made it easier to identify the genome-
wide profiles underlying cis-regulatory networks (Pavesi, 2016). To decipher the 
roles of SMAD4 during limb bud development, I have used different genome-
wide approaches between two embryonic stages: before the establishment of 
the SHH/GREM1/FGF feedback loop in E9.5-E10.0 forelimb buds and during 
the propagation the feedback signalling pathway in E10.5 forelimb buds. The 
analysis includes chromatin immunoprecipitation in combination with deep 
sequencing (ChIP-seq) to identify SMAD4 complexes interacting regions, 
ATAC-seq to map accessible chromatin and RNA-seq to describe the 
differentially expressed genes between WT and Smad4-deficent forelimb buds. 
This allowed us to identify the direct transcriptional targets of SMAD4 and study 
the SMAD4-dependent processes during early limb bud development. 
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6.2.1. Smad43xFLAG mouse generation and validation 
The genome-wide profile of genomic regions bound by SMAD4 chromatin 
complexes by ChIP-seq required insertion of a 3xFLAG epitope tag into the 
endogenous SMAD4 coding region by homologous recombination in mouse 
embryonic stem (ES) cells. Positive ES cell clones were injected into 
blastocysts at the Center for Transgenic Models, Basel. To avoid unspecific 
effects of co-inserted Neo cassette on Smad4 expression (Lewandoski, 2001), 
the floxed Neo cassette was deleted by mating chimeric males with CMV-CRE 
females (Figure 8A). Specific primer pairs were used to discriminate between 
Smad4+, Smad43xF and Smad43xF-∆Neo alleles (Figure 8B). The Western blot 
analysis shows specific detection of the Flag-tagged-SMAD4 protein in forelimb 
buds using FLAG antibodies (Figure 8C). Similarly, RT-qPCR analysis shows 
that transcription at the Smad4 locus is unaffected in Smad4+/+, Smad43xF/+ and 
Smad43xF/3xF mouse limb buds (Figure 8D, left panel). As expected, the junction 
of exon12 and 3’UTR is fully detected in Smad4+/+, partially (50%) in Smad43xF/+ 
and not in Smad43xF/3xF limb buds (Figure 8D, middle panel). The junction of the 
FLAG epitope tag and the 3’UTR is detected specifically in Smad43xF/3xF (100%) 
and Smad43xF/+ (50%) limb buds (Figure 8D, right panel). This analysis shows 
that the Smad4 locus has been correctly targeted. Furthermore, we performed 
fluorescent immunostaining using the mouse anti-Flag antibody on frozen 
sections of Smad4+/+ and Smad43xF/3xF forelimb buds. A highly specific staining 
is observed in Smad43xF/3xF limb buds in comparison to wild-type controls 
(Figure 8E, left panels). Together, this analysis demonstrates the specificity of 
the FLAG antibody and usefulness of the Smad43xF allele to study SMAD4-
dependent processes. SMAD4 is uniformly expressed in the limb bud 
mesenchyme at E9.5 and E10.5 (Bénazet et al., 2012, Figure 8E, left panels). 
Our Immunohistochemical analysis shows that SMAD4 is mostly present in the 
cytoplasm, and only a small fraction of the protein is detected in nucleus (Figure 
8E, high magnification). Smad43xF homozygous mice are perfectly normal, 
which shows that the inserted 3xFLAG epitope tag does not alter SMAD4 
function nor protein localisation.  
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Figure 8: Generation, characterisation and validation of the Smad43xFlag knockin 
mouse. 
(A) The Smad43xF allele was generated by homologous recombination in mouse ES cells. A 
vector containing two homology arms flanking the 3’ end of the Smad4 coding sequence 
and a 3xFLAG epitope tag was inserted in frame between the exon 12 and the 3’UTR of 
the Smad4wt allele. The targeting vector also contains a floxed Neo cassette downstream of 
the Smad4 sequence (targeting was done by Frédéric Laurent). Initially, the Smad43xF-Neo 
mouse was crossed with CMV-cre mouse to remove the Neo cassette and obtain the 
Smad43xF mouse (ΔNeo). The arrows indicate the primers used for genotyping. (B) 
Genotyping and validation of the different Smad4 alleles by PCR. The sizes of the PCR 
bands are written on the right. (C) Detection of the SMAD43xF protein by Western blot in 
Smad43xF/3xF E11.75 limb buds (done by Frédéric Laurent). (D) RT-qPCR analysis of 
E11.75 limb buds from Smad4+/+, Smad43xF/+ and Smad43xF/3xF mouse embryos to detect 
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different parts of the transcript: between exon 8 and 9, exons 12 and 3’UTR and between 
the FLAG and 3’UTR (done by Frédéric Laurent). (E) Fluorescent immunostaining using the 
mouse anti-Flag antibody on frozen sections of WT and Smad43xF/3xF limb buds. Scale bar: 
100µm (50µm in high magnification). Figure adapted from Frédéric Laurent’s PhD thesis. 
 
6.2.2. SMAD43xF ChIP-seq and ATAC-seq 
The genomic regions interacting with SMAD4 chromatin complexes were 
identified by ChIP-seq using limb buds from two embryonic stages: E9.75, 
characterized by essential high BMP activity and E10.5, characterized by low 
BMP activity (Bénazet et al., 2009, see Figure 2). Due to the small size of E9.75 
forelimb buds, I have dissected these early forelimb buds along with a small 
part of trunk tissue from ~160 Smad43xF/3xF mouse embryos in two replicates 
(Figure 9A). Furthermore, the profile of accessible/open chromatin was 
determined by ATAC-seq at E9.75 in wild-type (WT) forelimb buds along with a 
small part of adjacent flank tissue to be able to directly compare the SMAD4 
ChIP-seq and ATAC-seq profiles (Figure 9A). Our bioinformatics analysis 
shows that 40% of the regions enriched in SMAD4 chromatin complexes are 
located close to transcriptional start sites (TSS, ±5kb) while 20% are located 
further away (±100kb) from the nearest TSS. Phastcon analysis shows that 
SMAD4 bound regions are highly conserved in placental mammals (Figures 
9C). HOMER analysis using known motifs identified the SMAD4 consensus as 
the most enriched motif (Figure 9D, Kim et al., 2011). De novo motif search 
discovery also established SMAD motifs as most enriched (Figure 9D, Kim et 
al., 2011). To further validate the SMAD43xF ChIP-seq dataset, we performed 
the ChIP-qPCR using two known BMP responsive elements (BREs). The BRE 
near the Id1 and Msx2 genes show significant enrichment at the target sites 
and similar enrichment is observed in the SMAD4 ChIP-seq dataset (Figure 9F). 
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Figure 9: SMAD43xF ChIP-seq and ATAC-seq experiments using E9.75 forelimbs. 
(A) E9.75 forelimbs were dissected with a portion of trunk attached to perform ChIP-seq 
and ATAC-seq experiments. (B) Barplot showing the distribution of SMAD4 occupied 
regions to the nearest TSS. (C) Histogram showing phastcon conservation of SMAD4 
bound regions. SMAD4 occupied regions are conserved. (D) Hierarchical clustering of the 
high-affinity matches for the enriched known and de novo SMAD4 motifs. (E) De novo motif 
analysis showing the top 5 motifs in SMAD4 bound regions. (F) ChIP-qPCR validation for 
two known SMAD4 binding regions: the BMP responsive element (BRE) on the Id1 
transcription unit and the BRE of the Msx2 gene (Korchynskyi and Dijke, 2002, Brugger et 
al., 2004). 
 
At E10.5, when BMP activity is lower, fore and hindlimb buds from ~200 
Smad43xF/3xF embryos were used for ChIP-seq (in duplicate) and ATAC-seq was 
performed using E10.5 WT forelimb buds (ATAC-seq dataset from Javier 
Lopez-Rios, Figure 10A). Similar to the E9.5 ChIP-seq dataset, the regions 
enriched in SMAD4 chromatin complexes are located ±5kb or ≥±100kb away 
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from the closest TSS and are conserved in placental mammals (Figure 10B and 
10C). Surprisingly, de novo and known motifs analysis using HOMER (Heinz et 
al., 2010) identified the homeobox motif PKNOX1 as the top enriched de novo 
motif (Figure 10D, E). Similar to the SMAD4 ChIP-seq at E9.5, the BREs near 
the Id1 and Msx2 target genes are also enriched at E10.5, which validates both 
datasets (Figure 10F). 
 
 
Figure 10: SMAD43xF ChIP-seq and ATAC-seq experiments using E10.5 limb buds 
(forelimbs and hindlimbs). 
(A) E10.5 limb buds were dissected and pooled to perform ChIP-seq and ATAC-seq 
experiments. (B) Barplot showing the distribution of SMAD4 occupied regions to the 
nearest TSS. (C) Histogram showing phastcon conservation of SMAD4 bound regions. 
SMAD4 occupied regions are conserved. (D) Hierarchical clustering of the high-affinity 
matches for the enriched known and de novo SMAD4 motifs. (E) Results from the de novo 
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motif analysis showing the top 5 motifs in SMAD4 bound regions. (F) ChIP-qPCR validation 
for two known SMAD4 binding regions: the BMP responsive element (BRE) on Id1 
transcript unit and the BRE of the Msx2 gene (Korchynskyi and Dijke, 2002, Brugger et al., 
2004). 
 
 
6.2.3. Comparative analysis of the transcriptome in wild-type 
and Smad4-deficient forelimb buds 
To identify SMAD4-dependent gene regulatory networks, I performed RNA-seq 
analysis using WT and Smad4-deficient forelimb buds. It has been shown that 
constitutive Smad4 inactivation is embryonically lethal (Chu et al., 2004). 
Therefore, I have conditionally inactivated Smad4 (Smad4∆/∆c) in the limb bud 
mesenchyme using the Prx1-CRE driver line (Logan et al., 2002). By E9.5, the 
Prx1-CRE transgene is activated in developing forelimb buds (Logan et al., 
2002), and I estimated that CRE -mediated deletion of the Smad4flox/flox allele 
requires about 10hrs (see Figure 4B).  
Therefore, the earliest stage used for RNA-seq analysis are WT and Smad4∆/∆c 
forelimb buds isolated from mouse embryos at E10.0, i.e at the time the 
feedback signalling system is set-up and mesenchymal BMP4 expression is 
high and essential for limb bud development (Bénazet et al., 2009). The RNA-
seq analysis shows that 669 genes are differentially expressed (DEGs) between 
WT and Smad4∆/∆c E10.0 forelimb buds (fold change ≥1.2; FDR set to <0.1). 
Out of 667 DEGs, 306 are down- and 361 are up-regulated genes (Figure 11B). 
The top 25 DEGs are shown in Figure 11C. GO analysis identifies sterol 
biosynthesis as the top enriched term among the down-regulated DEGs. In 
contrast, the most enriched terms in the up-regulated DEGs are related to 
developmental and cellular processes (Figure 11D). 
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Figure 11: Transcriptome analysis in WT and Smad4∆/∆c forelimbs at E10.0 
(A) Forelimbs of WT and Smad4∆/∆c E10.0 embryos were used to perform RNA-seq 
experiment. (B) Heatmap showing the differentially expressed genes (DEGs) identified by 
comparing WT and Smad4∆/∆c transcriptomes. N=3 and n=4 biological replicates for WT 
and Smad4∆/∆c forelimbs, respectively. DEGs showing a fold change ≥1.2 and FDR<0.1 
were analysed. (C) Top 25 down-regulated (top panel) and up-regulated (bottom panel) 
genes in Smad4∆/∆c forelimbs, normalized to the expression mean in WT samples. (D) GO 
analysis of down-regulated and up-regulated genes in Smad4∆/∆c forelimbs. Note that sterol 
biosynthetic processes are most enriched among the down-regulated genes, while GO 
terms for general developmental processes are more enriched in up-regulated genes 
(bottom panel). 
 
Similarly, the DEGs in WT and Smad4∆/∆c forelimbs were also identified using 
forelimb buds at E10.5 (Figure 12A), i.e. when the self-regulatory feedback 
signalling system is active and mesenchymal BMP activity is lowered due to 
GREM1-mediated antagonism (Bénazet et al., 2009, 2012). Using the same 
statistical threshold as for E10.0, 386 DEGs were identified, 143 of which are 
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down- and 243 up-regulated (Figure 12B). The top 25 DEGs for each category 
are shown in Figure 12C. In contrast to E10.0, GO analysis at E10.5 no longer 
detected sterol biosynthesis, but terms related to developmental processes 
(Figure 12D). This indicates that SMAD4-mediated BMP signal transduction 
controls genes functioning in developmental process at both stages, while its 
effect on cholesterol biosynthesis may be limited to the onset of limb bud 
development (see chapter 6.2.7). 
 
Figure 12: Transcriptome analysis in WT and Smad4∆/∆c forelimbs at E10.5 
(A) Forelimbs of WT and Smad4∆/∆c E10.5 embryos were used for RNA-seq analysis. (B) 
Heatmap showing the differentially expressed genes (DEGs) identified by comparing WT 
and Smad4∆/∆c transcriptomes. N=3 and n=4 biological replicates for WT and Smad4∆/∆c 
forelimbs, respectively. DEGs showing a fold change ≥1.2 and FDR<0.1 were analysed. 
(C) Top 25 down-regulated (top panel) and up-regulated (bottom panel) genes in Smad4∆/∆c 
forelimbs, normalized to the expression mean in WT samples. (D) GO analysis of down-
regulated and up-regulated genes in Smad4∆/∆c forelimbs. Note that global development 
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processes are the most enriched in both datasets. Sterol biosynthesis is no longer present 
in the top terms. 
 
6.2.4. Identification of the SMAD4 target gene regulatory 
networks: Intersection of the ChIP-seq, ATAC-seq and 
RNA-seq datasets 
To identify the direct transcriptional targets of SMAD4 complexes, the 
SMAD43xF ChIP-seq, ATAC-seq and RNA-seq datasets were combined. First, 
we identified the genomic regions bound by SMAD4 that overlap with ATAC-seq 
peaks. The regions of open chromatin that interact with SMAD4 complexes 
were considered as potential cis-regulatory modules (CRMs). Next, these 
CRMs were associated with DEGs located within a distance up to ±1Mb. This 
parameter was chosen as it has been established for several developmental 
regulator genes that CRMs can be located as far away as ±1Mb. For example, 
the CRM that regulates Shh expression in the posterior limb bud mesenchyme 
is located at around 800kb upstream of the Shh TSS (Lettice et al., 2003). By 
intersecting these three datasets, we have identified 306 candidate 
transcriptional targets of SMAD4 in forelimb buds at E10.0 (Figure 13A). Next, 
the association of SMAD4 bound CRMs and DEGs within a particular 
topologically associating domain (TADs, Dixon et al., 2012, appendixes 12.7 
and 12.8) was analysed in comparison to genes, whose expression is not 
changed in Smad4-deficient limb buds. These results show a significant larger 
number of SMAD4 interacting CRMs located within the TADs of DEGs than 
genes whose expression is not altered in Smad4-deficient limb buds genes 
(Figure 13B). Among the 306 SMAD4 transcriptional target identified 143 are 
down- (Appendix 12.1) and 163 up-regulated (Appendix 12.2) in Smad4∆/∆c 
forelimb buds at E10.0. The GO analysis of the 143 down-regulated SMAD4 
target genes is enriched for functions in sterol metabolism (Figure 13C, right bar 
plot), while the up-regulated SMAD4 target genes function predominantly in 
developmental processes (Figure 13C, left bar plot). 
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Figure 13: Identification of the putative SMAD4 targets in forelimb buds at E9.75-
E10.0 
(A) Schematic representation of the intersection between the ChIP-seq (E9.75), ATAC-seq 
(E9.75) and RNA-seq (E10.0) dataset. The total numbers of ChIP peaks, ATAC peaks and 
DEGs are indicated. This intersection identifies 306 candidate SMAD4 target genes in limb 
buds at E9.75-E10.0. (B) Boxplot representing the number of SMAD43xF ChIP-seq peaks 
within a topologically associated domain (TAD) harbouring genes either down- or up-
regulated in Smad4∆/∆c limb buds. The differentially expressed genes are the ones located 
nearest to the SMAD4 interacting region coinciding with accessible chromatin as identified 
by ATAC-seq. (C) GO enrichment analysis for biological processes for the down- and up-
regulated candidate SMAD4 target genes. 
 
The same approach was used for the E10.5 datasets, which identified 188 
candidate SMAD4 targets genes (Figure 14A). The significantly lower number of 
target genes identified could reflect the much lowered BMP activity. The 
SMAD4 ChIP-seq peaks are again more significantly abundant in TADs of 
DEGs than genes with unaltered expression (Figure 14B). In Smad4∆/∆c forelimb 
buds at E10.5, 125 SMAD4 target genes are down- (Appendix 12.3) and 63 up-
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regulated (Appendix 12.4) and in both groups genes functioning in 
developmental and cellular processes are enriched (Figure 14C).  
Taken together, this initial analysis shows that SMAD4 directly regulates the 
expression of genes essential for developmental process in both limb bud 
stages, while it appears to also regulate the expression of genes in the 
cholesterol biosynthesis pathway during the onset of limb bud development.  
 
Figure 14: Identification of the putative SMAD4 targets in forelimb buds at E10.5 
(A) Schematic representation of the intersection between the ChIP-seq (E10.5), ATAC-seq 
(E10.5) and RNA-seq (E10.5) dataset. The total numbers of ChIP peaks, ATAC peaks and 
DEGs indicated. This intersection identifies 188 candidate SMAD4 target genes in limb 
buds at E10.5. (B) Boxplot representing the number of SMAD43xF ChIP-seq peaks within a 
topologically associated domain (TAD) harbouring genes either down- or up-regulated in 
Smad4∆/∆c limb buds. The differentially expressed genes are the ones located nearest to 
the SMAD4 interacting region coinciding with accessible chromatin as identified by ATAC-
seq. (C) GO enrichment analysis for biological processes for the down- and up-regulated 
candidate SMAD4 target genes at E10.5. 
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6.2.5. Potential roles of SMAD4 in regulating Grem1 expression 
dynamics in limb buds 
 
The cis-regulatory complexity of Grem1 expression 
Previous publications from our lab have shown that several CRMs located in the 
Fmn1 locus are involved in regulating Grem1 expression in developing limb 
buds. Based on the evolutionary conservation, three likely functionally relevant 
CRMs were initially identified, called GRS1 (Grem1 Regulatory sequence 1), 
HMCO2 and HMCO3 (Zuniga et al., 2012). It has been shown that deletion of 
these elements impairs the Grem1 expression in developing limb buds. In 
addition, another element GRE1 (GLI responsive element 1) has been shown to 
participate in the regulation of Grem1 expression (Li et al., 2014). The GRS1, 
GRE1 and HMCO2 CRMs are located within the 70kb global control region 
(GCR, Figure 15 blue square), which is essential for normal Grem1 expression 
in mouse limb buds (Zuniga et al., 2004). Nevertheless, the combined activity of 
these CRMs can not explain the dynamic spatio-temporal expression of Grem1 
(see Figure 4), suggesting the existence of other CRMs. 
To identify all the potential Grem1 regulatory elements, we have used published 
Hi-C data from embryonic ES cells (Dixon et al., 2012), in combination with 4C-
seq, and different ChIP-seq and ATAC-seq datasets to map potential additional 
CRMs in Fmn1-Grem1 genomic landscape (mm9 chr2:113,143,398-
113,798,025). This analysis revealed a 320kb sub-TAD within the Grem1-
specific cis-regulatory landscape (Figure 15, dashed triangle). Indeed, the 4C 
peaks identifying the interactions of distant genomic regions with the Grem1 
proximal promoter (used as a viewpoint) are contained mostly in the Grem1 
subTAD region, which corroborates the Grem1 specific cis-regulatory potential 
of this 320kb region (Figure 15, 4C track in red). Evolution conservation 
analysis of the Grem1 sub-TAD using the ECR browser (Ovcharenko et al., 
2004) to compare mouse, human, pig and bovine genomes identified eight 
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novel evolutionary conserved regions (ECRs), in addition to the four already 
known elements (GRS1, HMCO2, GRE1 and HMCO3, Figure 15, grey bars). All 
these ECRs are contained within ATAC-seq peaks and overlap regions 
decorated by H3K27ac marks indicative of active enhancers (Infante et al., 
2013). In addition, they are enriched in SMAD43xF (my results), HoxA13 (Sheth 
et al., 2016) and/or GLI3 chromatin complexes (collaboration with Andrew P 
McMahon, USC, Figure 15). The chromatin accessibility, H3K27ac and 
interaction with transcription factor complexes points to the potential cis-
regulatory activity of these ECR regions. The transcriptional activity of these 
elements has been tested by Laurène Ramos Martins using LacZ reporter 
constructs, which establishes that many of these regions are enhancers that 
drive limb specific LacZ expression, making them candidate CRMs for 
regulating Grem1 expression (data not shown). 
Furthermore, the binding of CTCF and Cohesin complexes as revealed by 
ChIP-seq (DeMare et al., 2013) identifies 6 structural elements within the 
Grem1 subTAD (Figure 15, light blue bars).  
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Figure 15: Grem1 genomic landscape 
UCSC genome browser view showing the Hi-C profile (top red triangle; Dixon et al., 2012), 
4C-seq (with Grem1 TSS as viewpoint), ATAC-seq, and different ChIP-seq data for the 
Grem1 cis-regulatory landscape. The sub-topologically associated subdomain (subTAD) for 
Grem1 is delineated by the black dashed triangle on the Hi-C profile. Potential cis-
regulatory modules (CRMs) interacting either with SMAD4, HoxA13 (Sheth et al., 2016) or 
GLI3 (collaboration with Andrew P McMahon, UCS) are highlighted by grey boxes. These 
are evolutionary conserved regions (ECR, from 1 to 8) and the HMCO3, GRE1, HMCO2 
and GRS1 elements (Li et al., 2014; Zuniga et al., 2012). These elements are decorated by 
H3K27ac marks (Infante et al., 2013). The global control region (GCR) of Grem1 is 
indicated by the blue square and the structural elements (I to VI) interacting with CTCF and 
Cohesin chromatin complexes are highlighted in light blue (DeMare et al., 2013). The 
arrowheads indicate the motif orientation of the CTCF regions. The Grem1 exon 2 
interacting with SMAD4 at E9.75 and E10.5 is highlighted in red. 
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Coding exon 2 of Grem1 is highly enriched in SMAD4 chromatin 
complexes 
My SMAD43xF ChIP-seq analysis shows that among the Grem1 CRMs, the 
GRS1 element and the Grem1 coding exon 2 are significantly enriched (Figure 
15 red bar). Alignment of SMAD43xF ChIP-seq profiles at E9.75, E10.5 and 
E12.5 shows that the SMAD4 complexes interactions with Grem1 coding exon 2 
are dynamic. The SMAD4 occupancy of Grem1 coding exon 2 is highest in 
forelimb buds at E9.5 and decreases as limb bud development progresses 
(Figure 16A). As exon 2 encodes the GREM1 protein, this region is evolutionary 
conserved but inaccessible/closed as no corresponding ATAC-seq peak is 
observed (Figure 16A). The dynamics of the SMAD4-Grem1-exon 2 interactions 
were validated using ChIP-qPCR (Figure 16B). This most prominent interaction 
in forelimb buds at E9.5 is interesting in light of the fact that SMAD4 is required 
to activate Grem1 expression during the onset of forelimb bud development 
(Bénazet et al., 2009, 2012). Therefore, it is possible that the interaction of 
SMAD4 with Grem1 exon 2 is relevant to Grem1 activation in limb buds. To test 
this hypothesis, I used whole mount in situ hybridisation to analyse Grem1 and 
LacZ transcripts in Grem1∆ORF/+ embryos, in which one copy of the Grem1 
exon2 is replaced by a LacZ cassette (Michos et al., 2004, Figure 16C). 
Interestingly, the activation of LacZ transcription is delayed in comparison to 
Grem1 expression as LacZ transcripts are only detected at E10.5 instead of 
E9.5 (Figure 16D). Thus if coding exon 2 is replaced by LacZ, its expression is 
not activated at E9.5, which suggests that the interaction of SMAD4 with Grem1 
coding exon 2 is required for the temporally correct early activation of Grem1 
expression. The transcriptional enhancing potential of exon 2 was assessed in 
LacZ transgenic reporter assay by Laurène Ramos Martins (Figure 16E). As 
only 2 of 12 transgenic embryos show LacZ staining in limb buds, Grem1 
coding exon2 is unlikely to serve as a classical transcriptional enhancer. 
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Figure 16: Grem1 exon 2 is enriched in SMAD4 chromatin complexes and is able to 
drive LacZ reporter activity 
(A) UCSC genome browser view of Grem1 exon 2: SMAD43xF ChIP-seq peaks at E9.75, 
E10.5 and E12.5 with the corresponding ATAC-seq profiles at E9.75 and E10.5. (B) ChIP-
qPCR validation of the SMAD4 interacting with Grem1 exon 2. (C) Scheme showing the 
Grem1wt and the Grem1∆ORF alleles (Michos et al., 2004). (D) Grem1 and LacZ WISH in 
Grem1∆ORF/+ limb buds at E9.5, E10.5 and E11.5. (E) Scheme showing the Grem1 exon 2-
LacZ construct. Representative limb buds of transgenic embryos (E10.5 and E11.5) 
showing the LacZ reporter activity driven by Grem1-exon 2 (construct and analysis done by 
Laurène Ramos Martins). Scale bars: 100µm. 
 
 
SMAD4 chromatin complexes interact with the GRS1 enhancer 
region 
The interaction of SMAD4 chromatin complexes with the Grem1 regulatory 
region 1 (GRS1), is only significantly enriched in forelimb buds at E9.75 (Figure 
17A). The low level interaction of SMAD4 complexes with regions A and B of 
the GRS1 was confirmed by ChIP-qPCR (Figure 17A). The GRS1 is a robust 
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CRM that is able to drive strong and dynamic LacZ expression in forelimb buds 
(Figure 17C, Zuniga et al., 2012). CRISPR/Cas9 mediated deletion of this 
element shows that GRS1 is required for normal levels of Grem1 transcripts 
throughout limb bud development (Viviane Tschan, data not shown). The loss 
of GRS1 in Grem1∆GRS1/∆GRS1 and Grem1∆ORF/∆GRS1 forelimb buds (GRS1 
deletion over a Grem1 null allele) results in precocious termination of Grem1 
expression (Figure 17D). In addition, Grem1∆ORF/∆GRS1 forelimbs display a large 
spectrum of skeletal phenotypes. About 50% of the embryos show carpal bone 
fusions, syndactily or soft tissue fusion (Figure 17E arrows). These results show 
that the GRS1 regulates Grem1 expression likely in synergy with other CRMs. 
As GRS1 regulates Grem1 expression, the low level SMAD4-GRS1 interaction 
may contribute to its transcriptional regulation but not specifically to Grem1 
activation. 
 
In addition to Grem1 locus, I also analysed the genome-wide profile of the 
SMAD43xF interactions with genomic regions to identify the GRNs, whose 
expression is directly controlled by SMAD4 in E10.0 limb buds. To this aim, I 
have focused my analysis on the E9.75-E10.0 datasets, where the BMP activity 
is high, with DEGs expressed at levels detectable by whole mount RNA in situ 
hybridization (WISH) to assess their spatial distribution (Appendix 12.5). 
Furthermore, genes with known functions during limb bud development were 
given priority. Combining the unbiased GO analysis (Figure 13C) with WISH 
screening allowed me to identify two main GRNs directly controlled by SMAD4, 
namely an early limb patterning and a cholesterol biosynthesis gene network. 
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Figure 17: A Grem1 cis-regulatory module (CRM) is enriched in SMAD4 chromatin 
complexes 
(A) SMAD43xF ChIP-seq and ATAC-seq profiles peaks map to the GRS1 region. (B) ChIP-
qPCR validation of the SMAD4 interacting with the GRS1 element. (C) Transgenic 
embryonic limb buds showing the dynamic LacZ reporter activity driven by the GRS1 
element. (D) Grem1 WISH in WT, Grem1∆ORF/+, Grem1∆GRS1/∆GRS1 and Grem1∆ORF/∆GRS1 at 
E10.5 and E11.5. White scale bars: 100µm. Deletion of the GRS1 CRM results in 
precocious termination of Grem1 expression. (E) Skeletal preparation of WT and 
Grem1∆ORF/∆GRS1 E14.5 limbs. Black scale bars: 90µm. 
 
6.2.6. Identification of a SMAD4 controlled gene regulatory 
network in early limb buds 
Combination of the genomics analysis at E9.75-E10.0 (chapter 6.2.4) with the 
results of the WISH screen (appendix 12.5) identified many novel SMAD4 
targets genes with functions in early limb bud patterning (Figures 18 and 19). 
This network of SMAD4 transcriptional targets down-regulated in the Smad4∆/∆c 
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forelimb buds (Figures 18 and 19A) contains known targets of BMP signal 
transduction such as the Id genes (Id1, Id2 and Id3, Hollnagel et al., 1999; 
Korchynskyi and Dijke, 2002), Msx2 (Brugger et al., 2004) and the inhibitory 
SMADs, Smad6 and Smad7 (Zhao et al., 2000). Interestingly, while Grem1 
expression is down-regulated (Figure 4, Bénazet et al., 2012), the BMP 
antagonist Smoc1 is up-regulated in Smad4∆/∆c forelimbs (Figure 18). In 
addition, several genes functioning in limb bud patterning are down-regulated in 
early Smad4∆/∆c forelimb buds (Figures 18 and 19A) such as Tbx2 (Nissim et 
al., 2007), Lhx2 (Tzchori et al., 2009), Alx4 (Kuijper et al., 2005), and Pkdcc 
(Probst et al., 2011a). In particular some of the down-regulated genes have 
been associated with congenital limb skeletal malformations. These genes 
include Sfrp2 (Morello et al., 2008), Snai1 (Chen and Gridley, 2013) and Prrx2 
(Taher et al., 2011).  
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Figure 18: SMAD4 target genes involved in early limb bud patterning. 
Heatmaps: blue and red boxes represent the down- and up-regulation, respectively, 
normalized to the expression mean in WT samples. WISH analysis of SMAD4 target genes 
involved in early limb bud patterning in WT and Smad4∆/∆c forelimbs. The scale bars 
represent 100µm. Asterisks show up or down-regulation in the anterior part of Smad4∆/∆c 
forelimbs. 
 
Several of the transcriptional targets of SMAD4 are up- or down- regulated 
specifically in the anterior forelimb bud mesenchyme of Smad4-deficient 
forelimb buds such as Smoc1, Tbx2, Snai1, Mxd4, Smad7, Id1, Id2, Msx2, Alx4 
and Prrx2 (Figures 18 and 19A, asterisks). This suggests that SMAD4 controls 
the GRNs mainly in the anterior mesenchyme, which points to potential 
functions in patterning the anterior limb bud. Furthermore, we have checked the 
regulatory potential of some of the CRMs associated with SMAD4 target genes 
using LacZ reporters in transgenic founder embryos. Interestingly, two main 
LacZ expression patterns were identified. Either the LacZ pattern recapitulates 
major aspects of the spatial expression of associated SMAD4 target gene (see 
e.g. Id1 and Msx2) or LacZ expression is restricted to the anterior limb bud 
mesenchyme (see Id2, Lhx2, Alx4, Prrx2 and Pkdcc, Figure 19A). This analysis 
corroborates the idea that SMAD4 directly controls the expression of patterning 
genes predominantly in the anterior limb bud mesenchyme. Most importantly, it 
identifies a SMAD4-controlled GRN network in the anterior mesenchyme of 
early forelimb buds (Figure 19B). 
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Figure 19: The limb patterning network controlled by SMAD4. 
(A) Snapshots of SMAD4 bound CRMs and corresponding ATAC-seq profile are shown on 
the left. LacZ activity associated with these CRMs in embryonic limb buds at E10.5. The 
heatmaps show the relative expression changes as coloured boxes, normalized to the 
expression mean in WT samples. WISH for the associated SMAD4 target. The scale bars 
represent 100µm. Asterisks indicate the altered expression in the anterior part of the 
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Smad4∆/∆c forelimbs. (B) The gene regulatory network controlled by SMAD4 which is 
involved in early limb bud patterning. 
 
6.2.6. SMAD4 controls the expression of enzymes in the 
cholesterol biosynthesis pathway 
The most surprising discovery of our analysis was that SMAD4 controls the 
expression of many enzymes involved in cholesterol biosynthesis pathway, as 
almost all of them are down-regulated in Smad4∆/∆c forelimb buds at early 
stages (Figure 20A and 20B). Next, I checked their spatial expression patterns 
in WT and Smad4∆/∆c forelimbs (Figure 20C). This showed that most of these 
enzymes are expressed at only low levels and in a rather uniform manner 
during limb bud development, which precluded detection of spatial differences 
in expression (data not shown). However, for some genes such as Pmvk, 
Dhcr7, Mvd, Pcsk9, Tm7sfr2 or Sc5d the transcriptional down-regulation can be 
detected in forelimb buds lacking Smad4 expression (Figure 20C). This down-
regulation of enzymes functioning in cholesterol biosynthesis indicated that the 
cholesterol production by Smad4∆/∆c limb bud mesenchymal cells could be 
altered. 
To detect potential alterations in cholesterol and its intermediates, a quantitative 
Gas-Chromatography / Mass Spectrometry (GC/MS) analysis using WT and 
Smad4∆/∆c forelimb buds was done in collaboration with Prof. Dorothea Hass, 
University Children's Hospital, Heidelberg, Germany. This analysis showed that 
sterol intermediates lanosterol, demosterol, lathosterol and 7DHC (Appendix 
12.6) seemed slightly increased if comparing Smad4∆/∆c to the WT forelimb 
buds at different embryonic stages. Unfortunately, the differences were not or 
barely significant with exception of the increased lanosterol and demosterol 
levels in forelimb buds at E11.0 (Appendix 12.6). The trend toward 
accumulation of sterol intermediates could be a consequence of the significantly 
reduced expression of the enzymes functioning in cholesterol synthesis in 
Smad4-deficient forelimb buds, as it is the case for different congenital 
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metabolic diseases that affect cholesterol synthesis (Porter and Herman, 2011). 
The quantity of cholesterol followed the same trend in the Smad4∆/∆c forelimb 
buds, but the differences were only significant only at E11.0 (Appendix 12.6). 
While these results are intriguing, they also indicate that the GC/MS method 
may not be sensitive enough to detect quantitative differences of sterol 
intermediates and cholesterol in early mouse forelimb buds as the only 
significant differences were seem in more advanced forelimb buds. 
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Figure 20: The enzymes essential for cholesterol synthesis are down-regulated in 
Smad4∆/∆c forelimbs. 
(A) Schematic representation of the cholesterol synthesis pathway. The down-regulated 
enzymes in Smad4∆/∆c forelimbs are indicated in red and the main cholesterol intermediates 
in bold. The blue asterisks show the direct targets of SMAD4. (B) Heatmap showing the 
down-regulation of genes involved in the cholesterol biosynthesis in WT and Smad4∆/∆c 
forelimbs (normalized to the expression mean in WT samples). The blue asterisks indicate 
the direct transcriptional targets of SMAD4. (B) WISH analysis of genes encoding enzymes 
of cholesterol biosynthesis in WT and Smad4∆/∆c forelimbs. Scale bars: 100µm. 
 
 
6.2.7. Graded SHH signalling and the expression of SHH 
targets in responding cells are altered in Smad4-
deficient forelimb buds 
The carboxy terminal cholesterol-modification of the SHH is crucial for its 
activity and spatial distribution (Hentschel et al., 2016). In limb buds, he SHH 
ligand that is produced by the ZPA cells in the posterior mesenchyme and the 
spead of its posterior to anterior graded distribution is restricted by modifying 
the ligand with cholesterol (Li et al., 2006). Because of the transcriptional 
changes that affect the cholesterol biosynthesis pathway in Smad4∆/∆c forelimb 
buds, I decided to check if the spread of the SHH ligand is altered in mutant 
limb buds. While the spatial distribution of Shh transcripts was not changed 
between E10.0 and E11.5 in Smad4-deficient forelimb buds (Figure 21A), 
immunohistochemical detection of the SHH ligand revealed a defect in the 
posterior to anterior spreading of the SHH ligand. While no differences are 
observed at E10.0, the SHH ligand remained more posteriorly restricted in 
Smad4-deficient forelimb buds at E10.5 in comparison to WT controls (Figure 
21B). At E11.5, the SHH ligand remains restricted and levels are increased 
most posteriorly in Smad4∆/∆c forelimb buds (Figure 21B).  
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Figure 21: The spread of SHH is altered in Smad4∆/∆c forelimb buds 
(A) WISH for Shh in WT and Smad4∆/∆c forelimbs from E10.0 to E11.5. (B) 
Immunohistochemical detection of SHH protein distribution in WT and Smad4∆/∆c forelimb 
buds. White scale bars: 100µm; black scale bars: 10µm. 
 
The spatio-temporal expression of three direct transcriptional targets of SHH 
signal transduction were assessed (Figure 22). The Gli1 expression levels, a 
direct effector of SHH signalling are not changed at E10.0 (Figure 22A). The 
Ptch1 expression domains is expanded distal-anteriorly in mutant forelimb buds 
in comparison to WT controls (Figure 22B) and is up-regulated in the 
transcriptome of Smad4∆/∆c forelimb buds at E10.0 (left panels, Figure 22B). In 
addition, the Hhip1 expression domain was enlarged and an ectopic posterior 
domain was observed (Figure 22C). By E10.5 and E11.5, the Ptch1 and Gli1 
expression domains appear more posteriorly restricted (Figures 22A and 22B) 
in agreement with the posterior restriction of the SHH ligand (Figure 21B left 
panels), while Hhip1 expression remains increased in the posterior 
mesenchyme at E10.5 and E11.5 (Figure 22C). As neither of these three SHH 
targets contains SMAD4 interacting CRM in their TADs (data not shown), the 
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transcriptional alterations observed in Smad4-deficient limb buds are caused by 
altered SHH signal transduction rather than being a direct effect of the Smad4 
deficiency on their transcriptional regulation. As the observed transcriptional 
alterations are quite dynamic (Figure 22), I decided to also assess the potential 
effects of altered cholesterol synthesis on the cellular response to paracrine 
SHH signalling using WT and Smad4 mutant limb bud cells in culture.  
 
Figure 22: Molecular responsiveness to SHH signalling is altered in Smad4∆/∆c 
forelimb buds 
Barplots show the fold change between WT and Smad4∆/∆c (from RNA-seq). Comparative 
WISH analysis of WT and Smad4∆/∆c forelimb buds from E10.0 to E11.5 for SHH 
transcriptional targets genes: Gli1, Ptch1 and Hhip1. Scale bars: 100µm. 
 
6.2.8. SHH signal transduction in Smad4∆/∆c limb bud cells 
depends on cholesterol 
In addition to SHH, Smoothened (SMO), the G-protein coupled receptor that 
activates SHH signal transduction is cholesterol modified. This modification is 
crucial for activation of SHH signal transduction. Binding of SHH to the 
transmembrane receptor PTCH1 supresses the inhibition of SMO by PTCH. 
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Cholesterol modification of SMO then changes its conformation and triggers a 
series of intracellular events that activate signal transduction (Huang et al., 
2016; Xiao et al., 2017). To study the potential effects of intracellular cholesterol 
concentration changes in mesenchymal cells from Smad4∆/∆c forelimb buds on 
the SHH signal transduction, we set-up a culture system for limb mesenchymal 
progenitors (LMPs). Forelimb buds were collected at E10.25 (32-34s) and 
following removal of the ectoderm and cell dissociation, they were plated in 
lipid-depleted medium in 2-wells of a 96 well plate. One well was treated with 
SAG, a SMO agonist which bypasses the cholesterol activation (Huang et al., 
2016), and the other well served as untreated control. I assessed SHH signal 
transduction 24hrs later by monitoring Gli1 and Ptch1 transcript levels using RT-
qPCR analysis (Figure 23A). If LMPs are cultured in lipid-free medium, the 
Smad4∆/∆c LMPs fail to maintain Ptch1 and Gli1 expression at levels 
comparable to the WT LMPs (Figure 23B). In cultures treated with SAG, the 
expression of both SHH transcriptional targets is comparable in LMPs from WT 
and Smad4∆/∆c forelimb buds (Figure 23B).  
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Figure 23: The response to SHH signal is altered in mesenchymal cells from 
Smad4∆/∆c limb buds. 
(A) Experimental design using cultured limb mesenchymal progenitors (LMPs) in lipid 
depleted medium for analysis. (B) Expression of the SHH transcriptional targets Gli1 and 
Ptch1 in LMPs without treatment or SHH antagonist SAG treatment. 
 
These studies show that Smad4∆/∆c LMPs are unable to maintain SHH target 
gene expression in lipid-depleted medium as a likely consequence of the 
significant down-regulation of the enzymes required for cholesterol 
biosynthesis. This indicates that the endogenous cholesterol synthesis is crucial 
for activating SHH signal transduction in LMPs from early mouse forelimb buds. 
Furthermore, bypassing cholesterol-dependent activation of SMO by SAG 
shows that the transcriptional targets Ptch1 and Gli1 are up-regulated to a 
similar extent in WT and Smad4∆/∆c LMPs, which indicates that the downstream 
components of the SHH signal transduction cascade are functional in Smad4∆/∆c 
LMPs 
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7. Discussion 
7.1. Unbiased genome-wide analysis of the 
SMAD4 cistrome 
As few direct transcriptional targets of the BMP/TGFβ signalling pathway were 
known, I combined SMAD4 ChIP-seq with open chromatin (ATAC-seq) and 
RNA-seq analysis to identify the SMAD4 cistrome and direct target genes 
during early mouse forelimb bud development. In particular, the Smad43xF allele 
used for ChIP-seq is a new and powerful tool to identify the CRMs interacting 
with the endogenous SMAD4 protein in vivo. 
Several previous studies aimed at gaining insights into how BMP/TGFβ 
signalling controls transcription of its targets using SMAD4 ChIP-on-chip 
approaches that focused on promoter regions (Fei et al., 2010; Koinuma et al., 
2009; Qin et al., 2009). These methods gave good first insights but are limited 
by their biased analysis that excludes SMAD4 binding sites in located in distant 
non-coding cis-regulatory regions. SMAD4 ChIP-seq studies were also done in 
different cell lines using commercial SMAD4 antibodies which revealed the 
difficulty to map the interactions of the endogenous SMAD4 protein with CRMs 
(Kennedy et al., 2011; Kim et al., 2011; Morikawa et al., 2011; Tsankov et al., 
2015). In contrast to commercial ChIP-grade SMAD4 antibodies, which do not 
work in limb buds, the SMAD43xF mouse is a powerful tool to perform in vivo 
ChIP-seq experiments with the endogenous SMAD4 protein. It allows to benefit 
of the excellent ChIP-grade mouse anti-FLAG antibody (Laurent et al., 2017; 
Osterwalder et al., 2014), bypassing the lack of efficient commercial SMAD4 
antibody, and avoiding any overexpression system that can potentially give rise 
to false positive interaction. 
The nucleo-cytoplasmic shuttling and the DNA weak binding of SMAD4 itself 
posed two main challenges with respect to the SMAD43xF ChIP-seq analysis 
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that I have done. This nucleo-cytoplasmic shuttling is controlled by a nuclear 
localization signal (NLS) and a nuclear export signal (NES) in the SMAD4 
protein (Reguly and Wrana, 2003). This dynamic sub-cellular localisation might 
be the cause of the dynamic functionality observed for SMAD4 by ChIP-seq in 
human embryonic stem cells (Kim et al., 2011; Tsankov et al., 2015) and can 
also contribute to the differences in the SMAD4 cistromes that I identified in 
forelimb buds at E9.75 and E10.5. Furthermore, the interactions of SMAD4 with 
DNA are rather weak, which might also be a consequence of the dynamics of 
nucleo-cytoplasmic shuttling (Shi et al., 1998). These SMAD4 particularities 
might explain that the SMAD4 cistrome is smaller in contrast to a classical 
transcription factor such as HAND2 
Direct and indirect interactions of SMAD4 with genomic DNA  
The enrichment of SMAD4 chromatin complexes in proximity to promoters is a 
known binding characteristic of SMAD proteins (Morikawa et al., 2013). 
Promoter-enhancer interactions are key to spatio-temporal regulation of 
transcription regulation and enhancers in developmental genes are often 
located very distant to the promoter. Therefore, we have decided to analyse not 
only proximal but also distant regions enriched in SMAD4 chromatin complexes. 
However, as promoter-promoter interactions are involved in transcription 
regulation (Joshi et al., 2015; Li et al., 2012), we have decided to considerate all 
the SMAD4 bound regions, even the ones located ±5kb from TSSs. 
The enrichment of a genomic region in SMAD4-containing chromatin complexes 
does not mean that SMAD4 directly interacts with the candidate CRM. Our 
HOMER (Heinz et al., 2010) de novo and known motif analysis of the SMAD43xF 
ChIP-seq datasets illustrates the complexity of SMAD4 interactions with DNA. 
Both E9.75 and E10.5 SMAD43xF ChIP-seq are enriched for the SMAD4, 
SMAD2 and SMAD3 consensus motifs containing the GTCT sequence that has 
been identified in hECS (Kim et al., 2011). In addition it has been shown in vitro 
that SMAD3 and SMAD4 directly bind the palindromic sequence GTCTAGAC 
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(Zawel et al., 1998). As SMAD2/3 are the R-SMADs acting down-stream of 
TGFβ, these results indicate that target regions might be shared between the 
TGFβ and BMP signalling pathways (Lee et al., 2000). The top-enriched motif 
from my analysis of forelimb buds at E9.75 is the specific SMAD4 binding motif 
that contains the CAGA box and a CG-rich sequence identified in promoter 
regions of previously identified targets of BMP signal transduction (Morikawa et 
al., 2013).  
In addition, the identified ASH1 motif is associated with the histone-lysin-N-
methyltransferase that regulates the H3K36me mark, which modulates the 
expression of Hox genes (Tanaka et al., 2011). The MYOD binding motif 
enriched in the SMAD4 cistromes at both limb bud stages is associated with 
local histone acetylation and the PU.1 identified in the E10.5 forelimb bud data 
set is also associated with regions enriched in monomethylation of H3K4 
(Morikawa et al., 2013). Taking together these results suggest that the SMAD4 
chromatin complexes might contain or be associated with co-factors that 
modulate chromatin accessibility at the level of histone modifcations. This could 
explain why a fraction some SMAD43xF ChIP peaks do not overlap with ATAC-
seq peaks. In addition, SMAD4 might interact with pioneer factors that function 
in opening chromatin to make it accessible for the transcription machinery 
and/or transcriptional enhancing complexes at SMAD binding sites (Morikawa et 
al., 2013).  
In the SMAD4 cistrome of forelimb buds at E10.5 the PKNOX1 (or PREP1) 
motif is also significantly enriched. PREP1 is a member of the TALE (three 
amino acid loop extension) superfamily together with the PBX transcription 
factors. PREP1 dimerizes with PBX1 to control the FGF and the Wnt signalling 
pathway in stem cells and is known to interact with SMAD4 (Laurent et al., 
2015, Bailey et al., 2004). As PBX transcription factors and PREP1 are crucial 
for the onset of limb bud development (Capellini et al., 2011), my results 
suggest that SMAD4, PREP1 and PBX1 interact directly during the onset of 
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limb bud development and establishment of the SHH/GREM1/FGF signalling 
feedback loop. 
These interactions of SMAD4 with different co-factors likely determines its 
functions in possibly altering chromatin states during activation of transcription 
in proximity to promoters or/and to regulate spatio-temproal aspects of gene 
expression by interacting with CRMs. This associations are likely cell-
type/lineage-specific and provides the dynamic specificity (Morikawa et al., 
2013) also detectable by comparing the SMAD4 cistromes in forelimb buds at 
E9.75 to E10.5. The differences in the enrichment of SMAD4 binding motifs 
between both limb bud stages overlap with the change from high to low BMP 
activity that occurs between initiation (≤E10.0) and propagation (≥E10.5) of the 
SHH/GREM1/FGF feedback signaling system. Furthermore, as phospho-
SMAD2 bind to its targets in a dose-dependent manner (Lee et al., 2011), we 
can speculate that this decrease in BMP activity triggers the change in the 
range SMAD4 target genes observed (see below). 
 
7.2. Transition from high to low BMP activity 
causes a change in the range of SMAD4 target 
genes in early limb buds 
 
The change from high to BMP low activity observed when the 
SHH/GREM1/FGF feedback signalling system is established (Bénazet et al., 
2009; Pignatti et al., 2014) is also clearly apparent in the changes of 
differentially expressed genes between WT and Smad4-deficient for limb buds 
within the 10hr time window analysed. With this short time window, we expected 
minimal fold changes in differential gene expression. Nevertheless, at E10.0, 
when the BMP activity is still high, we observe many more DEGs (669 genes) 
than at E10.5 (346 genes), and only 151 DEGs are shared between the two 
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limb bud stages. This drop of SMAD4 dependent gene regulation is apparent 
when focusing on the direct SMAD4 target genes. There are 306 direct SMAD4 
targets in forelimb buds at E9.75-10.0 in contrast to only 190 genes at E10.5. 
The two stages share only 26 direct SMAD4 target genes. This divergence fits 
with the two phases of BMP activity: i) during initiation of limb bud outgrowth 
(E9.0 to E10.0), high BMP results in high levels of SMAD4-dependent 
transcriptional regulation of target genes, while ii) the activity of 
SHH/GREM1/FGF feedback signalling system (E10.5) lowers BMP activity, 
which in turn decreases SMAD4 dependent regulation of target genes. In 
addition, the range of SMAD4 target genes is different when BMP4 activity is 
low. The transition between these two phases occurs as a consequence of the 
BMP-dependent transcriptional activation of Grem1, which lowers BMP activity 
and antagonising BMP ligands (Bénazet et al., 2009) 
BMP activates Grem1 expression via SMAD4 
Grem1, a critical node in the SHH/GREM1/FGF feedback signalling system, is 
regulated in a complex but robust manner by the different CRMs located in the 
Grem1 sub-TAD. My analysis identifies an unexpected interaction of SMAD4 
chromatin complexes in Grem1 coding exon 2 and the corresponding SMAD4 
binding site overlaps a ASH1 motif (Figure 24). As discussed before ASH1 motif 
is associated with the histone-lysine-N-methyltrasnferase which regulates the 
H3K36me marks (Dorighi and Tamkun, 2013). Indeed, there is an enrichment of 
H3K36 methylation in the Grem1 coding exon 2 at E10.5, which is characteristic 
for transcribed exons (Wagner and Carpenter, 2012). During transcriptional 
elongation, RNA polymerase II (Pol-II) recruits the Rpd3S histone deacetylase 
to remove histone acetylation marks in transcribed regions in a H3K36me 
dependant manner (Lee et al., 2013). Lee et al. (2013) shows that chromatin 
remodelling by modulating nucleosomal spacing with H3K36me, is crucial for 
Rsp3S functions and Pol-II mediated transcriptional elongation. Taken together, 
these results indicate that SMAD4 might be part of the chromatin complexes 
that recruit ASH1 to coding exon 2 of the Grem1 transcription unit to rearrange 
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the chromatin and induce H3K36 methylation. By this mechanism the Grem1 
coding region would be deacetylized by Rpd3S, which then allows the 
continuation of Grem1 transcription in a SMAD4-ASH1 independent manner. 
This hypothesis would explain the dynamics of the SMAD4 interactions with 
Grem1 coding exon 2 and the lack of open chromatin and histone acetylation. 
Unfortunately, the H3K36me ChIP-seq profile for E9.5 forelimb buds is not 
available, which would be needed to understand if the H3K36 methylation of the 
Grem1 coding exon 2 is indeed higher at E9.5 than E10.5 similar as seen for its 
dynamic interactions with SMAD4 complexes. Transcriptional regulation through 
fine-tuning Pol-II activity would constitute a novel SMAD4 function, but as the 
current analysis focused on the interaction of SMAD4 complexes with regions of 
open chromatin, I would have missed other target genes whose expression 
initiation could be SMAD4-H3K36me sensitive. This chance observation of the 
binding to coding exon 2 of Grem1 paves the way for an interesting follow-up 
analysis. 
 
 
Figure 24: Grem1 coding exon 2 is decorated with H3K36me marks 
UCSC genome browser view of the Grem1 locus (mm10): alignment of the ASH1 motif, the 
SMAD4-3xF ChIP-seq peak (E9.75 and E10.5) and the H3K36me ChIP-seq profiles 
(E10.5, E11.5 and E12.5, ENCODE). Note that the Grem1 coding exon 2 is enriched in 
SMAD43xF chromatin complexes encompassing the ASH1 motif and decorated by H3K36 
methylation only at E10.5. 
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After initiation, the expression of Grem1 is regulated in a dynamic spatio-
temporal fashion as limb bud development progresses. This fine regulation 
needs to be robust as loss of Grem1 expression results in drastic phenotypes 
(Zuniga et al., 2004). It appears that this dynamic expression is orchestrated by 
the many CRMs present in the Grem1 genomic landscape, which likely have 
differential and/or redundant activities. Deletion of the GRS1 element 
uncovered its role during up-regulation and termination of Grem1 expression. 
However, we can not exclude a more general role that is not revealed by its 
deletion as several CRMs might function in a similar and/or redundant manner 
(Cannavò et al., 2016). We are deleting other CRMs individually or in 
combination to test the robustness of the system and to understand how the 
dynamics of Grem1 expression is regulated (this study is done by Laurène 
Ramos Martins). 
However, these candidate CRMs can only contribute to the spatiotemporal 
regulation if they can interact with the Grem1 promoter. Many studies have 
identified CRMs regulating gene expression that located many kilobases away 
from the relevant promoter and TSS (Lettice et al., 2003; Zuniga et al., 2012). 
The 3D architecture of chromatin is important for these interactions. In 
particular, chromatin loops within TADs allow specific interactions of CRMs with 
the respective promoter. This looping depends on CTCF and Cohesin binding 
sites that drive the 3D conformation of the chromatin and organize the TADs 
(Rao et al., 2014). The orientation of the CTCF binding sites is responsible for 
the intra-TAD chromatin configuration and establishing boundaries between 
TADs. A chromatin loop can be formed between two converging CTCF and a 
TAD boundary is formed between two diverging CTCF (Gómez-Marín et al., 
2015; Rao et al., 2014). Six such structural elements are present in the Grem1 
genomic landscape. Using these data, I have been able to come up with two 
possible models for the 3D architecture of the Grem1 genomic landscape: i) the 
first is the “loop in the loop” model (Figure 25A), ii) the second is the “loop and 
loop” model (Figure 25B). In both cases, the CRMs interacting with either with 
HoxA13, GLI3 or SMAD4 in closer proximity and able to interact with the Grem1 
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promoter. However, the in situ Hi-C profile from B-lymphoblastoid cells (Rao et 
al., 2014) points to the formation of a small loop in a bigger loop (Figure 25C), 
which is in favour of the “loop in the loop” model.  
 
 
 
Figure 25: Models for the likely chromatin configuration of the Grem1 genomic 
landscape 
Two basic chromatin configurations are possible at the Grem1 locus. (A) Scheme of the 
“Loop in the loop” model for the 3D chromatin architecture. The CTCF/Cohesin binding 
sites are indicated by the blue arrows (I to VI), the functionally relevant CRMs by grey 
boxes. Regions enriched in HoxA13 chromatin complexes are indicated in yellow, the GLI3 
interaction regions in pinks and SMAD4 binding regions in green. The Grem1 exons are 
represented by the dark blue boxes. (B) “Loop and loop” model. (C) In situ Hi-C profile for 
the Grem1 genomic landscape in human B-lymphoblastoid cells (Rao et al., 2014). The 
loop calling is represented by the yellow squares. The smaller loop is within the bigger loop, 
which is in support of the “Loop in the loop” model. 
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As there is good evidence that many chromatin interactions and contacts are 
conserved between cell types and during evolution (Rao et al., 2014; 
Vietri Rudan et al., 2015), I propose the “loop in the loop” model as more 
feasible model for the 3D chromatin architecture at the Grem1 locus. Within this 
conceptual framework, the different CRMs detect the information from signalling 
inputs and interact with the Grem1 promoter in a dynamic and temporally 
controlled manner as limb bud development progresses. 
 
7.3. SMAD4 has multiple functions during early 
limb bud development 
The unbiased WISH screen and genome wide-analysis of the SMAD4 
transcriptional targets has allowed me to identify the limb bud GRNs controlled 
by SMAD4. These SMAD4 GRNs include known BMP targets such as Id1, Id2, 
Id3 (Hollnagel et al., 1999), Msx2 (Brugger et al., 2004), Smad6 and Smad7 
genes (Benchabane and Wrana, 2003; Ishida et al., 2000), which validate the 
unbiased analysis and identified GRNs. More importantly, my analysis identified 
many novels SMAD4 targets, the majority of which are linked to limb defects 
and have established functions in different processes during mouse limb bud 
development. 
First, my analysis identifies an additional BMP antagonist called Smoc1 
(Rainger et al., 2011) as a direct SMAD4 target in early limb buds. Interestingly, 
Smoc1 expression is negatively regulated by SMAD4, which contrasts with the 
positive regulation of the BMP antagonist Grem1. This balance between 
SMAD4-mediated activation and repression of BMP antagonists likely reflects 
the fine-tuned auto-regulation of the spatial BMP activity in early limb buds. 
During the onset of limb bud development, BMP signalling via SMAD4 inhibits 
Smoc1 in the anterior and induces Grem1 in the posterior limb bud 
mesenchyme. This indicates that the anterior part remains free of BMP 
antagonists, which enables BMP/SMAD4 to regulate the expression of their 
 
92 
anterior target genes, which is corroborated by the early down-regulation of 
many SMAD4 target genes in the anterior of Smad4-deficient limb buds. In 
contrast, the BMP/SMAD4-mediated induction of Grem1 in the posterior 
mesenchyme results in the establishment of the SHH/GREM1/AER-FGF 
feedback signalling system.  
The Wnt inhibitor Sfrp2 is also a direct SMAD4 target, whose expression is 
down-regulated in the Smad4∆/∆c forelimb buds as other Wnt antagonists like 
Dkk1 or Wif1 (my study and Klaus and Birchmeier, 2008). The inhibition of Wnt 
signalling decreases in Smad4 mutant limb buds, which indicates a direct and 
indirect regulation by SMAD4. Wnt signalling participates in limb bud initiation 
and outgrowth by interfering with the FGFs that induce the AER and promote 
proliferation of the limb bud mesenchyme (Geetha-Loganathan et al., 2008). 
Therefore, the reduced Wnt inhibition in Smad4 deficient limb buds might 
explain their slightly increased size (Bénazet et al., 2012). 
A significant fraction of SMAD4 targets are related to the establishment of axes 
polarity during initiation of limb bud outgrowth. The coordinated establishment 
and outgrowth of the three axes depends on feedback interactions and SMAD4 
could be one of common transcriptional regulators involved in controlling their 
coordinated growth and patterning. For example, Tbx2 and Alx4 are SMAD4 
targets that are part of the limb patterning GRN and function in AP limb bud axis 
patterning by restricting Shh expression in the ZPA (Kuijper et al., 2005; Nissim 
et al., 2007). Furthermore, Pkdcc participates to the PD axis patterning by it 
being also regulated by retinoic acid signalling, which proximalizes the early 
limb bud (Probst et al., 2011b). Members of the LIM homeobox TF family, such 
as the SMAD4 target Lhx2, function in the coordinated control of all three axes 
during limb bud outgrowth (Tzchori et al., 2009). Finally, the SMAD4 
transcriptional targets Snai1 and Prrx2 have important functions during early 
limb bud development. However, as there is functional redundancy with Snai2 
and Prrx1 respectively, only double mutants in which both paralogues have 
been inactivated show strong limb phenotypes (Chen and Gridley, 2013; Taher 
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et al., 2011). In summary, my analysis identifies the limb bud GRN of SMAD4 
target genes, which reveals how the direct targets have diverse roles in key 
processes such as AER formation, LMP proliferation and axis patterning 
7.4. SMAD4 controls the embryonic cholesterol 
biosynthesis and thereby modulates SHH 
signalling 
The analysis of the SMAD4 target genes identified a second, rather unusual 
limb bud GRN that controls cholesterol biosynthesis by LMPs. 
 
The embryonic cholesterol biosynthesis is enhanced by SMAD4 
before the initiation of the SHH/GREM1/FGF feedback signalling 
system 
My analysis establishes that SMAD4 directly and positively regulates the 
expression of several enzymes in the cholesterol synthesis pathway in early 
limb buds. In addition, SMAD4 also controls the expression of the sterol 
regulatory element binding transcription factor 1 (Srebf1), which a master 
regulator of these enzymes (see chapter 4.4.). These genes are significantly 
down-regulated in early Smad4-deficient limb buds (E10.0) as by E10.5 levels 
in wild-type become similarly to mutant limb buds (Figure 26). This reveals the 
early precocious down-regulation of several of these enzymes involved in 
cholesterol synthesis in Smad4-deficient forelimb buds. This analysis shows that 
SMAD4 is directly required to up-regulate several of the enzymes of the 
cholesterol synthesis during initiation of limb bud development prior to 
establishment of the SHH/GREM/FGF feedback signalling system (Figure 26). 
This shift from SMAD4-dependent enhancement of cholesterol synthesis during 
the onset of limb bud development to its decrease during feedback signalling 
points to specific roles during limb bud development. 
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Figure 26: The expression of the enzymes for cholesterol biosynthesis in early limb 
buds is increased prior to establishing the feedback signalling system  
Scheme showing the dynamic transcriptional regulation of the cholesterol biosynthesis 
enzymes in WT (black line) and Smad4∆/∆c (blue line) forelimb buds between E10.0 and 
E10.5. The scheme below shows the signalling interactions (E10.0) before and after 
establishing the SHH/GREM1/AER-FGF feedback signalling system. Blue: BMP activity; 
yellow: SHH; red: GREM1; green: AER-FGF signalling. Between the WT and the Smad4∆/∆c 
forelimb buds, the differences in expression of cholesterol biosynthesis enzymes is only 
apparent during the onset of limb bud development. 
 
 
Balancing embryonic cholesterol synthesis with uptake of maternal 
cholesterol 
Postnatally, the adjustment of plasma cholesterol levels is crucial as an excess 
is linked to an increased risk of cardiovascular diseases. The strict regulation of 
plasma cholesterol levels depends on the intracellular balance between 
cholesterol synthesis and cholesterol uptake. It has been shown that treatment 
with statins (a HMG-CoA reductase) directly inhibits cholesterol synthesis but 
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indirectly increases the cholesterol uptake by cells (Cohen, 2008, Kostner, 
2007). 
Cholesterol levels of cells and tissues that synthesize and take up cholesterol 
are controlled by regulatory feedback, which provides a possible straight 
forward explanation to the observed trend that cholesterol accumulation in 
Smad4∆/∆c forelimb buds in spite of the decreased expression of cholesterol 
synthesis enzymes (GC/MS appendixes 12.6, Figure 20B). As they are down-
regulated in the Smad4-deficient forelimb buds, the cholesterol uptake may 
simply increase to balance the deficiency. During the developmental stages 
relevant to my analysis, the mouse embryo starts to synthetize its own 
cholesterol but still depends on maternal cholesterol (Woollett and Heubi, 2000, 
2008). In Smad4∆/∆c forelimb buds the cholesterol uptake is likely enhanced 
further as the expression of another direct SMAD4 target, Pcsk9 is also down-
regulated. The PCSK9 enzyme modulates the amount of LDL-receptors (LDL-
R) by controlling their degradation (see Chapter 4.4.) and its down-regulation 
may result in an increase of LDL-R levels in membranes of LMPs, which would 
increase their cholesterol uptake (Figure 27). As this is a working hypothesis 
and the situation may be more complex, I plan to directly assess the potential 
higher levels of LDL-R on cell membranes of Smad4-deficient LMPs using 
FACS analysis. 
 
Altered cholesterol levels affect SHH signal transduction  
One of the main functions of cholesterol during development is the regulation of 
SHH signalling. It was shown that cholesterol modification of the SHH signalling 
peptide restricts its posterior to anterior spread in the limb bud. If the cholesterol 
modification is disrupted, the graded distribution of SHH gradient expands 
anteriorly in limb buds (Li et al., 2006a). My analysis shows that while the Shh 
expression is not changed, the SHH ligand remains more posteriorly restricted 
during progression of Smad4 deficient limb bud development. This is a likely 
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consequence of the tendency to increased cholesterol accumulation. Hence, 
the expression domains of the SHH transcription targets Gli1 and Ptch1 
remains also more posteriorly restricted. One possibility is that the SHH protein 
is “hyper-cholesterol-modified” in Smad4 mutant limb buds due to the increased 
uptake. To directly evidence the potential hyper-cholesterylation of the SHH 
ligand I plan to assess the cholesterol modification of SHH by comparative 
Western blot analysis of WT and Smad4∆/∆c forelimbs. 
However, the cholesterol modification is also involved in SMO activation and 
thereby in the stimulation of the SHH signal transduction in responding cells 
(Huang et al., 2016; Xiao et al., 2017). In early Smad4∆/∆c forelimb buds, SHH 
signal transduction could be enhanced by increasing SMO activity in agreement 
with the observed transcriptional up-regulation of the SHH target genes Hhip1 
and Ptch1. However, Gli1 is not up-regulated at these early stages, but the 
differential effect on Gli1, Ptch1 and Hhip1 expression in Smad4∆/∆c forelimbs 
can be explained by differences in GLI binding sites in the CRMs regulating the 
differential response of these three genes. It is indeed known that low and high 
affinity GLI binding sites are responsible for differential responsiveness to SHH 
signalling (Cohen et al., 2014; Oosterveen et al., 2012; Parker et al., 2011; 
Peterson et al., 2012). Furthermore, we have noticed that Ptch1 is more 
sensitive to changes in SHH activity than Gli1. Hence, Ptch1 is a better readout 
for SHH signal transduction than Gli1 (data not shown). In particular, in early 
mouse forelimb buds at E10.0, the kinetics of Ptch1 and Hhip1 up-regulation 
might be faster than for Gli1 in early mouse forelimb buds. Furthermore, in 
contrast to the GLI1 transcriptional activator, both PTCH1 and HHIP1 are strong 
SHH ligand antagonists (Jeong and McMahon, 2005). The observed early 
enhancement of SHH activity in Smad4-deficient limb buds will up-regulate the 
expression of both antagonists PTCH1 and HHIP1, which in turn will inhibit SHH 
signalling. This provides a straightforward explanation for the decrease in Ptch1 
expression and the up-regulation of Hhip1 during Smad4∆/∆c limb bud 
development progresses. Finally, as PTCH1 and HHIP1 limit the spread and 
SHH signal transduction in the neural tube (Ribes and Briscoe, 2009), the up-
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regulation of Ptch1 and Hhip1 in Smad4∆/∆c forelimbs provides an alternate 
explanation for the more posteriorly restricted SHH ligand in mutant limb buds 
(Figure 27). 
 
Figure 27: Causes and consequences of maternal cholesterol addiction. 
SMAD4 directly regulates the cholesterol biosynthesis and uptake by positive regulation of 
the expression of cholesterol biosynthetic enzymes, Srebf1, Ldlr and Pcsk9 (black arrows), 
which are involved in embryonic intra-cellular cholesterol synthesis. Cross-regulation 
between these enzymes is indicated by grey arrows. In the E10.0 Smad4∆/∆c forelimb buds, 
these genes are down-regulated (dashed blue arrows). This results in increased LDL-R 
recycling, which in turn increases uptake of extra-cellular maternal cholesterol (=maternal 
cholesterol addiction; red arrows). This enhances both SHH signal transduction and 
increased posterior retention of the SHH ligand (orange arrows). Cholesterol depletion 
results in reduction of SHH activity (light grey arrows). 
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Are Smad4∆/∆c LMPs addicted to maternal cholesterol? 
In addition to observed alteration in vivo, I have been able to show that the 
culture of LPMs from Smad4∆/∆c and WT limb buds in lipid free medium disrupts 
the maintenance of SHH signal transduction in Smad4 deficient LMPs. These 
results indicate that Smad4-deficient LMPs depend on enhanced cholesterol 
uptake to maintain SHH signal transduction. As E10.0 mouse embryos are 
mostly depending on the maternal cholesterol (Woollett and Heubi, 2000), the 
Smad4∆/∆c LPMs might be dependent of the maternal cholesterol (Figure 27). 
Therefore, our results show that SMAD4 promotes the autonomous cholesterol 
production of the limb bud cells. This task might be crucial for a robust and fine 
regulation of SHH gradient and activity, independently of the maternal diet. 
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8. Conclusions and Outlook 
The major aim of my PhD research was to investigate of the roles of BMP 
signalling during the early limb bud development through the activity of the 
nuclear mediator SMAD4. Therefore, I have identified and functionally analysed 
the transcriptional gene regulatory networks controlled by SMAD4 during the 
onset of limb bud development. 
 
Figure 28: The gene regulatory network controlled by SMAD4 during the onset of 
limb bud development 
SMAD4 regulates limb bud developmental genes in the anterior limb bud (in blue), initiates 
Grem1 expression (in red) and regulates the SHH gradient and signal transduction by 
directly controlling cholesterol biosynthesis and uptake (in yellow). 
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Using different genome-wide approaches (ChIP-seq, ATAC-seq, RNA-seq), 
mouse molecular genetics and cell-biochemistry has allowed me to uncover and 
study the facets of SMAD4 functions during initiation of limb bud development. 
The different key functions of SMAD4 during early limb bud development are 
driven by high mesenchymal BMP activity. First, SMAD4 initiates Grem1 
expression, which is a key step in inaugurating the SHH/GREM1/FGF feedback 
signalling system that regulates limb bud outgrowth and proliferative expansion 
and patterning of mesenchymal progenitor. By activating Grem1 in the posterior 
and restraining Smoc1 in the anterior, SMAD4 creates an BMP antagonist-free 
region specifically in the anterior limb bud mesenchyme. This in turn allows 
BMPs to regulate the expression of many genes involved in the anterior part of 
the early limb bud by SMAD4-mediated transcriptional regulation. Most 
interestingly, SMAD4 directly fine-tunes the spatial distribution of the SHH 
ligand, reception and transduction of the SHH signal in early limb buds by 
directly controlling the expression of genes involved in embryonic cholesterol 
biosynthesis and uptake of maternal cholesterol. These multi-functional control 
of the onset of limb bud development by SMAD4 is crucial to correct 
establishment of the feedback signalling system and orderly progression of 
subsequent limb bud development. 
I have discovered in vivo this novel role of BMP/SMAD4 mediated signal 
transduction in regulating SHH signalling via controlling cholesterol synthesis 
and levels during the onset of limb bud development. We are now wondering 
whether the BMP/SMAD4 mediated control of cholesterol metabolism and SHH 
signal transduction is a limb bud-specific or general mechanism. The 
developing spinal cord is another excellent model to study the opposing effects 
of the BMP and SHH signalling pathways (Jessell, 2000). Therefore, we have 
established a collaboration with Dr. Anna Kicheva (IST, Vienna, Austria) to 
investigate the effects of the Smad4 deficiency in the neuronal progenitors of 
the spinal cord using an inducible Sox2-CRE transgene for spatio-temporally 
controlled inactivation. A recent paper shows that inactivating the cholesterol 
modification of SMO alters the identity of the ventral neuronal progenitors in the 
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spinal cord (Xiao et al., 2017). This study encourages us to investigate if 
SMAD4-mediated regulation of cholesterol biosynthesis also impacts on SHH 
signal transduction and neuronal patterning in the developing spinal cord. 
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9. Materials and Methods 
9.1. Mouse husbandry and embryo analysis 
9.1.1. Ethics statement 
All experiments with mice were performed with strictly respecting Swiss laws, 
the 3R principles and of the Basel Declaration. They were classified as grade 0, 
which implies no or only minimal suffering. The researchers are licensed for 
animal experimentation by successfully completing the LTK-1 course and 
fulfilling the continuing animal education course requirements. 
9.1.2. Mouse strains 
For this study, the following mouse strains were used: the Grem1 null (Michos 
et al., 2004), Smad43xF (generated by Frédéric Laurent) and Prx1-Cre transgene 
(Logan et al., 2002) alleles, which are maintained in a NMRI background. The 
Smad4 conditional (Smad4flox/flox, Yang et al., 2002) allele is maintained in a 
mixed background. To inactivate Smad4 in the mesenchyme, Prx1-CreTg/+ mice 
were crossed with mice carrying the Smad4∆ allele to generate the Prx1-
CreTg/+Smad4∆/+ mice. Prx1-CreTg/Tg Smad4∆/+ males were crossed with 
Smad4flox/+ females to obtain experimental embryos that carry a constitutive 
Smad4 null allele and a conditionally inactivated Smad4 allele (Prx1-
CreTg/+Smad4∆/∆c, referred as Smad4∆/∆c), and control embryos (Prx1-
CreTg/+Smad4+/+, referred as WT). All mice and embryos were genotyped by 
PCR using the primers listed in Table 9.7.2. 
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9.1.3. Generation of LacZ reporter transgenic embryos 
Candidate CRM regions were amplified by PCR from mouse genomic DNA (for 
primers see Table 9.7.1). They were then cloned into a Hsp68-LacZ reporter 
vector using the Gibson Assembly® Method (performed by Jens Stolte). 
Transgenic embryos were generated by pronuclear injection at the Center for 
Transgenic Models, Basel. Founder embryos were stained for LacZ activity as 
described below. 
9.1.4. Whole-mount LacZ staining of mouse embryos 
Embryos were isolated in ice-cold PBS and staged by counting their somite 
numbers, before fixation in 1% formaldehyde, 0.2% glutaraldehyde, 0.02% 
NP40, 0.01% sodium deoxycholate in PBS for 20 min at 4°C. Embryos were 
then washed 3 times in PBS for 5min at room temperature (RT), and incubated 
for at least 4hrs in the dark in 1mg/mL X-Gal in dimethyl formamide, 0.25mM 
K3Fe(CN6), 0.25mM K4Fe(CN6), 0.01% NP40, 0.4mM MgCl2. Cells expressing 
β-galactosidase activity turn blue. The reaction was stopped by washing the 
embryos 3 times in PBS for 5min at RT. 
9.1.5. Whole-mount in situ hybridization (WISH) 
Embryos were isolated in cold-PBS and transferred in a 2mL Eppendorf tube to 
be fixed overnight in 4% paraformaldehyde (PFA) in PBS at 4°C. The next day 
they were rinsed twice in PBS-0.1% Twen-30 (PBT) and dehydrated in a graded 
series of 25%, 50%, 75% MetOH/PBT and 2 times in 100% MetOH (5min 
each). The dehydrated embryos were stored at -20°C in 100% MetOH. For the 
first day of the WISH, embryos were rehydrated in reverse gradient series of 
75%, 50%, 25% MethOH/PBT and washed twice in PBT (5min each). Embryos 
were bleached in 6% hydrogen peroxide (H2O2)/PBT for 15min and washed 3 
times in PBT (5min each). This step was followed by treatment with 10µg/mL 
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proteinase K in PBT for 15min. To inactivate the proteinase K, embryos were 
washed with fresh 2mg/mL glycine in PBT for 5min. After 2 washes in PBT 
(5min), embryos were re-fixed in fresh 0.2% glutaraldehyde, 0.1% Tween-20 in 
4% PFA (in PBS) for 20min, and rinsed again twice in PBT (5min). Then, they 
were equilibrated in 2mL of prewarmed prehybridization buffer (50% deionized 
formamide, 5xSSC pH 4.5, 2% BCl blocking powder, 0.1% Tween-20, 0.5% 
CHAPS (Sigma C3023), 50µg/mL yeast RNA (Sigma R8759), 5mM EDTA, 
50µg/mL heparin (Sigma H5515) at 70°C for at least 1hr. The prehybridization 
buffer was then replaced by 1mL of fresh prewarmed prehybridization buffer 
containing 10µl/mL of digoxigenin-labelled RNA riboprobe (see below) and 
incubated overnight at 70°C. 
On the second day, the riboprobe-containing prehybridization buffer was 
recovered and replaced by pre-warmed prehybridization buffer, followed by a 
series of 75%, 50% and 25% prehybridization buffer in 2xSSC (0.3M NaCl, 
0.03M sodium citrate pH 4.5). All these steps were performed for 5min at 70°C. 
Embryos were then washed twice in 2xSSC, 0.1% CHAPS for 30min at 70°C in 
a rotating wheel. To remove unbound RNA probe, embryos were treated with 
20µg/mL RNase A (Roche 10109169001) in 2xSSC,0.1% CHAPS for 45min at 
37°C. This was followed by 2 washes at RT of 10min using 100mM maleic acid 
disodium, 150mM NaCl pH 7.5. Then 2 additional washes at 70°C for 30min 
were done. Next, the embryos were washed for 3 times 5min each in fresh 
TBST (140mM NaCl, 2.7mM KCl, 25mM Tris-HCl pH 7.5, 1% Tween-20). 
Embryos were then blocked in 10% lamb serum/TBST for 1hr or more, at RT. 
This blocking solution was replaced with a solution containing anti-digoxigenin-
Alkaline Phosphatase Fab Fragments (Roche 11093274910) diluted 1:5000 in 
1% lamb serum in TBST. Embryos were incubated overnight at 4°C with gentle 
rocking. 
On the third day, embryos were washed 3 times in TBST for 5min and 5 times 
for 1hr to 1.5hrs at RT. The last wash was overnight at 4°C.  
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On the fourth day, the embryos were equilibrated 3 times in NTMT (100mM 
NaCl, 100mM Tris-HCl pH 9.5, 50mM MgCl2, 1% Tween-20) for 10min each, 
and transferred into 1mL of BM purple Alkaline Phosphatase substrate (Roche) 
at RT. The in situs were developed in the dark and checked roughly every hour 
until reaching appropriate probe-specific signal intensity. The development was 
stopped by washing the stained embryos 5 times in PBT (10min) and twice in 
PBS. Pictures were taken using a Leica MZ FLII stereomicroscope and the 
Leica Application Suite V3 software. Embryos were stored in 4% PFA (in PBS) 
at 4°C. 
9.1.6. Digoxigenin-labelled RNA probe preparation 
The plasmids containing the cDNA of interest were linearized and transcribed 
using the appropriate T3, T7 or SP6 RNA polymerase with the DIG RNA 
labelling kit (Roche). The dig-UTP riboprobes were purified using the mini Quick 
Spin RNA columns (Roche). For the WISH screen, all cDNAs of interest were 
generated by PCR amplification (see Table 9.7.4.) using primers that include 
the binding site for SP6. After transcription, riboprobes were also purified. 
Before use, the riboprobes were heated at 85°C for 5min and equilibrated in 
prehybridization buffer at 70°C. Probes in prehybridization buffer were stored at 
-20°C and re-used several times. 
9.1.7. Culture of limb mesenchymal progenitors (LMPs) 
Forelimbs (32-34 somites) were collected in ice-cold PBS and incubated in cold 
2% Trypsin (Gibco 15090-046)/PBS at 4°C for 30min. The reaction was 
stopped by adding an excess of EMFI medium containing serum: DMEM (Gibco 
41966029) containing 4.5g/L Glucose (Gibco 41966-029), 10% FCS 
(PanBiotech P30.3302), 100U Penicillin, 0.1mg/mL Streptomycin (Sigma P-
0781) and 200mM L-Glutamine (Sigma G-7513). The limb bud ectoderm was 
removed using forceps and a sharp dissection needle. Limb buds were 
transferred into a 1.5mL tube containing 500µL EMFI medium and dissociated 
as single cells by pipetting up-and-down. Limb bud cells were centrifuged at 
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2.5rpm for 5min at 4°C. After resuspending the pellet into 500mL EMFI medium 
using lipid depleted FCS (see protocol below), cells were plated in two wells of 
a 96 well plate. After 8-9hrs of culture, one well of each duplicate was treated 
for 24hrs 0.5µM SAG (Millipore 566660) to activate SHH signal transduction. 
The day after, cells were harvested, flash frozen in RLT buffer (Quiagen) and 
stored at -80°C for subsequent RNA extraction and RT-qPCR analysis. 
Lipid depleted FCS preparation: 500mL FCS were stirred overnight at 4°C with 
10g Cab-osil M-5 (ACROS Organics 7631-86-9). The mix was then centrifuged 
for 10min at 3000rpm and the supernatant filtrated under sterile conditions. 
Insulin-Transferrin-Sodium-Selenite media supplement (Sigma I-1884-1) was 
dissolved in 50mL water, acidified by adding 250µL HCl and filtrated under 
sterile conditions. 25mL of the Insulin-Transferrin-Sodium-Selenite solution was 
added to 500mL of lipid depleted FCS. Aliquots of 30mL were frozen at -20°C 
and used for preparing lipid depleted EMFI medium. 
9.1.8. Limb bud collection for GC/MS 
E10.0 (30 somites), E10.5 (35 somites) and E11.0 (40 somites) forelimbs were 
collected in ice-cold PBS. Two forelimbs from one embryo were recovered with 
a P1000 pipette and flash frozen in a drop of PBS into a 2mL Eppendorf tube 
containing liquid nitrogen. After evaporation of the liquid nitrogen forelimbs were 
stored at -80°C. 
9.1.9. Skeletal preparations 
The skeletal preparations were done by Nathalie Riesen. E14.5 embryos were 
isolated in ice-cold PBS and euthanized by cutting the head. They were 
incubated overnight in tap water at room temperature. The day after, embryos 
were scalded in hot water (65-70°C) for 20-30 seconds, eviscerated (liver 
biopsies were taken for genotyping), and the skin of the limbs were peeled off. 
Embryos were then fixed in 95% ethanol for a minimum of 24 hrs. Alcian blue 
staining (30mg Alcian Blue 8GX (Sigma), 85% ethanol, 20% glacial acetic acid) 
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was performed overnight and followed by 3 washes in 95% ethanol on the 
second day. Embryos were then cleared in 1% potassium hydroxide (KOH) for 
10min, counterstained with Alizarin red (50mg Alizarin red (Sigma) in 1% KOH) 
for 1hr and cleared in 1% KOH for an additional hour. Embryos were then 
moved through progressively higher ratios of Glycerol:1% KOH (80:20, 60:40, 
40:60 and 20:80) according to their speed of clearing and stored in 80% 
glycerol in water. Pictures were taken using a Leica MZ FLII stereomicroscope. 
 
9.2. Generation of transgenic mice using 
CRISPR/Cas9 genome editing 
9.2.1. ES cell targeting 
The design of the CRISPR strategy and the targeting of ES cells were 
performed by Nathalie Riesen and Aimée Zuniga. SgRNA (see Table 9.7.6.) 
were designed using the website http://crispr.mit and were cloned in the px459 
vector. For transfection, 300000 G4 ES cells were plated in a 6cm dish on a 
monolayer of EMFIs in ES medium: DMEM (Gibco 41966029), 15% FCS 
(PanBiotech P30.3302), 100U Penicillin, 0.1mg/mL Streptomycin (Sigma P-
0781), 200mM L-Glutamine (Sigma G-7513), 1mM βMercapto-Ethanol (Gibco 
31350-010), 107U/mL EsGRO LIF (Gibco 13275-029), 1x Non-Essential Amino 
Acids (Gibco 11140-035), 100mM Sodium Pyruvate (Gibco 11360-39). The next 
morning, the medium was changed for 1.75mL ES medium per plate, and the 
evening cells were transfected by using the FuGENE method (Promega TM-
328). Plasmids (5µg) were diluted in 125µL OptiMEM (Gibco 51985-026) and 
25µL FuGENE were mixed with 100µL of OptiMEM. 125µL DNA-mixture was 
combined with 125µL of diluted FuGENE reagent and incubated for 15min at 
RT. 250µL of this mix were then added per dish. After 12hrs, the transfection 
was stopped by changing the medium, and 24hrs later cells were split into new 
6cm dishes (1:3) containing DR4 resistant feeders. Cells were selected using 
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puromycin (2µg/mL, Sigma P8833) for 48hrs, and then the medium was 
replaced by ES medium. The positive clones were grown for 4 to 6 days and 
picked to be expanded and screened for the correct deletion. The positive 
clones were used to generate transgenic mice by aggregation chimera. 
9.2.2. Superovulation of oocyte donor females  
On day 0, female NMRI mice of 13 weeks were injected intraperitoneally using 
25G needle with 5 IU PMSG (Pregnant Mare Serum Gonadotropin – Pregnyl 
from Organon). On day 2, mice were injected with 5 IU hCG (Folligon from 
Intervet). PMSG and hCG were dissolved in sterile PBS to 50 IU/mL and 
aliquots of 1mL were stored at -20°C. The hCG injection was done 46 to 47hrs 
after the PMSG injection and matings were set using these primed females and 
NMRI males. 
9.2.3. Pseudo-pregnant females  
On day 1, bedding from a NMRI male was added to each cage of NMRI 
females. Mating between these females and vasectomized males were set on 
day 3.  
9.2.4. ES cell preparation for aggregation  
ES cells for aggregation were prepared by Nathalie Riesen. On day 5, ES cells 
from a confluent 6 cm dish were trypsinized and dissociated by pipetting up and 
down in ES medium. Cells were then pre-plated for 30min to remove excess 
EMFIs. ES cells were collected and counted. After centrifugation (1200rpm, 
5min), ES cells were re-suspended to 1.5x106cells/mL in aggregation medium: 
18mL DMEM (Gibco 41966029), 66mg Ca-lactate (Sigma 21185) and 4% FCS. 
Drops of 50µL ES cells were made on a 10cm Petri dish, covered by mineral oil 
(Sigma M5310) and incubated 10min before aggregation. 
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9.2.5. Embryo collection for aggregation  
All the solutions must be pre-warmed at 37°C. All the steps of the aggregation 
were performed by mouth pipetting. 
On day 5, Embryos (E2.5, morula stage) were flushed out of uteri using M2 
medium injected through the infundibulum. They were pooled in a 3cm dish in 
M2 Medium. At this stage, a selection was performed to keep only round 
embryos with a nicely formed zona pellucida, and 8 to 16 blastomeres and 
without black residue inside. These embryos were then treated with Tyrode’s 
acid solution (Sigma T1788) for few seconds to remove the zona pellucida. 
Then they were washed 3 times in M2 medium. 
Composition of the M2 Medium: 6.4mg/mL NaCl (Merck 1064041000), 
350µg/mL NaHCO3 (Merck 1063290500), 36µg/mL Na-Pyruvate (Merck 
1066190050), 50µg/mL Streptomycin. Sulf. (Sigma 56501) 160µg/mL KH2PO4 
(Merck 1048731000), 465µg/mL Ca-Lactate.3H20 (Sigma 44388), 356µg/mL 
KCl (Merck 1049361000), 294µg/mL MgSO4.7H20 (Merck 1058860500), 
1mg/mL Glucose (Sigma G8270), 621µg/Ml HEPES (Sigma 54457), 75µg/mL 
K-PenG (Sigma P7794) and 4mg/mL BSA (Sigma A3311) in Aqua ad inject 
(Braun/Aichele Medico 530108).  
9.2.6. ES cell-embryos aggregation  
10 embryos were gently placed in a drop of ES cells; without touching the 
monolayer of ES cells and incubated for 2hrs at 37°C 5% CO2. During this time, 
Petri dishes with 50µL drops of KSOM (Millipore MR-106-D) covered with 
mineral oil were prepared and prewarmed at 37°C. Aggregated embryos were 
then gently removed, the excess of cells detached by pipetting up and down. 
For generating good chimeras, an embryo must be aggregated with 5 to 10 ES 
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cells. Ten aggregated embryos were placed in a drop of KSOM, well separated 
from each other and incubated overnight at 37°C in 5% CO2. 
9.2.7. Preparation for transfer  
Around 20hrs after aggregation, embryos were mostly blastocysts and were 
ready for transfer. They were washed once in prewarmed M2 medium before to 
be kept in M2 at 37°C during the transfer. 
9.2.8. Embryo transfer  
Pseudo-pregnant females were anesthetized with a mix of Ketamine 
(100mg/mL), Xylazine (20mg/mL) and Acepromazine (10mg/mL). Subsequently 
they were shaved on the back, and a protective gel was added on the eyes. For 
the surgery, a first incision was made in the skin, on the middle line of the back, 
just posterior to the ribs. This first incision was used for transferring embryos to 
both uterus horns. The ovary was visible by transparency and a second incision 
was made in the peritoneum. The ovary was pulled out by the attached fatpad 
and clamped to keep the uterus out of the body wall. Ten embryos were loaded 
into a glass transfer capillary between two air bubbles. Using a needle, an 
incision was made in the uterus proximal to the oviduct and used to transfer the 
embryos. The uterus horn was placed back into the body cavity and the transfer 
was repeated from the other uterus horn. Finally, the incision on the mouse 
back was closed using sterile suture clips. These clips were removed 10 days 
after surgery. 
 
9.3. Molecular biology 
9.3.1. Chromatin Immunoprecipitation (ChIP) 
For ChIP-qPCR experiments, each duplicate contains dissected tissues from 45 
Smad43xF/3xF embryos at E9.75 (forelimbs with attached trunk) or E10.5 
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(forelimbs/hindlimbs) or E12.5 (forelimbs/hindlimbs). For ChIP-seq experiments, 
each duplicate contains dissected tissues from 80 Smad43xF/3xF embryos at 
E9.75 (forelimbs with attached trunk) or 100 Smad43xF/3xF embryos E10.5 
(forelimbs/hindlimbs) or 60 Smad43xF/3xF embryos E12.5 (forelimbs/hindlimbs). 
The ChIP protocol for embryonic tissues was setup by Marco Osterwalder in the 
group (Osterwalder et al., 2014). Smad43xF/3xF embryos were collected in ice-
cold PBS and dissected tissues were pooled in a 2mL Eppendorf tubes. After 2 
washes in ice-cold DPBS containing Ca2+ and Mg2+ (Gibco), the dissected 
tissues were transferred to a 2mL glass douncer (Tissue Grind Tube Size 2mL, 
Kimble-Chase) on ice. Cells were disaggregated applying 25 stokes with the 
pestle A (Tissue Grind Pestle LC 2mL, Kimble-Chase) and 25 stokes with the 
pestle B (Tissue Grind Pestle SC 2mL, Kimble-Chase). The nuclei solution was 
transferred back to the 2mL Eppendorf tube and the douncer was rinsed with 
300µL cold DPBS w/ Ca2+Mg2+ that were added to the sample. The solution 
was then centrifuged at 3000rpm for 3min (4°C) and the supernatant was 
discarded. The nuclei pellet was resuspended in 1.5mL RT DPBS w/ Ca2+Mg2+ 
containing 150µL 11X crosslinking buffer (0.1M NaCl, 1mM EDTA, 0.5mM 
EGTA, 50mM HEPES pH 8.0; with 11% formaldehyde added before using). The 
nuclei solution is crosslinked for 5min at RT on a horizontal shaker. 75µL 2.5M 
Glycine were added to stop the reaction, followed by 5min incubation at RT with 
horizontal shaking. The sample was then centrifuged for 3min at 3000rmp (4°C) 
and the pellet was re-suspended in 1.5mL ice-cold DPBS w/ Ca2+Mg2+. After re-
centrifugation for 3min at 3000rpm (4°C), the supernatant was discarded and 
the nuclear pellet was flash-frozen in liquid nitrogen and stored at -80°C. 
The day before the ChIP, antibodies were coupled to magnetic beads. For one 
ChIP sample, 20µL of Dynabeads® Protein G (Invitrogen) were rinsed 6 times 
in 1mL freshly prepared ice-cold BSA (5mg/mL in DPBS w/ Ca2+Mg2+) using a 
magnetic rack. Beads were re-suspended in a volume corresponding to 2.5x 
the original volume and transferred to a 2mL screw cap tube (Sarstedt). 2µg of 
anti-FLAG M2 antibody (Sigma, F1804) were added and the mixture was 
 
113 
incubated overnight on a rotating wheel at 4°C to couple the antibody with the 
beads. The following day, the frozen nuclear pellets were thawed on ice and re-
suspended in 6mL (for ChIP-qPCR) or 30mL (for ChIP-seq) cold Lysis buffer 
(50mM HEPES pH 7.5, 140mM NaCl, 1mM EDTA pH 8.0, 10% Glycerol, 0.5% 
NP40, 0.25% Triton X-100, 1x Complete Mini protease inhibitor cocktail from 
Roche). Several frozen nuclear pellets were pooled in Lysis buffer to reach the 
correct number of cells. Lysates were incubated at 4°C for 10min with rocking 
and centrifuged at 2500rpm for 10min (4°C). The supernatant was discard and 
the pellet resuspended in 5mL (for ChIP-qPCR) or 24mL (for ChIP-seq) of 
Protein extraction buffer (0.2M NaCl, 1mM EDTA pH 8.0, 0.5mM EGTA pH 8.0, 
10mM Tris-HCl pH 8.0, 1x Complete Mini protease inhibitor cocktail). After 
10min of incubation at 4°C on a rocking platform, the sample was centrifuged at 
2500rpm for 10min (4°C). The supernatant was discarded and the nuclear pellet 
was re-suspended in 1mL (for ChIP-qPCR) or 5mL (for ChIP-seq) of chromatin 
extraction buffer (1mM EDTA pH 8.0, 0.5mM EGTA pH 8.0, 10mM Tris-HCl pH 
8.0, 0.1% Na-Deoxycholate, 0.5% N-lauroylsarcosine, 3x Complete Mini 
protease cocktail). The sample was transferred into Covaris TC 12x12 tubes (5 
tubes of 1mL for ChIP-seq) and DNA was sheared using the Covaris Ultra-
sonicator S220 for 15min (5% duty cycle, 140 watts Peak Incident Power and 
200 cycles per Burst). During the time of sonication, Dynabeads®-antibody 
coupled complexes were rinsed 6 times in 1mL cold BSA/PBS and finally re-
suspended in the original volume (20µL per sample) and kept on ice. 
After sonication, the sheared chromatin was transferred to a new 1.5mL 
Eppendorf tube and centrifuged at 1300rpm for 10min (4°C). The supernatant 
was transferred into a 2mL screw cap tube to adjust the volume to 1.060mL for 
ChIP-qPCR or 5.060mL for ChIP-seq with Chromatin extraction buffer. Two 
aliquots of 30µL were taken and kept on ice: one for input control and one to 
run on an agarose gel to check at the quality of sonication. For the 
immunoprecipitation (IP), 300µL of Cocktail mix were added (for one sample 
130µL Triton X-100 10%, 3µL Na-Deoxycholate 10%, 26µL Complete protease 
inhibitor solution (from a 50x tablet dissolved in 1mL mQ H20), 131µL TE buffer 
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(100mM Tris HCl pH 7.4, 10mM EDTA pH 8.0) and 10µL mQ H20) to 1mL 
sample aliquots (1 aliquot for ChIP-qPCR and 5 aliquots for ChIP-seq). For 
each tube, 20µL of the freshly rinsed Dynabeads®-antibody coupled complexes 
were added and incubated for 6hrs on a rotating wheel (4°C). After IP, the 
samples were recovered in a 1.5mL Eppendorf tube and 1mL of fresh cold 
RIPA buffer was added (50mM HEPES pH 8.0, 1mM EDTA pH 8.0, 1% NP40, 
0.7% Na-Deoxycholate, 0.5M LiCl, 1x Complete Mini protease inhibitor 
cocktail), followed by 6 washes with 1mL of cold RIPA buffer on a magnetic 
rack. The beads were rinsed once with 1mL TE-plus (100mM Tris HCl pH 8.0, 
10mM EDTA pH 8.0, 50mM NaCl, 1x Complete Mini protease inhibitor cocktail) 
and centrifuged at 1000rpm for 3min (4°C). On the magnetic rack, the TE-plus 
was removed and the beads were re-suspended in 100µL of fresh elution buffer 
(1mM EDTA pH 8.0, 1% SDS, 10mM Tris-HCl pH 8.0). Elution of chromatin-
protein complexes from the Dynabeads® was processed for 15min at 65°C, 
with a strong shacking at 1300rpm. After centrifugation at 13000rpm for 1min, 
the elution buffer (containing the chromatin-protein complexes) was removed on 
the magnetic rack and transferred in a PCR microtube. The 30µL aliquots (for 
input control and gel verification) were also transferred into PCR microtubes 
with 120µL of Elution buffer. The reverse crosslinking was performed in a PCR 
machine at 65°C overnight (±19hrs). 
The next day, 5 aliquots for ChIP-seq were pooled, and transferred to a new 
1.5mL Eppendorf tube. For ChIP-qPCR, the samples were also individually 
transferred to a 1.5mL Eppendorf tube. They were treated with 0.2µg/µL RNase 
A (from bovine pancreas, Sigma) in TE (100mM Tris HCl pH 8.0, 10mM EDTA 
pH 8.0) for 1hr at 37°C. Then they were treated with 0.2µg/µL Proteinase K for 
2hrs at 55°C. Finally, the chromatin was purified using the QIAquick Gel 
Extraction Kit (Qiagen). The DNA was eluted in two steps of 30µL EB buffer. All 
samples (ChIP, input and for gel verification) were aliquoted and stored at -
20°C. To verify the quality of the sonication, 30µL of the sample for gel 
verification was loaded on a 1.5% agarose gel to estimate the range of DNA 
fragments sizes (with the maximal intensity between 100 and 300bp). 
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9.3.2. ChIP-seq library construction and sequencing 
Library construction was performed using the KAPA Hyper Prep Kit (ref 
KK8502). The samples were sequenced by the Genomics Facility Basel - ETH 
Zürich using an Illumina NextSeq 500 system (SR75). 
9.3.3. ChIP-qPCR 
To determine the enrichment of SMAD4 chromatin complexes on regions of 
interest (ROI), duplicates of ChIP and input samples were analysed using 
qPCR. The reaction was performed in 20µL containing 0.3µM of each primer 
diluted in EB buffer (10mM Tris-HCl pH 8.5), 50% of SYBR green and 1µL of 
chromatin (for primers see Table 9.7.7.). The program for qPCR is the same as 
the one used for RT-qPCR. A region in the β-actin locus (Galli et al., 2010) was 
used as normalizing control region (NCR). Fold-change enrichments between 
input and ChIP samples were calculated as follows: 
(CqROI ChIP) - (CqROI input) = ΔCqROI 
(CqNCR ChIP) – (CqNCR input) = ΔCqNCR 
Fold enrichment = 2-(∆CqROI-∆CqNCR) 
ChIP-qPCR results are shown as mean ± standard deviation (SD) and are 
based on the analysis of 2 biological replicates. To avoid artefact bias of fold 
enrichment, a Cq of 32 was defined as minimum background value threshold. 
9.3.4. ATAC-seq 
The ATAC-seq was performed by following the protocol of Buenrostro et al., 
2013, for 2 replicates. One replicate consists of a pair of forelimbs from a E9.5 
wild-type (WT) embryo with the attached portion of trunk (for carrier DNA as in 
the ChIP-seq experiment). After two washes in ice-cold PBS, dissected tissues 
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were transferred to a 2mL glass douncer (Tissue Grind Tube Size 2mL, Kimble-
Chase) on ice. Cells were disaggregated by applying 20 stokes with the pestle 
A (Tissue Grind Pestle LC 2mL, Kimble-Chase) and 20 stokes with the pestle B 
(Tissue Grind Pestle SC 2mL, Kimble-Chase). After cell counting, the volume 
corresponding to 75000 cells was centrifuged for 5min at 2300rpm (4°C). The 
supernatant was gently removed and the samples were rinsed with 100µL ice-
cold PBS and centrifuged for 5min at 2300rpm (4°C). The PBS was discarded 
and the samples were lysed in 50µL Lysis buffer (10mM Tris-HCl pH 7.5, 10mM 
NaCl, 3mM MgCl2 and 0.1% NP40) by pipetting them gently up-and-down and 
centrifuging for 10min at 2300rpm (4°C). After discarding the supernatant, the 
pellet of nuclei was transposed for 30min at 37°C using the Nextera DNA Prep 
Kit (Illumina 15028212) in a 50µL reaction mix (25µL TD (2x reaction buffer), 
2.5µL TDE1 (Nextera Tn5 Transposase) and 22.5µL nuclease-free H20). 
Immediately following the transposition, the samples were purified using a 
Qiagen MinElute PCR Purification Kit and the transposed DNA was eluted in 
13µL EB buffer (Tris-HCl pH 8.5) and stored at -20°C. The second day, 10µL 
transposed DNA fragments were amplified by PCR using 25µL KAPA HiFi 
HotStart Ready Mix (Roche 07958927001) with 25µM PCR Primer 1 and 25µM 
Barcoded PCR Primer 2.1 for the first replicate and Primer 2.2 for the second 
replicate in a total volume of 50µL. 
PCR Primer 1 5’-AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTCAGATGTG-3’ 
Barcoded PCR 
Primer 2.1 5’-CAAGCAGAAGACGGCATACGAGATTCGCCTTAGTCTCGTGGGCTCGGAGATGT-3’ 
Barcoded PCR 
Primer 2.2 5’-CAAGCAGAAGACGGCATACGAGATCTAGTACGGTCTCGTGGGCTCGGAGATGT-3’ 
 
PCR program details:  
72°C 5min  
98°C 30sec  
98°C 10min 
13 cycles 63°C 30sec 
72°C 1min 
4°C ∞  
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The amplified library was purified using QIAquick PCR purification kit and eluted 
in 30µL EB buffer. Sequencing was done using an Illumina NextSeq 500 
system (SR75) by the Genomics Facility Basel - ETH Zürich. 
9.3.5. RNA-seq 
Dissected WT and Smad4Δ/Δc forelimbs from E10.0 embryos (30 somites) and 
10.5 embryos (35 somites) were collected in RNAlater® (Sigma R0901), 
incubated overnight at 4°C and then stored at -80°C. Both forelimbs of an 
embryo were pooled for one replicate. After genotyping, 4 age-matched 
replicates of Smad4Δ/Δc and 3 replicates of WT forelimb buds per stage were 
sequenced. RNA was extracted using the Qiagen RNeasy micro kit. For each 
replicate, the quality of total RNA was analysed using the RNA 6000 Pico kit 
(Agilent 2100 bioanalyzer), which was followed by polyA RNA library 
preparation. Sequencing was done on the HiSeq 2500 machine using the 
single-read 50 cycles protocol. Library construction and sequencing were 
performed by the Genomics Facility Basel - ETH Zürich. 
9.3.6. RNA extraction and Real Time-quantitative PCR (RT-
qPCR) 
For RT-qPCR analyses of cultured limb bud mesenchymal cells (LMPs), total 
RNA was extracted using the RNeasy Micro Kit (Qiagen) and eluted in 14µL 
RNAse-free water. To synthetize cDNA, 10µL RNA were mixed with 1µL 
oligo(dT)12-18 (500ng) and 1µL dNTP mix (10mM each of dATP, dTTP, dGTP 
and dCTP). The reaction mixture was denatured at 65°C for 5 min to allow 
annealing and left on ice for at least 1min. Samples were transferred in PCR 
microtubes and the following reagents were added: 8µL 5x First Strand Buffer, 
1µL 0.1M DTT, 1µL RNAseOUT™ 40U/µL, 1µL Superscript™ III RT 200U/µL 
(all from Invitrogen). Samples were incubated for 1hr at 50°C and then 15min at 
70°C (in a PCR machine). cDNA samples were stored at -20°C.  
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The RT-qPCR reaction was done using the Bio-Rad CFX96 Real-Time PCR 
system using the iQ SYBR Green Supermix (Bio-Rad). Each PCR reaction was 
done in 20µL containing 0.3µM each primer, 50% SYBR green and either 0.5µL 
cDNA, or 1µL DNA diluted 1:100 in MiliQ H2O (for Cre genotyping) or 1µL 
ChIP/Input samples (for ChIP-qPCR). The program for qPCR is: 
95°C 3min  
95°C 10sec 13 cycles 60°C 1min 
95°C 10sec  
65°C 5sec  
95°C 5sec  
 
For gene expression analysis, the ribosomal protein L19 (RPL19) transcript was 
used as normalizer. Relative Cq values of the target transcripts were 
normalised to the Cq values of RPL19, and normalized fold expression level (2-
∆∆Cq) are shown as mean ± SD. 
For genotyping, the Dopamine Beta-Hydroxylase (DBH) genomic region was 
used as a normalizer. Results are reported as mean ± SD of normalized 
expression level (2-∆∆Cq). 
9.3.7. Gas Chromatography / Mass Spectrometry (GC/MS) 
The Gas Chromatography / Mass Spectrometry (GC/MS) was performed by Dr. 
Dorothea Haas, MD, in the University Children’s Hospital Heidelberg and the 
following protocol was provided to me. Samples (forelimb bud pairs from 12 
embryos each) were washed with PBS and hydrolyzed with ethanolic KOH. 5α-
cholestane was added as internal standard. The extraction was performed with 
water and n-hexane and the sample was derivatized with 50 µl MSHFBA to 
form the trimethylsilyl derivatives. For GC/MS analysis the quadrupole mass 
spectrometer MSD 5972A (Agilent) was run in the selective ion monitoring 
mode. The following characteristic mass fragments were used for quantification: 
m/z 217/357 (5α-cholestane, internal standard), m/z 329/368 (cholesterol), m/z 
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325/351 (7- and 8-DHC), m/z 343/372 (desmosterol), m/z 255/458 (lathosterol), 
m/z 393/498 (lanosterol), m/z 213/229 (8(9)cholestanol). We also quantify 
cholestanol, campesterol, beta-sitosterol and stigmastanol. Gas 
chromatographic separation was achieved on a capillary column (DB-5MS, 30 
m x 0.25 mm; df: 0.25; J & W Scientific) using helium as a carrier gas. The initial 
oven temperature of 100°C was raised after 2 minutes to 300°C at a rate of 
35°C per minute. The injector was held at 280°C and the transfer line at 290°C. 
1 µl of the derivatized sample was injected in a splittless mode. 
 
9.4. Histology 
9.4.1. Paraffin embedding of mouse embryos and tissues 
Embryos were collected in ice-cold PBS and fixed overnight in cold 95% ethanol 
containing 1% glacial acetic acid (Sainte Marie’s fixation). After 3 washes of 
30min in cold 95% ethanol, embryos were stored in 70% ethanol at 4°C. For the 
paraffin embedding, they were dehydrated through an ascending ethanol 
washes series: once 30min in 95% ethanol (10min if embryos are younger than 
E11.0) and 3 times 30min in absolute ethanol (10min if younger than E11.0). 
They were then cleared with xylene 3 times for 15min each and transferred to a 
50:50 (v/v) xylene/paraffin mixture for 30min at 60°C. Tissues were incubated 
with freshly melted paraffin 4 times for 1hr at 60°C. Finally, samples were 
embedded in a fresh paraffin wax (60°C) using a stereomicroscope for proper 
orientation. Paraffin blocks were incubated at RT for 1hr and then stored at 4°C. 
The Microm HM 355 microtome was used to cut sections of 6µm that were 
mounted on Superfrost Plus slides (Thermo Scientific) and stored at 4°C until 
use. 
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9.4.2. Immunohistochemistry (IHC) using paraffin sections 
The first day, sections of embryonic tissues were deparaffinised for 2x5min in 
xylene, followed by 2x5min in absolute ethanol, 2x5min in 95% ethanol and 
1x5min in PBS. Endogenous peroxidases were blocked by incubating the slides 
in 0.3% H2O2 (Sigma H1009) in methanol for 40min. After 3x5min washes in 
PBS, the sections were first blocked for 30min at RT in TNB solution. TNB 
solution consists of 0.1M Tris-HCl pH 7.5, 0.15M NaCl, 0.5% NEN blocking 
reagent from the TSA Biotin System kit (PerkinElmer NEL700). Sections were 
then blocked a second time in 5% goat serum, 0.2% BSA and 0.1% Triton X-
100 mixture in PBS for 40min at RT. Finally, the sections were incubated 
overnight at 4°C with anti-SHH Ab80 rabbit antibody (Gritli-Linde et al., 2001) 
diluted 1:600 in PBS containing 0.2% BSA and 0.1% Trition-X100. The second 
day, sections were first washed 3x5min in TNT solution (0.1M Tris-HCl pH 7.5, 
0.15M NaCl, 0.5%, 0.025% Tween-20) and then incubated for 45min at RT 
using biotinylated goat anti-rabbit antibodies (Vector Laboratories BA100), 
which was diluted 1:300 in TNT solution containing 2% non-fat dry milk (Sigma 
M7409). Sections were then washed 3x 5min in TNT and incubated 30min in 
the dark with Streptavidin-HRP from the TSA Biotin System kit (diluted 1:250 in 
TNB). After washing for 3x5min in TNT, sections were incubated exactly 9min in 
Biotinyl Tyramide diluted 1:50 in Amplification buffer (TSA Biotin System kit). 
Sections were washed again 3x5min in TNT and then incubated in Streptavidin-
HRP from the TSA Biotin System kit (diluted 1:250 in TNB) for 30min in the 
dark. To develop the sections, they were first washed for 3x5min in TNT and 
developed in DAB solution for 5 to 10min. The DAB solution is prepared as 
follows: 900µL of stable peroxide solution are mixed with 100µL of DAB 
substrate (Metal Enhanced DAB Substrate Kit, Thermofisher 34065). WT and 
Smad4Δ/Δc sections were developed in parallel for exactly the same time. Slides 
were then washed 3 x 5min in PBS and dried at 42°C for 1hr. Then they were 
mounted in Histomount medium (Life Technologies 008030). 
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9.4.3. Optimum Cutting Temperature (O.C.T) embedding of 
embryos to prepare frozen sections 
Embryos were collected in ice-cold PBS and fixed for 2hrs at 4°C in 4% 
PFA/PBS and washed 3 times in PBS (5min). Samples were then cryoprotected 
using a gradient of sucrose: 10% sucrose/PBS (w/v), 20% sucrose/PBS, 30% 
sucrose/PBS (1hr each) at 4°C. Then, the embryos were transferred into 
embedding molds, the 30% sucrose/PBS was carefully removed and replaced 
by 50:50 (v/v) O.C.T/30% sucrose. The orientation was checked using a 
stereomicroscope and the samples frozen by dipping and holding the bottom of 
the embedding mold into Isopentane cooled with dry ice. The frozen blocks 
were stored at -80°C and 10µm sections prepared using a Leica CM3050S 
Cryostat (-20°C). Frozen sections were mounted on Superfrost Plus slides and 
stored at -80°C. 
9.4.4. IHC using frozen sections 
Smad43xF/3xF or WT sections were washed 3x5min in PBS, once 30min in PBT 
(PBS with 0.2% Triton X-100) and again 5min in PBS. They were then blocked 
in 1% BSA in PBT for 1hr at RT and incubated overnight at 4°C with the 
monoclonal mouse anti-FLAG M2 antibody (Sigma, F1804) diluted 1:500 in 1% 
BSA/PBS. The second day, the sections were washed 3x5min in PBS, once in 
PBT and were incubated in the dark for 1hr at RT with the goat anti-mouse 
Alexa 488 secondary antibody diluted 1:500 in 1% BSA/PBS. Sections were 
finally washed 3x10min PBS, once in PBT (5min), nuclei counterstained in 
1µg/mL Hoechst-33258/PBS (5min) and rinsed again 3x5min in PBS. Then they 
were mounted in Mowiol 4-88 and dried overnight at RT in the dark. 
9.5. Genomics online resources 
All the sequences alignments were retrieved from UCSC (Flicek et al., 2014). 
Alignments between species were performed using the ECR browser 
(Ovcharenko et al., 2004) or VISTA alignment browser (Dubchak et al., 2000; 
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Frazer et al., 2004). TADs analysis was performed using the 3D Genome 
Browser (Wang et al., 2017). Other useful online resources used include the 
Galaxy browser (Sloggett et al., 2013), the VISTA enhancer browser (Visel et 
al., 2007) and the Mouse Genome Informatics website 
(http://informatics.jax.org). 
9.6. Bioinformatics Analysis 
All bioinformatics analysis for the ChIP-seq, ATAC-seq and RNA-seq 
experiments were performed by Iros Barozzi (Lawrence Berkeley National 
Laboratory, Berkeley, CA, USA). This part of the material and methods section 
was written by Iros Barozzi and provided to me for this thesis. 
9.6.1. ChIP-seq raw data analyses and annotation 
Short reads obtained from Illumina HiSeq were aligned to the mm9 genome 
using Bowtie v1.1.0 (Langmead et al., 2009). Only those reads with a unique 
match to the genome with two or fewer mismatches (-m 1 -v 2) were retained. In 
order to make different runs comparable, the 3’ of reads were trimmed to 63 bp 
before alignment. This step was performed using fastx_trimmer (-l 63), a tool 
part of the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) (v0.0.13). 
Peak calling was performed using MACS v1.4 (Zhang et al., 2008) with the 
following parameters: --gsize=mm --bw=300 --nomodel --shiftsize=100 --
pvalue=1e-2. Matched input DNA was used as control. Wiggle tracks were also 
generated with MACS; these were then re-scaled linearly according to 
sequencing depth (RPM, Reads Per Million sequenced reads). MACS was run 
with a permissive threshold (p-value 0.01) in order to identify a larger list of sub-
significant regions across biological replicates. Evidences from these replicates 
were combined using MSPC (Jalili et al., 2015), with the following parameters -r 
biological -s 1E-5 -W 1E-2. The confirmed peaks were assigned the best p-
value (as defined by MACS) among the overlapping peaks across replicates. 
Only the peaks showing reproducibility were retained for further analysis (we 
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termed this set as golden; one golden set per developmental stage). These lists 
of peaks were annotated to the TSS of the nearest RefSeq genes using the 
script annotatePeaks.pl available in HOMER (Heinz et al., 2010). A region was 
considered as promoter-proximal if annotated within 2.5 kbp from a RefSeq 
promoter. The remaining regions were divided into intragenic and intergenic, 
whether the region overlapped the body of an annotated gene or not. 
9.6.2. Motif enrichment and de novo motif discovery analyses 
The script findMotifsGenome.pl available in HOMER (Heinz et al., 2010) was 
used to perform enrichment analysis for known transcription-factor binding sites 
and motif discovered de novo. The script was run with the following arguments: 
-size -150,150 -len 6,7,8,9,10,12,14, using the summit of the peaks in the 
golden set as reference. The top ten most significant, over-represented known 
matrices along with the top ten motif discovered de novo were then used to 
scan every single region for high-affinity sites using FIMO (Grant et al., 2011) 
(v4.10.0). The following parameters were used: --thresh 1e-4 --no-qvalue. The 
resulting list of sites was transformed into a matrix in which each region was 
represented as a vector of p-values, one for each different motif, corresponding 
to the p-value of the highest-scoring site identified (p-value = 1 if no significant 
match was found). P-values were then log10-transformed and their sign 
inverted, then hierarchically clustered (Euclidean distance, complete linkage). 
9.6.3. Evolutionary conservation analysis of genomic regions 
enriched in SMAD4 chromatin complexes 
The genome-wide track of base-pair phastcons (Siepel et al., 2005) 
conservation scores in placental mammals was downloaded from the UCSC 
genome browser (Tyner et al., 2017) (track name: 
mm10.60way.phastCons60wayPlacental.bw). The coordinates of the peaks in 
the golden sets were converted from mm9 to mm10 using liftOver (Tyner et al., 
2017) (-minMatch=0.95). The base-pair scores for the 300 bp centered on the 
summit of the peaks were then extracted using bwtool (Pohl and Beato, 2014). 
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9.6.4. ATAC-seq raw data analysis and annotation 
Short reads obtained from Illumina HiSeq were aligned to the mm9 genome 
using Bowtie v1.1.0 (Langmead et al., 2009) (-m 1 -v 2, see “Chip-seq raw data 
analyses and annotation”). Accessible regions were identified using MACS v1.4 
(Zhang et al., 2008) with the following parameters: --gsize=mm --bw=150 --
nomodel --nolambda --shiftsize=75. Genome-wide profiles were generated 
using MACS and re-scaled linearly according to sequencing depth (RPM). Gene 
annotation was performed using HOMER (Heinz et al., 2010), as described in 
“Chip-seq raw data analyses and annotation”. Evidences from biological 
replicates were combined using MSPC (Jalili et al., 2015), using the following 
parameters -r biological -s 1E-10 -W 1E-6. The confirmed regions were 
assigned the best p-value (as defined by MACS) among the overlapping 
regions across replicates. 
9.6.5. RNA-seq data analysis 
Single-end reads obtained from Illumina HiSeq were aligned to the mm9 
reference genome and to the Mus Musculus transcriptome (iGenome refGene 
GTF) using TopHat v2.0.13 (Kim et al., 2013). The option --no-coverage-search 
was specified, while all the other parameters were left to default. Only uniquely 
mapped reads were considered for the analysis. Tracks for the UCSC genome 
browser (Tyner et al., 2017) were produced using genomeCoverageBed from 
BedTools v2.17.0 (Quinlan and Hall, 2010); these were linearly re-scaled 
according to sequencing depth (RPM). Gene-wise counts were computed using 
htseq-count from the HTSeq package (Anders et al., 2015) with -s set to no. 
Genes on chromosomes X, Y and M were excluded from further analysis. 
edgeR (Robinson et al., 2010) was used to identify differentially expressed 
genes (DEGs). Only genes showing expression (in terms of Fragments Per 
Million sequenced reads equal or higher than 1) in at least three samples were 
considered for further analyses. Libraries were normalized according to TMM 
normalization. Tag-wise estimation of dispersion was evaluated using prior.df = 
10. Differential expression between pairs of conditions was evaluated using the 
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exactTest R function. False discovery rates were estimated using Benjamini-
Hochberg correction (Benjamini and Hochberg, 1995). DEGs were defined as 
those genes showing a q-value <= 0.1 and a linear fold-change equal or higher 
than 1.2. Functional enrichment analyses were conducted using DAVID (Huang 
et al., 2009). 
9.6.6. Hierarchical clustering, plots and statistical testing 
Clustering, plots, heat maps and statistics were handled in the statistical 
computing environment R v3. 
 
9.7. Tables 
9.7.1. LacZ reporter primers table 
CRM Forward primer (5’-3’) Reverse primer (5’-3’) Size (bp) 
Alx4 +368kb CACTAAAGGGAACAAAAGCTGGTACCTCCTGAGTGCTGTCAGTTCG 
TTTGGATGTTCCTGGAGCTCGGTACCC
CCAGCGTAAATGCTGTGTA 885 
Id1 +3kb CACTAAAGGGAACAAAAGCTGGTACGGTACCGGATTCCCACTGGGGCTAAAG 
TTTGGATGTTCCTGGAGCTCGGTACCG
GTAGCCAATCACTCTTATTGC 1441 
Id2 -438kb CACTAAAGGGAACAAAAGCTGGTACCTGTCCTTTCTTTAATGTGATCCAA 
TTTGGATGTTCCTGGAGCTCGGTACCG
AGGGCTGCCATTAACACTC 842 
Lhx2 +472kb CACTAAAGGGAACAAAAGCTGGTACCCCTACTTCTGCCTCTCAAATGC 
TTTGGATGTTCCTGGAGCTCGGTACCT
GGAGAGAGAGCCTTTTATGTTTC 1771 
Msx2 -3.3kb CACTAAAGGGAACAAAAGCTGGTACCTAATGTTTATGCGCCGTGAA 
TTTGGATGTTCCTGGAGCTCGGTACCC
ACTGTCAGGAAGCCAACAA 1180 
Pkdcc -50kb CACTAAAGGGAACAAAAGCTGGTACGGTACCTGCAATTTGCAGCTTGCC 
TTTGGATGTTCCTGGAGCTCGGTACCG
GGCAGCGTGATATAGGAG 1238 
Prrx2 -87kb CACTAAAGGGAACAAAAGCTGGTACGGTACCAAGAAGAGTCTGAATCTCCC 
TTTGGATGTTCCTGGAGCTCGGTACCG
GTCTTGAACACCTCAGAAG 3228 
 
9.7.2. Genotyping primers table 
Locus Forward primer (5’-3’) Reverse primer (5’-3’) Size (bp) Allele 
LacZ 5’-GATCCCGTCGTTTTACAACG-3’ 5’-AATGTGAGCGAGTAACAACCCG-3’ 362 LacZ 
PrxCre 5’-GGCTCTCTCCTTAGCTTCCC-3’ 5’-CCTGGCGATCCCTGAACATGTCC-3’ 400 Tg 
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Smad4 
5’-ACAGCCTCCACACTTGTGCT-3’ 5’-TGTCTGCTAAGAGCAAGGCA-3’ 396 + 501 
WT + 
3xFlag 
5’-AAGAGCCACAGGTCAAGCAG-3’ 5’-CCTGACCCAAACGTCACCTTC-3’ 500 Δ 
5’-GGGCAGCGTAGCATATAAGAC-3’ 5’-CCTGACCCAAACGTCACCTTC-3’ 390 + 450 
WT + 
Fluxed 
 
9.7.3. qPCR primers table 
Locus Forward primer (5’-3’) Reverse primer (5’-3’) Size (bp) 
Cre 5’-ATACCGGAGATCATGCAAGC-3’ 5’-TTGCCCCTGTTTCACTATCC-3’ 88 
DBH 5’-AGGACATCAGCCACTCTGCT-3’ 5’AATTGTCTTGGTGGCCCTC-3’ 117 
Gli1 5’-CAAGTGCACGTTTGAAG-3’ 5’-CAACCTTCTTGCTCACACATGTAAG-3’ 76 
Hhip1 5’-GCTCTGTCGAAACGGCTACT-3’ 5’-GGTGTCTGTGTCAGACCGAA-3’ 129 
Ptch1 5’-GGCAAGTTTTTGGTTGTGGGTC-3’ 5’-TGCTGCTGATGGATGGGAAC-3’ 157 
Rpl19 5’-ACCCTGGCCCGACGG-3’ 5’-TACCCTTTCCTCTTCCCTATGCC-3’ 53 
 
9.7.4. WISH screen primers table 
Locus Forward primer (5’-3’) ATAT-SP6 sequence- Reverse primer (5’-3’) Size (bp) 
1500004A1
3Rik AGAACCAGAGAAGCCTGAGGTC 
ATATATTTAGGTGACACTATAGAAGAGGCT
ACGGGTGAGGTTATCT 746 
4933404O1
2Rik CCCGTGAGAGACATGAGCTAAG 
ATATATTTAGGTGACACTATAGAAGGGCTA
CAGAGTGAGATTCAGG 513 
5830417I10
Rik GAGGGTGAGTCTGAGGAAGAGA 
ATATATTTAGGTGACACTATAGAAACTTAC
GAGTCCACACGACAGG 594 
Abhd8 GCCCAGCCTATGCTCCATCTTCA ATATATTTAGGTGACACTATAGAAGCACTGAGTCTCCAACACTGAC 638 
Acot11 GGAGACTCTCTGTTCAGGCTTC ATATATTTAGGTGACACTATAGAAACTGAGTCAGAGTCCAGCCAAC 538 
Acta2 CCTGGAGAAGAGCTACGAACTG ATATATTTAGGTGACACTATAGAAGCTAGGCCAGGGCTACAAGTTA 588 
Adat3 GAAGACAAGCAGGTGACCAGTG ATATATTTAGGTGACACTATAGAACTGCAGTCTGGAAACTGAGAGG 738 
Adora2a ACCCCTTCATCTACGCCTACAG ATATATTTAGGTGACACTATAGAACTGCTGTAGCCCTGACCTAACT 609 
Akap9 TCTGGACTATCCTCGGTCTCTC ATATATTTAGGTGACACTATAGAAAAGGTACTCGTCCAGCAGCACT 540 
Ano1 CCTTCACGTCTGACTTCATCCC ATATATTTAGGTGACACTATAGAACTCATCAGAGTGCTCCTCCACAC 687 
Apba3 CCTGCAGACCATCTCCTACATC ATATATTTAGGTGACACTATAGAACGGTGGGCAGTGGATAATACTC 577 
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Arhgef19 CTCAGAGAGTACAAGAGGGTCTCC ATATATTTAGGTGACACTATAGAAGGACGAGGACACGTAGTAGGAT 592 
Atoh8 CTCTCCAAACTGGCCATCCTGA ATATATTTAGGTGACACTATAGAAGTATCGGGAACAGGAGTCAGAG 748 
B4galnt2 GGCCATCTCACAGGTGACTACT ATATATTTAGGTGACACTATAGAAACTTCAGGGTCCTACCCTAGCTC 700 
Bbc3 CTGGGTGCACTGATGGAGATAC ATATATTTAGGTGACACTATAGAACAGACTCCTCCCTCTTCTGAGAC 653 
Bcl11a CGGGATGAGTGCAGAATATGCC ATATATTTAGGTGACACTATAGAAGGTCAGGGGTCATGCTCATTTC 600 
Bcl9l AAGCAGCACCCTCCAGTACTTC ATATATTTAGGTGACACTATAGAAGGCCTGCTAGAAGGGTAGATTG 502 
Bnc2 GTCCTTGACCTGAGTACCACCT ATATATTTAGGTGACACTATAGAACACACACTGGCTATGGCAGTTC 500 
Cacng7 CTACACCCTTCCCTATGGTCAG ATATATTTAGGTGACACTATAGAAGAGATGGTCCGGGTACTTGATG 506 
Cc2d1a GTACCAGGACGTAGTACAGCGTAG ATATATTTAGGTGACACTATAGAAGTATCTTTGGAGAGGGCTGTGG 524 
Ccdc124 GGAGCTGGAAGATGCTTACTGG ATATATTTAGGTGACACTATAGAAGACTCAGCCTGGTTCTGTCACT 576 
Cldn10 GGTGCTAGTGTCTTCCACACTG ATATATTTAGGTGACACTATAGAAGTGGGTCCGTTGTATGTGTAGC 546 
Clstn3 GACCTAGACCCTGAACGAGAGAG ATATATTTAGGTGACACTATAGAAAGTCACTGCTGTCCTCTTCCTC 658 
Canter CAGCACACACCATCACAGATGCC ATATATTTAGGTGACACTATAGAATGCATGGTCCTCCTCTCTGGATG 564 
Col12a1 CATCATACAGGAGGGTGGAGAC ATATATTTAGGTGACACTATAGAACTAGAGACTGAACTCGGGGTGA 623 
Col1a1 CTCAACCCCGTCTACTTCCCTAC ATATATTTAGGTGACACTATAGAAACAGACCAAGAGAGAGGCAGAG 766 
Dhcr24 GACATCCACGTCTACCCCATCT ATATATTTAGGTGACACTATAGAAGACTAGCCCAGAGTCAGTCACAC 563 
Dhcr7 CCATCGACATCTGCCATGACCAC ATATATTTAGGTGACACTATAGAAGGCTCTCCATTCTCCAGATGAGC 671 
Dyrk1b CGACAACAGAGCCTACCGATAC ATATATTTAGGTGACACTATAGAAGTAGCAGCAAGTCCAGTCAAGG 557 
Fam171a2 GCAGGCTCTAACCGAGAAGAAG ATATATTTAGGTGACACTATAGAACCCAGCACATACCACAGATGAG 713 
Fam189a2 GCTACAGTGACTCTGAGGAGAGG ATATATTTAGGTGACACTATAGAAGATACTGTGAGACCCAGCAGAC 711 
Fam189b ACTCTCTAGGGGACCTGAAAGG ATATATTTAGGTGACACTATAGAACTGAGGTCATGCAGCTAGAGGT 741 
Fdft1 ACGTCCTCACCTACCTGTCAAG ATATATTTAGGTGACACTATAGAACTCTGCCCAGTTCCTAAAGGTC 577 
Fops CTGGTGTGTAGAACTGCTCCAG ATATATTTAGGTGACACTATAGAACTCGTAGCAGACACTGAACCAC 566 
Fras1 GGAGGACACTCTGGAGGAATAC ATATATTTAGGTGACACTATAGAAGGGGACAGTGCACAGATGTCTA 750 
Glis1 CAGGGGGACAGTCATTCTCTAC ATATATTTAGGTGACACTATAGAAAGGTAGGGAAGTACCCTGTGGT 527 
Gm5779 GAGGACCTCACTGAGATTAGGG ATATATTTAGGTGACACTATAGAAGCAGCTGGGAAAGTGTACTCAG 506 
Gng8 GACTCGGTCTCTGAGTGTCTGTC ATATATTTAGGTGACACTATAGAAGTCACCAGTGGGTCATCCTTAG 716 
Gpr162 CCTGTGACGACTACACAGATGG ATATATTTAGGTGACACTATAGAAAGTGGTCTAGGCCTACGAGGAGA 529 
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H2-D1 CTCCTCCGTCCACTGACTCTTAC ATATATTTAGGTGACACTATAGAACAGACACTGCAGAAGAGGGTGT 624 
H2-K1 CTGGTGAAGCAGAGAGACTCAG ATATATTTAGGTGACACTATAGAACTGGGAGAGACAGATCAGAGGT 558 
Hdac5 TCCCTCTGTGCTCTACATCTCC ATATATTTAGGTGACACTATAGAACCTCCTCTTTCTCACCTGTCTG 596 
Hop GGTGGAGATCCTGGAGTACAAC ATATATTTAGGTGACACTATAGAAGGGAAGTGAACTCAGGAGGTGT 588 
Idea ATCAACTCAGCAGCCCCTACAG ATATATTTAGGTGACACTATAGAAGACTCCATTCACCAGTCAGCAC 556 
Ier5l AAGAACCTCCTGGTGTCCTACG ATATATTTAGGTGACACTATAGAAGTAGCCGTTTTCTACCGTGGTC 729 
Inf2 GATCTCTCAGCTCCCAGTACTCC ATATATTTAGGTGACACTATAGAAGTACCTGCTGTCTCATGTCCAG 760 
Irf5 CTTCTACAGCCAGCTAGAGGCTAC ATATATTTAGGTGACACTATAGAACTTCACTACCACCAGACCATCC 708 
Lhx2 GATGCTGAACACCTGGATCGTG ATATATTTAGGTGACACTATAGAACTCTGTTTCCAGGCGAGATCCT 615 
Ltbp4 GTCTGAGACTCCTGACCCACCTA ATATATTTAGGTGACACTATAGAACCCTCTGTGTCTGTCCATCCTA 552 
Mamdc2 GGAGATCACACTACTGGGGTAGG ATATATTTAGGTGACACTATAGAAGAAAACAGAGGAGAGCCCTGAG 618 
Mafia GCTCTGTAACATCCTCCTGGAC ATATATTTAGGTGACACTATAGAAGGAGCAGAGGTAGAGAAGGACAC 519 
Mdn1 AGACAGAGTCCTAGCAGCAGTCC ATATATTTAGGTGACACTATAGAAGTGACCTCTACCTGGTCCCTAGT 547 
Mfap4 GGATGGCTATACCCTCTACGTG ATATATTTAGGTGACACTATAGAAAGCTGTCGTGAAGGGGTAGAAG 555 
Mib2 GCTGAGTACTCCTAACACCGTGAC ATATATTTAGGTGACACTATAGAAGTTCCTGATCTCCAGGCAGTCT 646 
Mt2 TGCTGGCCATATCCCTTGAGCCA ATATATTTAGGTGACACTATAGAATTGTGGAGAACGAGTCAGGGTTG 478 
Mxd4 CTGACAGCACACGTCACACTAC ATATATTTAGGTGACACTATAGAAGTAAGAGCCTGACACTGCTTCC 621 
Naif1 CCTACCCAGTACCACAGAGATCC ATATATTTAGGTGACACTATAGAAAGCAGAGTACTGGCTTGACCTC 583 
Nckap1l CTGCTGCCCTCTTCACTCTGTA ATATATTTAGGTGACACTATAGAAGAAGTGCAGGAGACAATAGCAGCTC 716 
Ndufs7 CAGCTGCGCAGAGTTCATCAGA ATATATTTAGGTGACACTATAGAAAGATGTCCACTGGCACAATGCG 502 
Nfatc4 TATAGCACACCCGCTCTGTACC ATATATTTAGGTGACACTATAGAAAAGCTAGAAGCTGGGCTAGGAG 588 
Nfkbil1 GGAGAAGGAACTGTGTGAGAGC ATATATTTAGGTGACACTATAGAAAGTCCAGAGCAGTGGTTAGAGC 569 
Nup210l GTGTGGCAGACACCTCAGTCTAC ATATATTTAGGTGACACTATAGAAGTGTTGTAGCCGACTCTGCACT 647 
Pard6a GATGCTCACGCAGAAGGTGACT ATATATTTAGGTGACACTATAGAAGGTGGCGATTCTCAATGACCAG 598 
Pcsk9 GATCTCAGGTCCTTCAGAGCAG ATATATTTAGGTGACACTATAGAAGAACCTCCAAGGATCTCTGTCC 560 
Pdk2 GGAAGATCGAGAGGCTCTTCAG ATATATTTAGGTGACACTATAGAACACTTAGGGACCACCACAGTTG 501 
Phactr3 GAGCACAGGACTATGACAGGAG ATATATTTAGGTGACACTATAGAAAGTCCCCAGCTATACCTCATCC 754 
Pave GGTCCACTCAAGGAGGAGTATG ATATATTTAGGTGACACTATAGAAGAGAGCGTACACACAGGGAAAC 771 
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Rec8 CCAGAGATCAGTCGAGGAGACT ATATATTTAGGTGACACTATAGAACTTCTGCTGCTTCTAGGGAGAG 781 
Rfx1 CCTCAAGTGGTCCTTCTACAGC ATATATTTAGGTGACACTATAGAAAGACTCTCCTAGCCTTCCCTGT 549 
Rgl3 CTCACCTACCTCCAGTGTGTCTC ATATATTTAGGTGACACTATAGAAACCTAAGCTAAGCTCCCAGCTC 784 
Rhpn1 ACATGACTCGAGGAGAGGGAAG ATATATTTAGGTGACACTATAGAAGTCCCCAAGAGTAGAGGACAGAC 555 
Rspo4 GGAGTCCCTGCATACACAATGG ATATATTTAGGTGACACTATAGAATGCAGAGAGCCACATGGAGGAT 572 
Rusc1 AGTAAGTGTGCTGGCTCTGGTG ATATATTTAGGTGACACTATAGAAAGGGCTAGAGACAGAGTGAGGAG 637 
Scd1 GACTACTCTGCCAGTGAGTACCG ATATATTTAGGTGACACTATAGAAGGGGACTTGCTCTATCCCTAGT 732 
Serinc2 CTGATGCAGACAGAGGAGTGTC ATATATTTAGGTGACACTATAGAACTTCTGGAGACCCTGAGAACAG 548 
Slc27a1 GTCAGACCTCAGACAGGCTCTT ATATATTTAGGTGACACTATAGAAGACAGCCAGGGCTATACAGAGA 661 
Srebf1 GGACAGCTTAGCCTCTACACCA ATATATTTAGGTGACACTATAGAAAGCCACTAAGGTGCCTACAGAG 751 
Thbs3 GAAACAGACGGAGCAGACCTAC ATATATTTAGGTGACACTATAGAACCAGGGTCTCCAGAACAGAGTT 515 
Tm7sf2 GGTATGAGGAGTCTGTCCTCACC ATATATTTAGGTGACACTATAGAAAGGTGGACCTGCTTCAGTAGAC 555 
Tmem119 ACAGAGTCTCCCCCAGTGTCTA ATATATTTAGGTGACACTATAGAAAGCAGGAACCCTTAGAGTAGCC 679 
TN CTACCTCTGGCCTCTACACCAT ATATATTTAGGTGACACTATAGAAGCCCTGACTGTGGTTATTGTCC 521 
Tnnt1 GAGGCAAAGAAGAGAGCAGAGG ATATATTTAGGTGACACTATAGAACTCTCCCAGGCAGTATGGAGAT 528 
TN GAAGCGTCTCGTCTCAGTCAGT ATATATTTAGGTGACACTATAGAACCCTGGCCCTCTTACATAGAAC 550 
Upk3b CCACAGACTGCTGCTAAGATCC ATATATTTAGGTGACACTATAGAAAAGCTACAGAGACCAGGCTACG 593 
Uqcr11 TACGTCTGCACATGCGTAGTGC ATATATTTAGGTGACACTATAGAAAGGCAGCCCTAGTGTCTGTCAA 391 
Wnt2b TGGAGAGCACTCTCAGACTTCC ATATATTTAGGTGACACTATAGAACTCAGCCTCCTAAATCCATCCC 634 
Wt1 GACTTCCAAGACAGCACACCTG ATATATTTAGGTGACACTATAGAAAGGAAGGCTCCTCTCTGTCCTA 536 
Zfp628 CTAATGGAGGAGCTGGCACTAC ATATATTTAGGTGACACTATAGAAGTACCAGTTGGACTGCAGGAAG 540 
Zfp78 GGTCAGAGGCCCTATGTATGTG ATATATTTAGGTGACACTATAGAACTGAGATGACCTCCCAGAACTC 777 
 
9.7.5. WISH probe cloning primers table  
Locus Forward primer (5’-3’) Reverse primer (5’-3’) Size (bp) 
Cyp51 GGGATAGAGCCCATCGAGAGAT CTCTCTCCACACTGGCTTCTTG 786 
Dhcr24 GACATCCACGTCTACCCCATCT GACTAGCCCAGAGTCAGTCACAC 563 
Dhcr7 CCATCGACATCTGCCATGACCAC GGCTCTCCATTCTCCAGATGAGC 671 
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Fdft1 ACGTCCTCACCTACCTGTCAAG CTCTGCCCAGTTCCTAAAGGTC 577 
Fops CTGGTGTGTAGAACTGCTCCAG CTCGTAGCAGACACTGAACCAC 566 
Id3 GGTGTCTCTTTTCCTCCCTCTC CCACCCAAGTTCAGTCCTTCTC 598 
Idi1 CTCAGGAGACAGCTCAGTGTACC CTAACTCAAGCCAGACCCCCTAC 710 
Lidl GATCTCTCAGCTCCCAGTACTCC GTACCTGCTGTCTCATGTCCAG 760 
Lhx2 GATGCTGAACACCTGGATCGTG CTCTGTTTCCAGGCGAGATCCT 615 
Mad CCTACCTCAATGACACCTCCAG GTCAGCTAGCCCTTCAGAAACC 585 
Mxd4 CTGACAGCACACGTCACACTAC GTAAGAGCCTGACACTGCTTCC 621 
Pcsk9 GATCTCAGGTCCTTCAGAGCAG GAACCTCCAAGGATCTCTGTCC 560 
Pave GGTCCACTCAAGGAGGAGTATG GAGAGCGTACACACAGGGAAAC 771 
Prrx2 GCAAGAACTTCTCGGTGAGC GAGGACAGAGACAGACAAGGCTA 735 
Sc5d GGTTAGCGTCGTATCCTTCCTC TACTGTCAGGACCATCCCTCAG 671 
Sfrp2 CCTGGAGACAAAGAGCAAGACC CCCTCGGGTCAAAGTACTACAG 591 
Srebf1 GGACAGCTTAGCCTCTACACCA AGCCACTAAGGTGCCTACAGAG 751 
Tm7sf2 GGTATGAGGAGTCTGTCCTCACC AGGTGGACCTGCTTCAGTAGAC 751 
 
9.7.6. CRISPR/Cas9 deletion strand table 
CRM strand 1 (5’-3’) strand 2 (5’-3’) Size (bp) 
GRS1 AGCGGCAGTTCGGCTTCCGG TCTCATACGATCCAGGAGAA 9909 
 
9.7.7. ChIP-qPCR primer table 
Locus Forward primer (5’-3’) Reverse primer (5’-3’) Size (bp) 
BRE Id1 AGAATGCTCCAGCCCAGTTT TGACGTCACCCATTCATAAAA 93 
BRE Msx2 CCATTAGGGCGAATTGTCAT GAGCCGCGTTAATTGCTCT 90 
Grem1 exon 
2 TCATTGTGCTGAGCCTTGTC CAACAGCTGAGGGGAAAAAG 70 
GRS1-A ATGAGACTTGGAGCAGCAGTT TCCTCGGTTATTGGGCAATA 123 
GRS1-B ACACACACAGAGCAAGAGGCT AACCGGTGCAGTCTCAGAAG 115 
Neg Grem1 ATCCAATCACGTGCATAACAA AAGCAAGGATCCATGGAACA 92 
Neg Id1 TTCTTCTCTGGCTGCCAGTG AACTGAGCCTTGCATCATGC 140 
Neg Msx2 GACTAGGGCTCTCTTTTCCTGA CATTTCTCCACCCCAGCTTA 84 
β-actin GATCTGAGACATGCAAGGAGTG GGCCTTGGAGTGTGTATTGAG 115 
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12. Appendixes 
12.1. List of down-regulated E10.0 SMAD4 targets 
Name FC≥1.2 FDR≤0.1  Name FC≥1.2 FDR≤0.1 
0610007P14Rik 1.223213211 0.056799258  Ehd1 1.22030945 0.039005303 
2010300C02Rik 1.504834891 0.073984364  Elovl1 1.222853191 0.07258805 
4933404O12Rik 2.004332684 0.044882612  Emilin1 1.352773594 0.038229041 
5730559C18Rik 1.290858343 0.019139858  Enho 1.346124066 0.090965994 
6330403K07Rik 1.508664379 3.89524E-07  Entpd6 1.241480606 0.098154326 
Abhd16a 1.24608185 0.09352162  Evx1 2.115921936 0.016857195 
Abhd8 1.444853433 0.031398748  Fam109a 1.339684573 0.013832231 
Acot11 1.510298434 0.000706461  Fam189a2 1.685234454 0.005669977 
Adck2 1.269849919 0.053510024  Fam73b 1.235010985 0.086811535 
Ak1 1.288264513 0.084434247  Fdft1 1.508039858 1.13E-08 
Alx4 1.276624344 0.048800519  Fstl1 1.25480529 0.056799258 
Arhgef19 1.685088225 0.010136361  Gm8801 73.48224447 0.000130513 
Asphd2 1.361954393 0.035797172  Gorasp1 1.248886959 0.083061136 
Atoh8 1.58651375 0.006026576  Gpc1 1.342314791 0.017366866 
B4galnt2 2.941716269 0.002239574  Gyltl1b 1.387249006 0.012330766 
Bcl11a 1.641380458 1.70703E-06  H2-K1 4.538026704 0.000805342 
Bmf 1.404071466 0.000262814  Hdac5 1.327257845 0.066331597 
Camkk1 1.415235228 0.09032415  Hoxb5 1.342350441 0.075793457 
Capn10 1.245119445 0.069714202  Id1 2.342791413 8.72E-14 
Ccdc114 1.503556462 0.080130779  Id2 1.323485236 0.006665039 
Cdc42ep4 1.230723108 0.026268054  Id3 2.343132461 1.86E-07 
Cdo1 1.364654367 1.33791E-05  Idi1 1.567668537 3.19E-05 
Cldn10 3.204662217 5.47353E-08  Idua 1.621408573 0.001754518 
Cnr1 1.654817759 0.065354795  Irf5 1.828965929 0.03063142 
Col9a1 1.397206172 0.073609136  Isyna1 1.289655106 0.067052356 
Coq2 1.322902689 0.029650811  Itgb5 1.250836931 0.024837689 
Cpm 1.297272519 0.092481427  Ivd 1.210725265 0.056799258 
Cyp51 1.461316389 2.9263E-05  Jag2 1.40250283 0.012385673 
Ddt 1.266929421 0.096916279  Kctd15 1.275631279 0.003800507 
Dennd4b 1.26803366 0.096293979  Klc4 1.322491584 0.039005303 
Dhcr7 1.687168612 3.69244E-12  Krt5 1.310752469 0.047302977 
Doc2a 1.311881765 0.049983445  Ldlr 1.481010476 1.57E-05 
Dpysl2 1.224445424 0.033878106  Lhx2 1.377767616 0.001699451 
Dtx3 1.281518615 0.09231527  Lmbr1l 1.299074779 0.050344764 
Efs 1.296565145 0.074977557  Lpcat3 1.227511788 0.063115812 
Map1lc3b 1.208616112 0.046004698 
 
Sfrp2 1.296565145 0.074977557 
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Mfap4 1.367496175 0.015928149 
 
Sgsm1 1.22030945 0.039005303 
Mfsd2a 1.305163384 0.073752477 
 
Sh3bp5l 1.222853191 0.07258805 
Mib2 1.392808946 0.0313346 
 
Shkbp1 1.352773594 0.038229041 
Mknk2 1.221946653 0.063023398 
 
Slc26a6 1.346124066 0.090965994 
Mnt 1.272643152 0.09352162 
 
Slc2a4 1.241480606 0.098154326 
Mogat2 1.313646569 0.008677396 
 
Slc38a6 2.115921936 0.016857195 
Mpped2 1.223213211 0.056799258 
 
Smad4 1.339684573 0.013832231 
Msx2 1.504834891 0.073984364 
 
Smad6 1.685234454 0.005669977 
Mt1 2.004332684 0.044882612 
 
Smad7 1.235010985 0.086811535 
Mt2 1.290858343 0.019139858 
 
Snai1 1.508039858 1.13E-08 
Mtch1 1.508664379 3.90E-07 
 
Sqle 1.25480529 0.056799258 
Mxd4 1.24608185 0.09352162 
 
Srebf1 73.48224447 0.000130513 
Ndrg1 1.444853433 0.031398748 
 
Stard4 1.248886959 0.083061136 
Nfatc4 1.510298434 0.000706461 
 
Stk36 1.342314791 0.017366866 
Nfs1 1.269849919 0.053510024 
 
Suox 1.387249006 0.012330766 
Pafah1b3 1.288264513 0.084434247 
 
Tbx2 4.538026704 0.000805342 
Palmd 1.276624344 0.048800519 
 
Thbs2 1.327257845 0.066331597 
Pank1 1.685088225 0.010136361 
 
Tmco6 1.342350441 0.075793457 
Pck2 1.361954393 0.035797172 
 
Toe1 2.342791413 8.72E-14 
Pcsk9 1.58651375 0.006026576 
 
Tsen34 1.323485236 0.006665039 
Pkdcc 2.941716269 0.002239574 
 
Ucp2 2.343132461 1.86E-07 
Pmepa1 1.641380458 1.71E-06 
 
Unc45a 1.567668537 3.19E-05 
Pmvk 1.404071466 0.000262814 
 
Wbp1 1.621408573 0.001754518 
Prrx2 1.415235228 0.09032415 
 
Wdyhv1 1.828965929 0.03063142 
Pth1r 1.245119445 0.069714202 
 
Wif1 1.289655106 0.067052356 
Ptpdc1 1.503556462 0.080130779 
 
Wnt5b 1.250836931 0.024837689 
Ptpru 1.230723108 0.026268054 
 
Zbtb8a 1.210725265 0.056799258 
Ptx3 1.364654367 1.34E-05 
 
Zfp14 1.40250283 0.012385673 
Pycr2 3.204662217 5.47E-08 
 
Zfp78 1.275631279 0.003800507 
Rab36 1.654817759 0.065354795 
 
Zfyve27 1.322491584 0.039005303 
Rab38 1.397206172 0.073609136 
 
Shkbp1 0.739221999 0.038229041 
Rhpn1 1.322902689 0.029650811 
    Rilpl2 1.297272519 0.092481427 
    Rnh1 1.461316389 2.93E-05 
    Rspo4 1.266929421 0.096916279 
    Rusc1 1.26803366 0.096293979 
    Samd1 1.687168612 3.69E-12 
    Sc5d 1.311881765 0.049983445 
    Scd2 1.224445424 0.033878106 
    Scn4b 1.281518615 0.09231527 
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12.2. List of up-regulated E10.0 SMAD4 targets 
Name FC≥1.2 FDR≤0.1  Name FC≥1.2 FDR≤0.1 
0610010F05Rik 1.273105085 0.069714202  Col12a1 2.269966443 0.000158317 
4932438A13Rik 1.470140636 0.020535029  Cx3cr1 2.531228175 6.4546E-05 
9430020K01Rik 1.209416141 0.094621319  Cyp1b1 1.459490179 0.000158317 
Acta2 2.881635984 0.001214181  
D630045J12
Rik 1.235482401 0.09536828 
Adamts9 1.487338344 0.005981323  
D830031N03
Rik 1.408348094 0.01302066 
Ahctf1 1.257322348 0.080130779  Dapk1 1.347587138 6.45938E-05 
Akap12 1.40910242 0.040021864  Ddx21 1.232108575 0.031753565 
Akap9 1.55211704 0.003476453  Dgkh 1.502180399 0.037056449 
Ankhd1 1.29782512 0.026223827  Dip2c 1.273581841 0.047302977 
Ano1 1.818360084 2.36053E-05  Dnajc13 1.222884788 0.09231527 
Apc 1.298197037 0.016437025  Dnajc2 1.238032937 0.007119986 
Arhgdib 1.338648021 0.037066172  Dock4 1.337828867 0.03063142 
Ascc3 1.220495361 0.056918764  Dock7 1.320985414 0.015299074 
Ash1l 1.325395395 0.022636805  Dync1h1 1.658706362 0.014285017 
Aspm 1.310442695 0.053604355  
E130114P18
Rik 2.242280347 0.002361324 
Asxl2 1.250567225 0.052275677  
E330013P04
Rik 1.636553183 0.023249153 
Atg2b 1.229051648 0.089607264  Eftud1 1.215564887 0.053822519 
Atp6v0e2 1.410200138 0.035091533  Ep400 1.332176341 0.073455313 
Baz1a 1.213954453 0.063023398  Fam43a 1.45761561 0.000168566 
Baz2a 1.247188844 0.07127768  Fez1 1.564071452 0.017366866 
Baz2b 1.293154627 0.018426838  Flnc 1.639152012 0.01329156 
Birc6 1.519544554 0.066331597  Fryl 1.343152566 0.016613589 
Bmp4 1.303693552 0.010187961  Gkap1 1.278909471 0.035565632 
Bnc1 1.400389972 0.076022368  Gldc 1.284840271 0.049412771 
Bnc2 1.508321253 0.000971332  Gm5860 2.027088716 0.090455686 
Bptf 1.312476885 0.014565125  Gm8994 18.33196422 0.02900654 
Cadm4 1.301536212 0.074977557  H2-T24 2.033852422 0.006665039 
Casc5 1.349435091 0.040138936  Herc1 1.499037309 0.042921494 
Ccdc80 1.496872439 0.00057127  Hic1 1.785760887 0.067052356 
Ccdc88a 1.242155564 0.045146856  Hipk2 1.307452722 0.056799258 
Cenpe 1.392559841 0.008569638  Hmcn1 1.945679564 0.001266265 
Cep170 1.247979739 0.026409533  Hopx 2.000106888 0.09276796 
Chd1 1.275838644 0.01665887  Hoxd13 1.353435296 0.043642618 
Chd7 1.34722048 0.065354795  Igfbp3 1.366188867 0.003543566 
Chd9 1.273240321 0.07258805  Ism1 1.447962226 0.037889567 
Chrna1 4.302732456 6.39271E-18  Itga8 1.500719406 0.013289505 
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Itgb3 1.420416371 0.042274448  Rgl1 1.210888172 0.075613128 
Itpr1 1.337880133 0.062830909  Rnasel 4.302732456 6.39271E-18 
Itsn2 1.271206004 0.017460401  Rnf150 1.328741552 0.015908128 
Jmjd1c 1.27819505 0.02273063  Rock2 1.213467697 0.091346996 
Kit 1.271872823 0.071456821  Rragd 1.406355677 0.054954981 
Larp1b 1.628684433 0.03785712  Rsf1 1.287593941 0.036354469 
Lats2 1.213096551 0.073455313  Sash1 1.243549639 0.063115812 
Lcor 1.286326594 0.09231527  Setbp1 1.263940721 0.055280462 
Loxl1 1.60227637 0.083061136  Setd2 1.408348094 0.01302066 
Lrrfip1 1.209524224 0.035473289  Sfrp1 1.323811506 0.098429423 
Luc7l3 1.257194474 0.045664283  Shisa3 1.232108575 0.031753565 
Magi3 1.227180964 0.077799941  Shisa7 1.479200646 0.097869431 
Mamdc2 1.524765082 0.083061136  Six1 1.247869873 0.066427079 
Mdn1 1.680598047 0.039823034  Slc8a3 1.222884788 0.09231527 
Med13 1.266791398 0.078245833  Smchd1 1.238032937 0.007119986 
Meox1 1.32673576 0.089583765  Smoc1 1.337828867 0.03063142 
Myf5 1.29782512 0.026223827  Snrnp200 1.275154004 0.098354292 
Myh10 1.818360084 2.36053E-05  Sorbs2 1.658706362 0.014285017 
Myl9 1.298197037 0.016437025  Spon1 2.242280347 0.002361324 
Myo5b 1.338648021 0.037066172  Srek1 1.201616904 0.084518133 
Nab1 1.220495361 0.056918764  Srrm2 1.31127167 0.065354795 
Ncapd2 1.325395395 0.022636805  Ssh2 1.262088185 0.066670988 
Nckap1l 1.310442695 0.053604355  Stk38l 1.45761561 0.000168566 
Ncor1 1.211792717 0.065650592  Stk39 1.564071452 0.017366866 
Ngfr 1.431169375 0.047273752  Sulf1 1.397904395 0.042274448 
Nin 1.410200138 0.035091533  Tbx19 1.343152566 0.016613589 
Nlrp1a 1.61428141 0.071456821  Tcf15 1.435320008 0.084842802 
Nol7 1.247188844 0.07127768  Tcf4 1.284840271 0.049412771 
Pcm1 1.262827826 0.081895568  Thsd4 1.307885144 0.062232478 
Pcsk5 1.249835766 0.044414578  Tnc 3.228952512 0.034316441 
Pde3a 1.303693552 0.010187961  Tnnt1 2.033852422 0.006665039 
Pim1 1.221057981 0.075613128  Topors 1.499037309 0.042921494 
Pkhd1l1 1.843030246 0.076329069  Trio 1.785760887 0.067052356 
Plagl1 1.312476885 0.014565125  Trip11 1.242842119 0.090596344 
Plekha6 1.301536212 0.074977557  Ttn 1.945679564 0.001266265 
Plxna4 1.349435091 0.040138936  Ubr5 1.298612923 0.0560448 
Polq 1.496872439 0.00057127  Upk3b 1.353435296 0.043642618 
Polr3a 1.251546203 0.036354469  Usp53 1.268446323 0.096098197 
Prpf8 1.392559841 0.008569638  Vax2 1.447962226 0.037889567 
Prrc2c 1.247979739 0.026409533  Vps13d 1.435002121 0.05838564 
Ptch1 1.275838644 0.01665887  Wdfy3 1.334215627 0.086811535 
Qser1 1.34722048 0.065354795  Wisp1 1.337880133 0.062830909 
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Xrn1 11.27819505 0.02273063  
Wt1 1.271206004 0.017460401  
Ylpm1 1.271872823 0.071456821  
Zeb1 1.628684433 0.03785712  
Zfml 1.216144599 0.077194163  
Zfp292 1.254141464 0.08078979  
Zfp74 1.259487643 0.056452159  
 
12.3. List of down-regulated E10.5 SMAD4 targets 
Name FC≥1.2 FDR≤0.1 
 
Name FC≥1.2 FDR≤0.1 
2610305D13Rik 4.619970705 0.001991779 
 
Elovl2 1.239404666 0.055784591 
6330403K07Rik 1.353588273 0.000546566 
 
Erbb3 1.333604808 0.048572688 
Abhd14a 1.355427296 0.029986532 
 
Fgfr2 1.397455482 0.000179595 
Acta2 2.400462392 0.005196229 
 
Fgfr3 1.42736082 0.008990632 
Aldh1a2 2.283367421 0.000289412 
 
Fndc5 1.965394259 6.6217E-07 
Alx1 1.513382553 0.018069258 
 
Fzd10 1.27113332 0.013500803 
Alx4 1.357309563 0.006144064 
 
Gabrb3 1.680025665 0.004992025 
Angpt1 1.353412474 0.083394116 
 
Gata2 1.945211276 0.000936015 
Asb4 1.494894253 5.28019E-05 
 
Gata3 1.698673545 0.0175389 
Asphd2 1.332305714 0.09503196 
 
Gata5 5.783389317 5.47101E-12 
Atoh8 1.444588287 0.075301781 
 
Gata6 1.860073566 0.075744724 
Baiap2l1 1.404523376 0.016173776 
 
Gchfr 2.016478848 0.003715917 
Bcat1 1.322356258 0.005967889 
 
Glis1 1.760618466 0.043329953 
Bcl11a 1.346759125 0.017406184 
 
Gm6682 3.728412699 0.029986532 
Bmp5 1.523089692 0.05309409 
 
Gm9199 100.8708348 2.89903E-05 
Ccdc141 1.65466589 0.005193884 
 
Gpx3 1.317074994 0.036843284 
Cdk5r1 1.373865966 0.078104418 
 
Grem1 2.118345336 2.14702E-11 
Cdo1 1.344156424 3.83944E-05 
 
Gsc 2.091532905 0.002758797 
Cdx1 1.824085654 0.09503196 
 
Hey1 1.397900999 0.008653745 
Cldn10 4.251051577 4.01232E-10 
 
Hoxb8 1.497658975 0.016173776 
Coq2 1.410782225 0.003688684 
 
Hr 1.602195775 0.036395698 
Crb2 1.641471701 0.01014109 
 
Id1 2.496708281 9.93875E-16 
Csf2rb 1.697824353 0.036049917 
 
Id2 1.551940362 4.23804E-07 
Cyp1b1 1.297407324 0.031093575 
 
Id3 2.582655579 1.83175E-09 
Des 2.311314246 0.000519718 
 
Igfbp4 1.296772072 0.003980822 
Diras2 1.914453053 0.000862856 
 
Irak1bp1 1.717902655 0.062933466 
Dkk1 3.725613563 6.81559E-16 
 
Irf5 2.91059218 2.24822E-06 
Dkk2 1.364160227 0.072729724 
 
Itga3 1.382776097 0.086584833 
Dpep1 1.897850231 7.28145E-07 
 
Jph2 2.006502376 0.000223032 
Efna3 1.633570021 0.003734445 
 
Kcnip3 1.628902274 0.012251099 
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Kctd13 1.363316763 0.03678417 
 
Smad7 1.364379553 0.005075381 
Kctd15 1.201186624 0.079937738 
 
Smad9 4.704523045 6.70383E-11 
Lhfp 1.245270492 0.09630261 
 
Smyd3 1.28943657 0.055784591 
Lhx2 1.448922718 0.00012372 
 
Snai1 1.625943442 0.00044489 
Meis3 1.735009285 0.001724936 
 
Snai2 1.478269605 1.82476E-06 
Mogat2 1.366304714 0.001677719 
 
Snhg6 1.41528784 0.055076437 
Mpp2 1.259832148 0.092164588 
 
Sowahb 1.772763629 0.015870524 
Msx2 3.133139691 3.21169E-18 
 
Spire1 1.222103383 0.070422456 
Mtmr11 1.340822746 0.023415401 
 
St3gal1 1.390079179 0.004389587 
Mycn 1.295475301 0.010649228 
 
Sv2a 1.53403362 0.005193884 
Myh3 4.513264386 0.00051811 
 
Syt7 1.757984855 4.1323E-05 
Mylpf 2.032415074 0.021511832 
 
Tbx2 2.005274655 1.45684E-08 
Myog 7.214930774 0.000253668 
 
Tbx3 1.472322155 6.24825E-06 
Nfs1 1.248895975 0.085359385 
 
Thbs2 1.878628799 0.000783597 
Pax1 6.076301242 2.83811E-15 
 
Tnni1 1.965492685 0.047236802 
Pcdh7 1.36163166 0.036898113 
 
Tshz1 1.365437427 0.00012372 
Pkdcc 1.747796183 2.65803E-07 
 
Ttn 3.304995298 0.011149265 
Pmepa1 1.359416637 0.082861523 
 
Unc5b 1.233824807 0.048365955 
Pou4f1 2.25929917 0.027751185 
 
Upk3b 3.369708068 0.034545596 
Ppm1m 1.348496256 0.064836824 
 
Ush1c 1.566590844 0.068563798 
Ppp1r14c 1.58925043 0.086797957 
 
Wdyhv1 1.43330712 0.011575155 
Ppp2r1b 1.244210313 0.022759408 
 
Wt1 2.667628433 0.007918727 
Prdm6 2.183499488 0.000267873 
 
Zfp503 1.216830312 0.073484866 
Prrx2 1.764758136 6.68235E-08 
    Psd2 1.603287481 0.006520976 
    Ptges 1.31442431 0.046901341 
    Pth1r 1.522504475 8.75461E-06 
    Ptpru 1.360930887 0.057436675 
    Rarb 1.326699637 0.05394564 
    Rasl12 1.48732778 0.037738494 
    Rbpms 1.214265015 0.087697872 
    Rgs5 3.446046865 1.83175E-09 
    Rspo4 2.672974934 8.78744E-23 
    Runx2 2.244776832 1.78088E-07 
    Rxfp2 1.738181157 0.07116529 
    Scd1 1.295704812 0.002758797 
    Scd2 1.225502847 0.029986532 
    Scn4b 1.622396896 0.001203892 
    Slc16a3 1.43717567 0.027455416 
 
   
Slc38a3 1.797917334 0.016134579 
 
   
Smad4 4.457697015 2.94151E-94 
 
   
Smad6 1.418101899 0.056234884 
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12.4. List of up-regulated E10.5 SMAD4 targets 
Name FC≥1.2 FDR≤0.1 
 
Name FC≥1.2 FDR≤0.1 
2310030G06Rik 1.650118041 0.059807184 
 
Ptgis 1.429125032 0.01014109 
Ankrd6 1.301570513 0.016450526 
 
Rapgef5 1.733292157 0.000472245 
Arhgef26 1.662223047 2.91013E-05 
 
Rgmb 1.727604332 9.52748E-08 
Bmp3 3.005347102 0.000253668 
 
Sash1 1.294005146 0.018927654 
Cacna1g 1.329255179 0.03678417 
 
Sema6a 1.297386967 0.054586591 
Camkv 1.493711991 0.002758797 
 
Sfmbt2 1.523483113 0.034088767 
Cbfa2t3 1.610057198 0.000948731 
 
Ska1 1.284429623 0.05915533 
Cdh4 1.598253052 0.041265602 
 
Smoc2 2.826609617 1.34424E-13 
Cgnl1 1.386480188 0.000208984 
 
Sorbs2 1.634033672 2.73057E-07 
Cln6 1.260096116 0.052335746 
 
Spry2 1.410420365 0.000370853 
Cpa2 1.402517053 0.013128303 
 
Srgap1 1.227995797 0.092512731 
Cpne5 1.552670699 0.004926138 
 
Srms 1.910879732 0.015431625 
Egr1 1.914656361 0.001271825 
 
Stambpl1 1.255539157 0.08799457 
Elf3 1.354580856 0.090004931 
 
Stc1 1.49821295 0.029178832 
Elovl7 1.805183656 0.032054834 
 
Stk38l 1.499392347 5.96723E-05 
Enpp5 1.570888219 0.003715917 
 
Syne2 1.386775436 0.099079413 
Fam69c 1.783714696 0.035569151 
 
Synrg 1.429148997 0.001866157 
Gldc 1.531116837 2.89903E-05 
 
Syt13 1.513325361 0.01151969 
Gsg1l 5.445416132 3.83863E-17 
 
Tbx19 212.395487 0.004039331 
Hemk1 2.122968991 0.036898113 
 
Tbx4 1.744224272 0.098563338 
Hic1 3.202513174 1.15411E-07 
 
Tcf15 1.465162912 0.077695558 
Hist2h2bb 6.838020283 0.070234156 
 
Tdrkh 1.568022679 0.016173776 
Hmcn1 1.728292144 0.016134579 
 
Thbs1 1.412328419 0.00083572 
Itsn2 1.247887278 0.043311275 
 
Tubb4a 1.778693913 0.013500803 
Jmjd7 1.575642141 0.056609109 
 
Wfikkn2 3.4247874 3.14784E-11 
Lrig3 1.253999376 0.059807184 
 
Xrn1 1.310146706 0.096993443 
Mertk 1.321740003 0.035569151 
 Mtss1 1.274045271 0.008540741 
 Myl12b 1.237308862 0.088064112 
 Myo5b 1.622816836 0.006649154 
 Nab1 1.397221384 0.000546566 
 Nes 1.415448776 0.000340858 
 Nfatc2 2.15559656 6.24825E-06 
 Ngfr 1.562271502 0.007828651 
 Nnat 1.354111416 0.000289412 
 Pea15a 1.257700158 0.01942771 
 Pmaip1 2.156528457 0.020820366 
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12.5. WISH screen 
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Expression pattern of 90 potential SMAD4 direct targets tested by WISH in 
E10.0 WT embryos. 
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12.6. Sterol intermediates and cholesterol quantification 
by GC/MS in WT and Smad4-deficient forelimb 
buds 
 
(A) Quantification of Lanosterol, Lathosterol, Demosterol, 7-dehydro-cholesterol 
(7DHC) and cholesterol by GC/MS in forelimb buds at E10.0, E10.5 and E11.0. 
(B) Simplified cholesterol synthesis pathway with the sterol intermediates 
quantified by GC/MS. 
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12.7. Analysis of SMAD4-interacting regions located in 
TADs of target genes involved in limb patterningx 
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The E9.75 SMAD43xF ChIP-seq track (in blue) is aligned with the Hi-C track 
from ES cells in red (Dixon et al., 2012). TADs are represented by the yellow 
and blue lines. The TAD of the SMAD4 target genes is highlighted in grey. The 
black arrow shows the SMAD4 target gene and the blue arrows show the 
SMAD4 bound regions within the TAD. Pth1r, Snai1, Pkdcc and Tbx2 genes are 
not associated with a TAD in ES cells. 
12.8. Analysis of SMAD4-interacting regions located 
in TADs of target genes involved in the 
cholesterol synthesis 
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The SMAD43xF ChIP-seq track (in blue) is aligned with the Hi-C track from ES 
cells in red (Dixon et al., 2012). TADs are represented by the yellow and blue 
lines. The TAD of the SMAD4 target genes is highlighted in grey. The black 
arrow shows the SMAD4 target gene and the blue arrows show the SMAD4 
bound regions within the TAD. 
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